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Abstract 
Previous research has identified that distress is common in patients with kidney 
failure who undergo dialysis treatment and that this is associated with poor 
outcomes (Chilcot, Davenport, Wellsted, Firth, & Farrington, 2011a). Few studies 
have examined the effectiveness of psychological interventions aimed at improving 
psychological distress in this patient group. Expressive Writing (EW) is a therapeutic 
technique that typically involves participants writing about a stressful or traumatic 
event for 15-20 minutes on 3-5 consecutive days (Pennebaker & Buell, 1986) and 
has been associated with improvements in psychological (e.g. well-being) and 
clinical (e.g., immune function) outcomes in several populations, including breast 
cancer patients (Craft, Davis & Paulson, 2012). The aims of the current study were 
to establish feasibility of using EW with this patient group. This was done by 
identifying the factors associated with distress, gauging acceptability and safety of 
the intervention, recording recruitment and retention rates and by establishing its 
potential clinical efficacy. The study consisted of two phases; a screening phase 
which used a cross-sectional questionnaire survey of 97 patients, and a trial phase 
which randomised 30 patients into two groups (EW or control), with a 3-month 
follow-up. Results indicated that self-reported symptoms of fatigue and pain, and 
illness perceptions predicted a significant amount of variance (35%) in distress, 
above demographic and clinical variables. The EW intervention was found to be 
feasible in terms of uptake and agreement to randomisation. However, retention 
rates were lower than some previous EW studies suggesting that modifications are 
needed to the writing protocol in order to increase adherence.  Despite poor 
retention, results indicated improvements in distress (d=0.23) and systolic blood 
pressure (d=0.71) for the EW group, when compared to the control group at follow-
up. This suggests that, with modification, EW may be cost effective way to reduce 
distress in dialysis patients. These findings are discussed with reference to 
limitations and future research, as well as implications for clinical practice. 
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1.0 INTRODUCTION 
1.1 Kidney Disease 
The kidneys are a pair of vital bodily organs that perform many functions essential 
to life. Their main purpose is to sift blood and filter out metabolic waste products, 
excess salt and water. They also serve to regulate the body’s level of certain 
chemical substances (e.g., sodium, phosphorus and potassium) and release 
important hormones which stimulate the production of red blood cells, regulate 
blood pressure and help maintain calcium for bones. Kidney disease occurs when 
nephrons (small units inside the kidneys) lose their filtering capacity. In most cases, 
this happens as a result of another underlying physical disorder, such as diabetes or 
high blood pressure. These conditions cause structural abnormalities, which lead to 
a decrease in kidney functioning.  
An international classification system was developed by the US Kidney Foundation 
in their Kidney Disease Outcomes Quality Initiative (Eknoyan & Levin, 2002). This 
defines five stages of kidney disease based on estimated Glomerular Filtration Rate 
(eGFR), a numerical rating to indicate how efficient the kidneys are at filtering 
wastes from the blood. This is calculated using the four-variable MDRD 
(Modification of Diet in Renal Disease) formula based on a patient’s serum 
creatinine level, age, sex and ethnicity, and has been endorsed by the Department 
of Health for England (UK Renal Association, 2011). A person whose eGFR 
remains below 60 for at least 3 months is considered to have Chronic Kidney 
Disease (CKD). According to the K/DOQI guidelines, an eGFR of >90 with other 
evidence of kidney damage characterises stage 1; 60-90 indicates a slight decrease 
in functioning and characterises stage 2; 30-69 indicates a moderate decrease and 
characterises stage 3; and 15-30 indicates a severe decrease and characterises 
stage 4. Finally, an eGFR of less than 15 implies established kidney failure. At this 
stage, the reduction in kidney functioning is so severe that it is not compatible with 
life and individuals are usually diagnosed as having “End Stage Kidney Failure” 
(ESKF) or “End Stage Renal Disease” (ESRD). This coincides with excess fluid, 
metabolic toxins and electrolytes rapidly accumulating in blood and bodily tissues. 
These substances must be removed by another method if life is to be sustained and 
means patients must undergo renal replacement therapy (or ‘RRT’) in order to 
survive.  
Diseases of the kidney have assumed epidemic proportions and are among the 
leading causes of death in the industrialised world (Eknoyan et al, 2004). According 
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to the 2010 Global Burden of Disease study, CKD was ranked 18th in the list of 
causes of total number of global deaths during that year (Lozano, Naghavi & 
Foreman, 2013), and is thought to affect approximately 10% of the global population 
(e.g., Coresh et al, 2005; Che, Wildman & Gu, 2005). Although this figure is 
alarming in itself, the high co-occurrence of CKD with cardiovascular diseases and 
diabetes mellitus means that this figure may in fact be a severe underestimation of 
the total global prevalence (Jha et al, 2013).  
1.2 Renal Replacement Therapy (RRT) 
In general, choice of RRT treatment modality tends to be influenced by non-medical 
factors including the preferences of the patient and provider, and judgments about 
which modality will have the most favourable outcomes on adherence and quality of 
life (QOL; Christensen & Ehlers, 2002). There are three RRT options available: 
transplant and two types of repetitive dialysis known as haemodialysis (HD) and 
peritoneal dialysis (PD). 
1.2.1 Transplant 
In the late 1960s transplant became a viable option for RRT. At present, 
approximately 28% of ESRD patients have a functioning renal graft which comes 
from a brain dead or living donor (USRDS, 1999). For most patients, the transition 
from pre to post-transplant means increased independence from health providers 
and more responsibility for managing one’s own treatment e.g., monitoring 
immunosuppressive status.  
1.2.2 Haemodialysis (HD) 
HD treatment involves a vascular connection being made between an artificial 
kidney (dialyzer) and the patient, usually through an arteriovenous fistula 
permanently placed in the patient’s forearm. During the treatment process, blood 
travels through tubes into the dialyzer machine, which acts like a kidney by filtering 
the blood. The cleaned blood then flows through another set of tubes back into the 
body. This process is typically performed three times a week by a nurse or a trained 
technician in a clinic setting with each session lasting approximately three to four 
hours (NIDDK, 2002), although it is recommended that suitable patients should be 
offered the choice between home and hospital-based HD (NICE, 2002). 
1.2.3 Peritoneal dialysis (PD) 
PD treatment involves the patient taking a more active role and is usually performed 
by the patient at their residence (Kusiak, Dixon & Shah 2005). The most common 
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form is continuous ambulatory peritoneal dialysis (CAPD). In this procedure, a 
permanent catheter is surgically implanted into the abdomen. A sterile tube 
connects the catheter to a bag of dialysis solution which is elevated to allow flow to 
the peritoneal cavity. Once this is completed, the bag is hidden away under the 
patient’s clothing. Over the next 4-8 hours, the patient’s blood filters through the 
peritoneal membrane leaving toxins and excess fluid in the solution. After this phase 
is completed, the bag is lowered and the used solution is drained back into the bag. 
This solution is then discarded ready for the procedure to begin again. Each 
treatment takes one hour and is repeated 3 to 6 times each day (Christensen and 
Ehlers, 2002). 
1.2.4 Prevalence of RRT 
Transplant remains the modality of choice for patients considered fit for major 
surgery and chronic immunosuppression (UK Renal Association, 2013). However, a 
report by Grassman, Gioberge, Moeller and Brown (2005) found that, due to a 
shortage of donors and a high transplant rejection rate, HD has become the most 
commonly used modality of RRT across the world. This report details the outcome 
of a survey collecting demographic information from 122 countries with established 
dialysis programmes. It revealed that the total number of patients worldwide on 
some form of dialysis treatment in 2005 was approximately 1.4 million, and that the 
number was growing at an annual rate of 7%. However, the incidence and 
prevalence of patients treated with dialysis varies substantially across countries and 
regions, with a disproportionately high percentage (about 80%) of patients living in 
developed countries (White, Chadman, Jan, Chapman & Cass, 2008). The main 
factors thought to be contributing to the rising number of dialysis patients include; 
universal ageing in population, increasing access of younger patients to treatment in 
countries where access was previously limited, and growing numbers of people 
diagnosed with type 2 diabetes (El Nahas & Bello, 2005). Currently, the RRT 
population in the UK is around 40,000, with around 25,000 on dialysis in total (Gilg, 
Castledine & Fogarty, 2010).  
1.3 Psychological Impact of Dialysis 
“…as long as the struggle for survival was the main issue, emotional problems were 
suppressed.”  
Belding Scribner as cited in Levy (1996) 
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Contrary to the above quote, it is now well recognised that physical illness can result 
in psychological distress, particularly in the case of chronic illness. It has been 
suggested that about 20-25% of patients suffering from chronic medical problems 
also experience clinically significant psychological symptoms (White, 2001).  
Since the 1960s, when HD first became a practical treatment for kidney failure, it 
has vastly increased the survival rate of patients with CKD. Clinicians have also 
learnt a lot about how to minimize the side effects to make it a more tolerable and 
effective treatment. However, it remains a complicated and inconvenient therapy 
that requires a coordinated effort from a multi-disciplinary health care team. 
Furthermore, there are a number of physical and emotional challenges associated 
with dialysis treatment which can inflict considerable amounts of stress on patients’ 
lives. Some of these will be outlined below. 
1.3.1 Restrictive lifestyle 
ESRD imposes restrictions on all areas of life. Firstly, patients must incorporate the 
dialysis treatment procedure into their daily lives. Since an average HD session 
takes approximately 3-5 hours and takes place three times a week, it consumes a 
significant proportion of a patients’ time. The process of treatment adjustment has 
been characterised by Thorne (1993) as ‘negotiation’ and encompasses a number 
of limitations in lifestyle. Polaschek (2003) interviewed a group of male Caucasian 
dialysis patients who discussed these limitations and highlighted particular 
difficulties with organising travel and holidays. They explained how the relaxation 
and freedom usually connected with holidays is contradicted by the relentless 
requirements of the dialysis regime. Patients also talked about a sense of 
‘ongoingness’ which meant they felt frustrated and pressurised to maximise their 
free time when off dialysis. 
Dialysis patients also have to adhere to a controlled diet, limit their fluid intake and 
follow a complex regime of medications, particularly when they suffer from one or 
more co-morbidities. Dietary restrictions are considered by many to be most difficult 
component of treatment for ESRD patients (Khalil et al, 2010). The main dietary 
restrictions prescribed include protein, potassium, sodium, calcium and phosphorus 
(Oka & Chaboyer, 1999). If these substances are not restricted, patients risk 
elevations in potassium and sodium concentration and fluid overload, which can 
have serious long-term consequences (Kutner, 2001). The medication regime may 
consist of up to 12 different drugs, which facilitate the management of blood 
pressure, anaemia, abnormalities of mineral metabolism and other problems related 
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to co-morbidities. HD recipients also have to restrict their salt and fluid intake, which 
forms another challenging element of treatment (Christensen & Moran, 1998). 
Patients are also instructed to ingest no more than 1 L of fluid per day due to 
irregularity of fluid clearance achieved by dialysis treatments. Failing to adhere to 
this could potentially result in cardiac failure, hypertension, pulmonary oedema and 
premature death (Leggat et al, 1998). 
Maintaining any kind of normality in the face of this commitment to treatment is 
difficult and demands radical rearranging and modification of routine activities 
(Curtin, Mapes, Petillo & Oberley, 2002). As a result, non-adherence to treatment is 
common and problematic for HD patients and is associated with a number of 
psychological factors including depression, illness and treatment perceptions, and 
self-efficacy (Clark, Farrington & Chilcot, 2014). 
1.3.2 Loss, dependency and death  
According to the UK Renal Registry 16th Annual Report (UK Renal Association, 
2013), the relative risk of death on RRT in 2012 was 6.1 times that of the general 
population (for all age groups collectively). Enduring conflicts about life and death as 
well as dealing with uncertainty about the future, loss and dependency are unique 
issues faced by those undergoing HD treatment. Some of these were emphasised 
in a qualitative study by Hagren, Pettersen, Severinsson, Lützén & Clyne (2001) 
who analysed interview transcripts of a group of male and female Swedish dialysis 
patients, and identified loss of freedom, dependence on the dialysis machine as a 
lifeline and reliance on caregivers as the main ‘areas of suffering’. In a later study, 
the same group of researchers conducted interviews to gain a more in depth 
understanding of how these issues impacted on patients’ lives (Hagren, Pettersen, 
Severinsson, Lützen, & Clyne, 2005). From analysis, they recognised a number of 
themes including ‘not finding space for living’, ‘feelings evoked in the care situation’ 
and ‘attempting to manage restricted life’. The interviewees complained of not being 
able to live life to its full, not being able to fully participate in society, and feelings of 
vulnerability and ‘emotional distance’ from caregivers. The authors suggest that the 
feeling of ‘emotional distance’ could signify an underlying ‘existential struggle’ 
caused by the fact that the illness acts as a continuous threat to patients’ existence 
and means patients feel as though they are essentially living on ‘borrowed’ time.  
In a similar vein, it is possible that patients may experience a sense of ambivalence 
towards the dialysis machine itself, as it can represent a life-line as well as a 
significant burden. Polashek (2003) commented that patients are forced to cope 
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with the paradox of being dependent on the machine, while remaining independent 
in the rest of their lives. This issue is often worsened by renal staff and family who 
put pressure on the individual to lead a ‘normal life’ between dialysis sessions, since 
they may show no signs of illness. As well as being a constant reminder that their 
time is limited, the intrusiveness of the treatment also reminds patients that the 
situation is beyond their control (Devins et al, 1983). Alexander (1976) labelled this 
idea as the ‘double bind’, referring to the fact that patients are forced to balance 
their gratitude for the technology with their frustration at the imposition it places on 
their lives. This has more recently been termed the ‘compliance-independence tight 
rope’ (Curtin, Oberley & Sacksteder, 1997). Researchers have also suggested that 
it may be difficult for renal patients to put forward their viewpoint or voice their 
experiences of suffering, since it is so different from the dominant discourse of 
professionals, which appears to neglect the chronicity of the condition and 
accompanying treatment (Faber, 1999). 
1.3.3 Social difficulties 
The complex HD treatment regime can have an extreme impact on a patient’s social 
world, including family relations and friendships. High levels of sexual and marital 
dysfunction have been found in dialysis patients, which have been partly attributed 
to the physical effects of dialysis and partly to social constraints of illness (House, 
1987). Patients have also reported strong feelings of guilt about the perceived 
burden on family life and about spending so much time in clinic, away from family 
members (Tong et al, 2009).   
The time constraints as well as impaired physical ability associated with HD 
treatment can also affect patient ability to maintain active employment. This can 
lead to substantial financial struggles, and add to the burden placed on families. 
Studies have found that dialysis patients aged 18-64 work significantly less 
compared to the general working age population. For example, a Dutch study found 
that only 35% of ESRD patients of working age were still employed at the start of 
dialysis, compared to 61% of the general population (van Manen et al, 2001).  
1.3.4 Symptom burden  
Studies have shown that patients on dialysis suffer from a high number of 
symptoms, thought to be comparable to those of patients with cancer and HIV, and 
that symptom burden strongly correlates with depression (Weisbord et al, 2005). 
Tiredness, pain and itching appear to be the most important physical symptoms 
reported (Merkus et al, 1999; Davison & Jhangri, 2010). Pain symptoms can include 
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those related to renal failure and its treatment (e.g., muscle cramps and fistula pain) 
as well as non-specific symptoms such as headaches and back pain (Devins et al, 
1990). Gamondi et al (2013) asked 123 patients to complete a set of self-report 
measures of pain, associated symptoms and overall symptom burden at several 
dialysis units in Switzerland. The results showed patients experience multiple and 
severe symptoms which interfere with daily living and affirmed that the dialysis 
treatment itself can actively trigger pain for some individuals.  
Other commonplace symptoms which coincide with dialysis include lack of appetite, 
thirst and nausea (Gamondi et al, 2013). Recent studies have confirmed other 
frequent symptoms for dialysis patients are insomnia and lack of sleep (Mucsi et al, 
2004). Unfortunately, such symptoms are often left un-recognised by renal staff, 
possibly due to the fact that physicians and staff accept them as part of the ESRD 
experience (Claxton et al, 2010). 
Dialysis patients are also likely to suffer from co-morbidities, which act as either 
causes or consequences of kidney failure. Long-term survivors of kidney failure are 
almost certain to experience vascular access problems, bone disease, electrolyte 
imbalances, cardiac arrhythmia, hyperparathyroidism and one or more failed 
transplants over the course of their illness (Harris & Brown 1998).  
1.4 Depression in Dialysis Patients 
Considering the number of psychosocial stressors inflicted on dialysis patients, as 
well as the unpredictable and pervasive nature of the condition, it is not surprising 
that psychological distress, including depression and anxiety, is common within this 
population. However, although psychological distress is frequently referenced in the 
health care literature, it is seldom defined as a distinct concept (Ridner, 2004). Until 
recently, research within the nephrology field has mostly focussed on measuring 
specific psychiatric disorders, such as depression, anger and anxiety, rather than on 
the broader concept of emotional or psychological distress. Similar to other chronic 
illnesses, depression is typically considered to be the most important clinical 
psychiatric problem (Kimmel, 2002) although Cukor et al (2007) suggest anxiety 
disorders may also be highly prevalent. 
1.4.1 Depression: measuring prevalence 
Most data on depression in CKD patients is available from in-centre dialysis 
populations and has been determined by patient self-report questionnaires 
assessing presence and severity of symptoms (e.g., Cukor, Peterson, Cohen & 
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Kimmel, 2006; Kimmel, Cukor, Cohen & Peterson, 2007). Such studies have 
indicated the prevalence of depression in ESRD to be about four times that of the 
general population. However, a number of issues have been raised regarding these 
findings, mainly centred on confusion with defining and recognising depression and 
the lack of well-validated assessment tools. These issues will be discussed in 
further detail below. 
In clinical terms, ‘depression’ has a specific definition as a psychiatric disorder with 
established diagnostic criteria. These criteria are outlined within the Diagnostic and 
Statistical Manual of Mental Disorders – Fourth Edition (DSM-IV; APA, 1994) as low 
mood or anhedonia (loss of interest or pleasure in everyday activities) present for at 
least two weeks, accompanied by other somatic, cognitive and behavioural 
symptoms. These include; loss of energy, over or under-eating, problems with 
sleep, agitation, difficulty concentrating, feelings of worthlessness, helplessness, 
excessive guilt and thoughts about death and suicide. Physicians tend to 
differentiate between different depressive disorders (such as major depression and 
dysthymic disorder, a milder more chronic type) on the basis of severity, duration 
and number of symptoms. In contrast, ‘depressive symptoms’ can include feelings 
of sadness accompanied by altered mood, somatic symptoms and loss of pleasure 
in activities, but not to a sufficient level of severity to warrant a clinical diagnosis. In 
reference to dialysis patients, researchers often fail to clarify the clinical distinction 
between different depressive disorders and depressive symptoms, which can lead 
to uncertainty regarding prevalence estimates (Cukor et al, 2006).  
The clinical diagnosis of depression requires trained professionals to conduct a 
diagnostic assessment. This is typically via a structured or semi-structured interview 
which can be costly and time-consuming. Therefore, when conducting depression 
screening with chronic illness patients, clinicians tend to rely on standardised self-
report measures which require patients to rate symptom severity or frequency. 
These are easier and quicker to administer. However, this creates difficulties since 
many of the somatic symptoms pinpointed by these measures overlap with 
symptoms of kidney failure (or uraemia), including loss of appetite, sleep disruption, 
fatigue and cognitive dysfunction (Cukor et al, 2007). These measures therefore 
lack specificity and tend to overestimate the prevalence of depression (Palmer et al, 
2013).  
The Beck Depression Inventory (BDI) and the Patient Health Questionnaire (PHQ) 
are two measures frequently used to screen for depression in this population 
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(Watnick, Wang, Demadura & Ganzini, 2005). The BDI is a 21-item questionnaire 
which has been validated in chronic dialysis patients and is therefore considered a 
reliable instrument (Hedayati, Bosworth, Kuchibhatla, Kimmel, & Szczech 2006). 
However, it has been criticized for being too extensive to be used as an effective 
repeated measure (van den Beukel et al, 2012). In order to manage the issue of 
criterion contamination, the Cognitive Depression Index (CDI) was developed as a 
subscale of the BDI which excludes somatic items. Sacks, Peterson & Kimmel 
(1990) have suggested this may be a more valid measure to use with ESRD 
patients. However, other researchers claim that the cognitive and somatic elements 
of depression cannot be easily separated. For example, Chilcot, Wellstead and 
Farrington (2008) screened HD patients with both measures and found that the BDI 
had a greater sensitivity and specificity when compared to a diagnostic interview, 
than the CDI. 
More recently, van den Beukel et al (2012) compared results obtained with the 5-
item Mental Health Inventory (MHI) (subscale) of the 36-item Short-Form Health 
Survey Questionnaire to scores obtained with the BDI. Their results suggest that the 
MHI may be an appropriate screening tool for depression among dialysis patients. 
This measure was originally designed to assess anxiety, depression, loss of 
behavioural or emotional control and psychological well-being (Ware, 1995). Since 
many dialysis patients present with a multitude of problems in addition to 
established depressive symptoms, the authors argue that this measure might be 
more suited to identifying the spectrum of depressive conditions common in this 
population. Novak, Mucsi & Mendelssohn (2013) discuss the application of this 
more holistic approach within the context of recent pressures to focus on patient-
reported outcomes (PRO). However, the question of which measure is the most 
appropriate for depression screening in dialysis patients remains subject to debate.  
Problems with variations in the definition of ‘depression’ and the lack of disease 
specific-validated assessment tools has therefore meant that establishing a 
definitive prevalence of depressive symptoms in dialysis patients has been 
challenging. The Dialysis Outcomes and Practice Patterns Study (DOPPS; Lopes et 
al, 2004) was a multicentre international observational study of dialysis outcomes 
which showed that, although the rate of physician-diagnosed depression varied 
considerably between countries (from 2% in Japan to 21.7% in USA), there was no 
significant difference in the rates of self-reported depressive symptoms (using the 
Centre for Epidemiologic Studies Depression Scale; CES-D). The authors 
concluded that the variation in physician ratings was due to a difference in cultural 
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beliefs. In addition, lower rates of depression are reported when symptoms are 
defined according to the DSM-IV (e.g., Soykan et al, 2004), whereas higher rates 
are reported when mild-moderate depressive symptoms are included using self-
report measures like the BDI (e.g., Kimmel, Thamer, Richard & Ray, 1998).  
A recent meta-analysis of studies of depression in adults with CKD (Palmer et al, 
2013) concluded that approximately 25% of adults with CKD have interview-based 
depression. This supports recent study findings that have estimated a prevalence of 
between 20-30% (Wilson et al, 2006; Martin, Tweed, & Metcalfe, 2004). Despite the 
debate surrounding prevalence, most researchers agree that it is the most important 
psychiatric problem (Kimmel, Weihs & Peterson, 1993). Some studies have 
proposed that prevalence is higher following the start of dialysis (Watnick, Kirwin, 
Mahnensmith & Conato, 2003), although this could be due to the confounding 
presence of other psychiatric disorders at this stage, such as adjustment disorder 
(Chilcot et al, 2011a). Studies looking at the relationship between extra-renal co-
morbidity and depression have shown contradictory findings, with some reporting an 
independent relationship (e.g., Chilcot et al, 2011a) and others reporting that 
increasing levels of co-morbidity increase depression (Boulware et al, 2006). The 
previously discussed issues with measuring depression, as well as problems 
measuring co-morbidity, could account for the mixed findings. 
1.4.2 Depression: effect on outcomes 
Depression has been associated with a number of clinically significant outcomes 
within the dialysis population. Amongst the most frequently studied outcomes are 
QOL and mortality. Research concerning the main effects of depression on these 
outcomes will be outlined below. 
With the increased survival of dialysis patients over the past decade, increased 
attention has been dedicated to QOL as an outcome of interest. There is some 
disagreement within the literature regarding an operational definition, however, the 
World Health Organisation (1995) defines it as “an individual’s perception of their 
position in life in the context of culture and value systems in which they live and in 
relation to their goals and expectations, standards and concerns” (p. 1405). They 
also point out that it is a broad-ranging concept which can be affected by a person’s 
physical health, psychological health, level of independence and relationship to 
features of their environment. The most widely studied aspect of QOL in the context 
of chronic illness is ‘Health Related Quality of Life’ (HRQOL). This construct 
provides information about a patient’s perception of the physical and psychosocial 
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impact of the illness and treatment on their lives. Both clinically diagnosed 
depression and the presence of depressive symptoms have been found to be 
associated with impaired HRQOL in dialysis patients (Finkelstein, Wuerth & 
Finkelstein, 2010). Furthermore, the Spanish Cooperative Renal Patients Quality of 
Life Study Group (Vasquez et al, 2003) found that anxiety and depressive 
symptoms were the most important predictors of HRQOL. Also, in a longitudinal 
study, high psychological distress was found to be associated with diminished QOL 
in dialysis patients over time (Franke, Reimer, Philipp & Heemann 2003). Overall, it 
is clear that psychological distress (including anxiety and depressive affect) has a 
significant impact on HRQOL. As a result, measures of depressive affect are often 
included as items and scales in QOL indices (Kimmel, 2001). 
The relationship between depression and mortality in CKD patients is a complex 
one. Early studies using a variety of self-report questionnaires to allow a cross-
sectional assessment of depressive symptoms were able to verify an association 
(e.g., Peterson et al, 1991). However, they were limited by small sample sizes and 
poor designs. In contrast, later studies with more robust designs failed to 
demonstrate any association (e.g., Kimmel et al, 1998). However, in a recent 
longitudinal study, Kimmel et al (2000) monitored depressive symptoms over a 
period of up to 5 years in chronic dialysis patients, which revealed some interesting 
results. They found that, although depressive affect did not predict mortality, time-
variant changes of depressive affect were strong predictors of survival over time. In 
other words, acute changes in mood were related to lower survival rate. Also 
Hedayati et al (2008) found that dialysis patients were twice as likely to die or 
require hospitalisation within a year compared to those without depression. 
Interestingly, their data showed that physician diagnosed clinical depression was a 
better predictor of mortality than self-reported depressive symptoms. The same 
group of researchers ran a prospective observational cohort study of stage 2-5 CKD 
pre-dialysis patients and found that a diagnosis of major depressive episode at 
baseline was associated with an increased risk of a composite death, hospitalisation 
or progression to dialysis, independent of co-morbidities and disease severity 
(Hedayati et al, 2010). Adding to this, Drayer et al (2006) showed that depression 
was able to predict mortality after controlling for a number of demographic and 
clinical covariates. 
1.4.3 Depression: what mediates the relationship with outcomes? 
The mechanisms linking depression with poor outcomes in HD patients are not fully 
understood (Lopes et al, 2002). However, many researchers have proposed a 
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distinction between a biological and behavioural pathway (Khalil, Lennie & Frazier, 
2010). 
1) Biological pathway 
The biological pathway involves an impact on immune function leading to an 
inflammatory response. It is thought that ESRD has an underlying inflammatory 
component that may place sufferers at a higher risk of developing depressive 
symptoms (Raison & Miller 2001). For example, there is evidence of a link between 
depressive symptoms and pro-inflammatory cytokine levels.  Cytokines are a broad 
category of small proteins, important in cell signalling. If they are pro-inflammatory, 
this means they promote systemic inflammation, which can function to make a 
disease worse by producing fever and tissue destruction. During HD, these 
cytokines are produced and can enter the central nervous system (CNS) (Khalil et 
al, 2010). Evidence from animal studies suggests that when pro-inflammatory 
mediators are present in the CNS, behaviour consistent with depressive symptoms, 
such as decreased activity, weight loss and impaired learning, is observed (e.g., Wu 
& Lin, 2008). In addition, depressive symptoms have been hypothesised to 
stimulate cytokine production in people with chronic illness (Anisman, Merali & 
Hayley, 2008). Of further relevance, an association has been found between 
depressive symptoms and elevated levels of C-reactive protein (a marker of 
inflammation) in HD patients (Dogan, Erkoc, Eryonucu, Sayarlioglu & Agargun 
2005). However, researchers are yet to establish whether elevations in the 
cytokines lead to development of depressive symptoms or vice versa. 
Another possible mediating factor is malnutrition. It is well known that chronic HD 
patients with malnutrition, partly indicated by hypoalbuminemia (abnormally low 
levels of protein), have an increased mortality rate (Lopes et al, 2002). Additionally, 
depression is commonly associated with poor adherence to fluid intake, which can 
heighten malnutrition. A correlation between severity of depressive symptoms and 
degree of malnutrition has been presented (Koo et al, 2003). However, Kimmel et al 
(1998) failed to detect an association between the two factors in a group of African-
American patients.  
2) Behavioural pathway 
Another way of understanding the relationship between depression and outcomes is 
though the behavioural mechanism of adherence. As already discussed, although 
HD is a life sustaining treatment, it does not completely replace renal function. This 
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means patients have to engage in permanent lifestyle changes including dietary and 
fluid restrictions and a complex medication regime. Researchers know that lack of 
adherence to this regime increases risk of complications (Durose, Holdswroth, 
Watson & Przygrodzka, 2004) whereas strict adherence can result in a lower 
mortality risk (Kimmel et al, 1998).  
Few studies have examined the relationship between depressive symptoms and 
dietary adherence in HD patients. Taskapan et al (2005) found that HD patients with 
depressive disorders were less likely to adhere to fluid restriction and nutritional 
requirements than those without. Similarly Akman et al (2007) demonstrated dietary 
non adherence was twice as likely in ESRD patients with depression as those who 
were not depressed. Conversely, no association was found between depressive 
symptoms and adherence in a group of Chinese patients receiving haemodialysis 
(Pang, Ip & Chang, 2001). These findings were potentially limited by the study’s 
reliance on weight gain as a measure of adherence. 
It has been proposed that depressive symptoms could influence adherence to 
medication via the creation of distorted beliefs and thoughts about a lack of 
perceived benefit from medication (Khalil et al, 2013). Furthermore, depressive 
symptoms encompass negative impacts on motivation, memory, cognition and 
attention which may impact a patient’s sensitivity to the unpleasant side effects of 
medication (Wang et al, 2002). This relationship has been demonstrated in many 
chronic disease populations. For example, Wang and colleagues (2002) reported 
that severity of depressive symptoms was significantly associated with a decrease 
in medication adherence in patients with hypertension. However, there is no study 
to date which has showed this relationship for ESRD patients.  
In summary, despite a number of issues with measurement, the weight of evidence 
means we can be confident in stating that a relationship exists between depression 
and a number of health-related outcomes, including mortality. However, the exact 
nature of this relationship remains unclear. It is possible that the relationship is bi-
directional meaning depression leads to poorer health and vice versa, or depression 
could be independently associated with mortality. The pathways described above 
remain speculative due to mixed findings.  
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1.5 Illness Perceptions  
In recent years, researchers have continued to focus on the relationship between 
depression and health-related outcomes with the ultimate goal of identifying factors 
that are amenable to intervention and therefore could lead to favourable 
consequences for the dialysis patient, their social situation and the service provider 
(Hale, Treharne & Kitas, 2007). However, there has been slight shift in behavioural 
research away from compliance and depression, towards more modern concepts of 
illness beliefs, treatment beliefs and self-management (Kaptein et al, 2010). For 
example, studies in HD patients have documented an association between a 
number of different cognitive factors and self-management, including self-efficacy 
(Brady, Tucker, Alfino, Tarrant & Finlayson, 1997), locus of control, and general 
health-beliefs (Kutner, Zhang, McClellan & Cole, 2002). This development supports 
a move away from paternalistic approaches towards increasing ‘adherence’, to one 
which helps to empower patients and encourages shared decision making 
(Bodenheimer, Lorig, Holman & Grumbach, 2002) 
One way researchers have conceptualised the relationship between such cognitive 
factors and outcomes is using illness perceptions, a core component of Leventhal’s 
‘Common-Sense Model of self-regulation’ (CSM) (Leventhal & Camerson, 1987; 
Leventhal, Leventhal & Contrada, 1998). This model has been used extensively 
within research on chronic illness in order to understand the process of patients’ 
emotional adjustment and coping, following diagnosis. 
1.5.1 Common Sense Model of self-regulation (CSM) 
The CSM is an adapted version of several social cognitive or problem-solving 
models, and bares a strong resemblance to the transactional model of stress and 
coping (Lazarus & Folkman, 1984). Leventhal and his colleagues (1997) originally 
developed the CSM after studying the factors which influence health promoting 
behaviours. After discovering that different types of information were needed to 
influence both attitudes and actions to a perceived threat to health, they wanted to 
understand what types of adaptations and coping efforts might be required for those 
experiencing chronic illness. In essence, the model proposes that when an 
individual is diagnosed with a chronic illness, they construct an organised pattern of 
beliefs or personal mental model of their condition, in order to make sense of their 
symptoms. These mental models are known as ‘illness representations’ and are 
based on available concrete and abstract sources of information. These 
representations evolve over time as the individual gains new information and can 
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function to determine how they respond (Leventhal, Meyer & Nerenz, 1980). 
Evidence suggests illness representations, or perceptions, consist of the following 
five components (Petrie & Weinman, 2006): 
1) Identity. This is the label or name given to the condition and the symptoms 
that seem to coincide with it. 
2) Cause. These are the ideas an individual holds about the perceived cause or 
causes of the illness, which may not be bio-medically accurate. These 
beliefs are based on information gathered from personal experiences, as 
well as from the opinions and discourses of significant others.  
3) Time-line. This is a predictive belief about the likely duration of the illness, 
for example whether it is acute or chronic. These beliefs can be re-evaluated 
as time progresses. 
4) Consequences. This is what the individual understands the consequences of 
the condition will be and how it will impact on them physically and socially. 
5) Curability/controllability. This is an individual’s beliefs about whether the 
condition can be cured or controlled, and the degree to which they play a 
part in achieving this control. 
This set of dimensions is thought to be interrelated, functioning as group of beliefs 
or schema, rather than as single cognitions (Leventhal, 1998). The figure below is a 
diagrammatic representation of how this dynamic, self-regulatory system works. 
 
Figure 1. Diagram representing the Common Sense Model of Self-Regulation 
(Leventhal et al, 1997) 
As the diagram shows, the model postulates two different parallel pathways for 
processing a health threat, which continuously interact as the individual adapts to 
illness. The first pathway comprises a cognitive representation (which encompasses 
the five components outlined above) and related coping strategies (e.g., “what is it 
and what can I do about it objectively?”). The second pathway comprises an 
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emotional representation and related coping strategies (e.g., “how do I feel about 
it?”). Feedback loops allow for appraisal of the effectiveness of the coping 
strategies, which influences the cognitive and emotional representations, which then 
influences future coping. This process of continuous appraisal and re-appraisal is 
believed to reflect a common-sense ‘IF-THEN’ judgement which directly leads to 
coping or self-care behaviour. ‘IF’ is interpretation of illness and ‘THEN’ refers to the 
procedure adopted in response to threat. For example, a patient may hold the belief 
that ‘IF my treatment does little to control my disease, THEN undertaking the 
required facets of self-care may not be necessary’ (Leventhal et al, 1998).  
A meta-analytic review confirmed the a priori hypotheses of this model (Hagger & 
Orbell, 2003). It declared that negative cognitive representations (beliefs in serious 
consequences, a strong illness identity and a chronic timeline) were negatively 
related to adaptive illness outcomes (psychological well-being, social and role 
functioning and vitality), but positively related to the maladaptive illness outcome of 
psychological distress. High perceived control was also positively correlated with 
psychological well-being and vitality. The model posits that coping behaviour 
mediates the relationship between illness representations and outcomes, however, 
this review indicated only low-moderate correlations between the illness perception 
dimensions and coping behaviour. The authors argue this could be due to the 
measures of coping behaviours lacking specificity or the possibility that coping 
behaviours act as moderators by either exacerbating or hindering the influence of 
illness representation on outcomes. Therefore, the precise position of ‘coping 
behaviours’ as a mediating mechanism in this model, remains open to speculation. 
1.5.2 Illness perceptions in HD patients 
Several qualitative studies have investigated general illness perceptions for ESRD 
patients. Some have shown that HD is commonly perceived as an extremely 
demanding and burdensome treatment which disrupts work, family and social 
aspects of life. (e.g., Krespi, Bone, Ahman, Worthington & Salmon, 2004). Others 
have commented on the constant emotional and psychological adjustments to 
changing health states which can severely disrupt a patients’ integration of a 
positive sense of self into their social worlds (e.g., Gregory, Way, Hutchinson, 
Barrett, & Parfrey, 1998). A quantitative study by Griva, Jaysena, Davenport, 
Harrison & Newman (2009) measured illness perceptions across different treatment 
modalities of RRT. The research group found that dialysis patients reported 
significantly more symptoms, held lower control beliefs, and perceived more illness 
and treatment disruptiveness, than transplant patients. These findings echo those of 
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earlier studies which show that when treatment is perceived as less intrusive, 
overall illness and treatment perceptions are more positive (Devins et al, 1990). 
1.5.3 Illness perceptions and outcomes 
The five components of illness representations have been operationalised in the 
Illness Perception Questionnaire (IPQ), which also measures treatment perceptions 
(Weinman, Petrie, Moss-Morris & Home, 1996). This has been used to investigate 
the utility of the CSM model in understanding the role of illness perceptions in 
several varieties of chronic illness. A collection of studies have specifically focussed 
on how illness perceptions impact on physical and psychological health outcomes in 
ESRD patients.  
O’Connor, Jardine & Millar (2008) applied the CSM to the prediction of self-care 
behaviour in HD patients, in conjunction with the process model of coping (Lazarus 
& Folkman, 1984). Lazarus and Folkman’s model of coping suggests that patients 
may use two possible types of coping; problem-focussed or emotion-focussed, in 
order to alleviate psychological distress. O’Conner et al (2008) decided to integrate 
the two models, since previous research suggests that adherence to dietary and 
fluid restrictions and medication regimes may be enhanced through the adoption of 
problem-focussed coping strategies and that maladaptive coping strategies may be 
less helpful and associated with poor adherence (Penley, Tomaka & Weibe, 2002). 
The researchers found that illness perceptions predicted self-care behaviours over 
and above clinical and medical factors. Furthermore, scores indicating the use of 
emotional illness representations were better able to predict medication and dietary 
adherence than general psychological distress, highlighting the importance of 
measuring illness-specific distress when screening for psychological problems. 
Also, emotion-focussed coping was more closely associated with variation in 
adherence to fluid restriction, perhaps indicating that the use of emotion-focussed 
coping skills (such as positive-reframing) allows individuals to disregard or forget 
fluid restrictions and are less helpful for encouraging adherence to self-care 
behaviour. Finally, the importance of timeline beliefs were highlighted since those 
who believed their disease was temporary, were less likely to adhere to the dietary 
guidelines and vice versa. The importance of timeline beliefs was also highlighted 
by Chilcot, Wellsted & Farrington (2010), who compared differences in illness 
perceptions between fluid adherent and non-adherent HD patients. Their results 
indicated non-adherent patients held significantly lower timeline perceptions as 
compared to adherent patients, implying that ESRD patients who do not perceive 
 PART A: MAIN PROJECT  JENNIFER HUNT 
 
 
27 
 
that their illness is chronic, are less likely to adhere to recommended fluid 
restrictions. 
Two studies have examined how illness perceptions are associated with survival in 
dialysis patients. Van Dijk et al (2009) found that treatment control beliefs play a 
major role. Patients who perceived their treatment to be less effective suffered from 
a higher level of mortality, after adjusting for clinical and socio demographic 
variables. An additional study by Chilcot, Wellsted, Davenport and Farrington 
(2011b) added weight to this claim by demonstrating that perceptions pertaining to 
treatment control predicted survival. Collectively, these results provide support for 
the theory that low perceived treatment control leads to maladaptive health-care 
behaviour such as non-adherence, which can in turn increase mortality.  
Illness perceptions have also been found to be important determinant of QOL in this 
population. After controlling for confounding variables, Timmers et al (2008) found 
that illness perceptions significantly contributed to aspects of QOL. More 
specifically, the results showed that a strong illness identity, many perceived 
negative consequences and low personal control were associated with lower well-
being. These findings endorse those of earlier studies that illustrate stronger 
emotional representations are associated with worse outcomes (O’Conner et al, 
2008). In a longitudinal study, Covic, Seika, Mardare and Gusbeth-Tatomir (2006) 
followed up patients after two years of treatment and concluded that a lower 
emotional response meant better physical scores. These researchers also found 
that illness perceptions improved over time. After the two years, patients had less 
negative emotional perceptions, a better understanding of their illness and a better 
perception of control. Illness perceptions can also predict depressed mood. 
Treatment disruptiveness was found to be a powerful predictor of levels of 
depressed mood in a group of ESRD patients (Griva, Davenport, Harrison & 
Newman, 2010) and Chilcot et al (2011b) found illness consequences, coherence 
and personal control independently predicted depression in a sample of HD 
patients. 
Taken together, findings from research on illness perceptions in the ESRD 
population indicate that they are an important determinant of health-related 
outcomes including treatment adherence, survival and QOL. Some researchers 
have even suggested they may be more powerful predictors of outcome than clinical 
factors (Chilcot et al, 2011b). 
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1.6 Interventions 
Since clinicians have been made aware of the important impact psychological 
distress and maladaptive illness perceptions can have on health-related outcomes 
in dialysis patients, increased emphasis has been placed on designing suitable 
methods to help ameliorate distress symptoms and improve maladaptive illness 
perceptions. The limited pool of research so far has mainly focussed on 
pharmacological and psychotherapeutic interventions. 
1.6.1 Pharmacological interventions 
Considering the amount of research to date indicating the existence of a significant 
link between depression and poor outcomes for dialysis patients, only a scarce 
number of studies have examined the pharmacological treatment of depression in 
this population. Most of the trials published have been limited by small sample sizes 
and other methodological problems. With regards to PD patients, a non-randomized 
observational study of anti-depressant medication reported some improvement in 
depressive symptoms (Wuerth, Finkelstein & Finkelstein, 2005). Another study by 
Atalay et al (2010) reported that treatment with selective serotonin reuptake 
inhibitors (SSRIs) was associated with a decrease in depressive symptoms in 
chronic PD patients. However, these findings were limited by a lack of control group 
and the fact that the average BDI score remained above the cut-off for depression 
at the end of treatment. With regards to HD patients, a study by Koo et al (2005) 
found that a group of depressed dialysis patients treated with an SSRI alongside 
psychotherapy had statistically lower depression scores at the end of treatment. 
However, again the findings were limited by a lack of placebo-control group and a 
short-term follow-up. Finally, a randomised controlled trial of treatment using 
fluoxetine in 14 chronic HD patients with major depression lead to a statistically 
significant improvement in depression after 4 weeks, although this improvement 
was not sustained at 8 week follow-up (Blumenfield et al, 1997).  
The exclusion of ESRD patients from large antidepressant trials has been largely 
due to concerns regarding the possibility of adverse events and the lack of data 
about the safety of using antidepressants with this patient group (Glassman et al, 
2002). Hedayati, Yalamachilli, & Finkelstein (2012) point out that many 
antidepressants are highly protein bound and not removed sufficiently by the 
dialysis procedure, which could cause a build-up of potentially toxic metabolites in 
the blood. There is also a risk of multiple drug interactions since dialysis patients 
frequently suffer from co-morbidities and are therefore prescribed numerous 
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medications. Furthermore, it is widely recognised that many antidepressants can 
have noticeable side effects and the possibility of cardiac side effects could be a 
particular problem for ESRD sufferers. Reviews of the literature to date have 
concluded that more trials are needed to establish the effectiveness of SSRIs, as 
well as research their side effects and possible drug-drug interaction (Hedayati et al, 
2012). 
1.6.2 Psychological interventions 
The treatment of psychological conditions in dialysis patients has received little 
attention, particularly with respect to psychological interventions. This means there 
is currently little evidence concerning the most effective treatment options for 
dialysis patients with co-morbid depression. A recent review by Sharp, Wild & 
Gumley (2005) found most psychological interventions aiming to improve fluid 
adherence in dialysis patients tend to use strategies and techniques from 
behavioural models, for example token economies (Carton & Schweitzer, 1996), 
self-regulation/self-monitoring (Christensen, Moran, Weibe, Ehlers & Lawton, 2002), 
social reinforcement (Mosley, Eisen, Bruce, Brantley & Cocke, 1993), skills training 
(Molaison & Yadrick, 2003), stress management (Tsay, 2003) and the adoption of 
functionally equivalent behaviours (Vipond, 1991). Other studies are multifaceted, 
using elements of cognitive or behavioural therapy, and many are supplemented 
with patient education. The authors of this review highlight some limitations of the 
research to date which include small samples, poor quality and lack of statistical 
power. In addition, many of the studies do not consider how the intervention impacts 
on psychosocial outcomes. However, they conclude that, overall, psychological 
interventions appear to have some clinical benefit and highlight the recent shift 
towards interventions utilising a more integrative approach, which have shown 
promise.  
It is thought that behavioural strategies alone are able to achieve good outcomes 
with dialysis patients in the short-term, but that cognitive behavioural therapy (CBT) 
has more potential to achieve long-term behaviour change (Kutner, 2001). CBT is a 
structured, short-term and goal-driven therapy which integrates both the principles 
of cognitive theory and behavioural techniques. Cognitive theory dictates that our 
emotions are driven by cognitive distortions, in other words, the misinterpretation of 
situations or events. CBT therefore aims to teach patients effective ways of 
managing low mood through the use of coping strategies such as thought 
challenging, problem-solving and adjustment of their behaviour. CBT is well-
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recognised as a viable treatment option for a number of psychiatric disorders in 
variety of populations (Beck, 2005). 
Since the 1990s, there has been a small but growing collection of evidence that 
supports the effectiveness of CBT with ESRD sufferers.  Hener, Matisyohu & Har-
Even (1996) reported a group of patients who had supportive therapy or CBT 
maintained better emotional, interpersonal, behavioural and cognitive adjustment to 
PD than those in the non-treatment group. Cukor (2007) adapted CBT treatment so 
it could be administered ‘chair side’ at the dialysis unit. This was conducted for 
individual patients with major depression, and resulted in a significant decrease in 
BDI scores at the end of treatment.  In addition, a recent trial of CBT with 84 HD 
patients with major depression was conducted in Brazil (Duarte, Miyazaki, Blay & 
Sesso, 2009). Patients were randomized into a control group (receiving standard 
care) or an intervention group who received 12 weekly group CBT sessions, 
followed by monthly maintenance sessions. Results showed a significant decrease 
in depression scores in the CBT group compared to the control group, which was 
confirmed with standardised interviews, and maintained 6 months after the 
intervention period. The group receiving CBT also showed significant improvements 
in some QOL dimensions (burden of kidney disease, cognitive function, quality of 
social interaction, sleep and overall health). The broader benefits of CBT have also 
been observed in a study of 69 ESRD patients in Louisiana after hurricane-related 
trauma (Weine, Kutner, Bowles & Johnstone, 2010). For this study, social workers 
were trained using kits supplied by the National Kidney Foundation, which applied a 
cognitive-behavioural framework. Those patients who discussed this material with 
their social workers achieved a significant amelioration of depressive symptoms 
compared to those who chose not to. Overall, these findings suggest how, with 
focussed training, CBT can be applied for more widespread use in this setting.  
Studies focussing on interventions designed specifically to alter illness perceptions 
in chronic illness populations have shown that inaccurate perceptions are amenable 
to change and that this can have a positive effect on health-related outcomes. For 
example, Petrie, Cameron, Ellis, Buick & Weinman (2002) designed a brief 
psychological hospital-based intervention to change inaccurate and negative illness 
perceptions of myocardial infarction (MI). The intervention consisted of the same 
broad framework, but specific content was adapted according to each individual’s 
illness beliefs. Sessions included education about the pathophysiology of MI, 
identifying and challenging extreme or negative illness beliefs and development and 
review of a recovery action plan. Results indicated that the intervention was 
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successful in changing patient’s perceptions of their MI, speed of return to work at 3 
months and lower reported rates of angina symptoms. Another study by Petrie, 
Perry, Broadbent & Weinman (2012) used text messages targeted to individual 
asthma patients’ individual illness and treatment beliefs which positively modified 
beliefs and increased adherence rates by 10%.  
So far, very few studies have applied similar approaches with ESRD patients. 
Karamanidou, Clatworthy, Weinman, Horne et al (2008) demonstrated the feasibility 
of using an intervention addressing treatment perceptions and improving patients’ 
understanding and perceived efficacy of phosphate –binding medications. Jansen, 
Heijmans, Rijken & Kaptein (2011) also designed a behavioural self-regulation 
intervention with the aim of generating ‘positive but realistic’ beliefs about disease, 
treatment and changing maladaptive beliefs, for a group of dialysis patients. They 
also wished to increase self-efficacy and stimulate behaviour that supported 
autonomy in patients and their partners. The intervention used a similar structure to 
that of Petrie et al (2002), and was successful in implementing an integrated 
approach in this setting. However, the study sample was small and the outcome 
was focussed on employment rather than health-related benefits. 
In summary, evidence for interventions focussing on reducing depression in dialysis 
patients has been mixed. There are some supportive findings for the use of anti-
depressants, although a number of issues remain unresolved. A few behavioural 
interventions have been applied, but only looking at the impact on behavioural 
change, and not on mood. With regards to CBT, although many existing studies 
suffer from small sample sizes and inadequate methodology, the results so far are 
encouraging. A couple of studies have also examined the feasibility and efficacy of 
using interventions designed to change maladaptive illness perceptions. In general, 
there seems to be a lack of research on the effectiveness of psychological 
interventions aimed at improving symptoms of psychological distress in HD patients 
and the impact of such interventions on physical health outcomes remains 
unknown. Little is known about which illness perceptions are associated with 
psychological distress or depression in dialysis patients and there is a need and for 
more trials of interventions designed to alleviate distress.  
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1.7 Expressive Writing (EW) 
1.7.1 Development of EW procedure 
Over the past 30 years, a large base of experimental findings has accumulated to 
demonstrate the clinically meaningful changes brought about through the process of 
EW, or emotional expression (Smyth & Pennebaker, 2008; Frattaroli, 2006). This 
model emerged from the core principle of psychotherapy; that the disclosure of 
emotional experiences is beneficial for clients. Pennebaker et al (1985, 1989) were 
the first to scientifically validate this process. They examined the consequences of 
the technique by manipulation using an experimental design. In their pioneering 
study, Pennebaker and Beall (1986) randomly assigned participants to write either 
about traumatic events or neutral topics, for several consecutive days. They 
compared the outcomes of four different writing groups: a trauma-fact group, a 
trauma-emotion group, a trauma-combo group and a control group. The surprising 
results revealed that, several weeks after writing, the trauma-combo group (who 
wrote about both the facts and emotions surrounding their trauma) exhibited a 
significant reduction in illness-related visits to their doctor, as compared to the other 
three groups. In a series of subsequent experiments, this group of researchers were 
able to show that, in order to obtain positive health effects, the writing instructions 
had to focus participants on the emotional evaluation of their experience, beyond a 
factual description of events (Pennebaker & Beall, 1986; Pennebaker, Colder & 
Sharp, 1990; Pennebaker & Francis, 1996). The idea that disclosing thoughts and 
feelings concerning a traumatic event can lead to objectively measurable health 
improvements was unique, and triggered a long tradition of research investigating 
the effects elicited by the EW paradigm.  
Early studies, mainly conducted with health college students, established the basic 
writing EW template to be replicated and adapted over time. The typical set-up 
involves asking participants to write about their deepest thoughts and feelings 
regarding an individually selected upsetting experience or a predetermined stressful 
situation for 15-20 minutes over 3 to 4 brief writing sessions. This is usually 
compared with a group instructed to write about unemotional neutral topics. After a 
decade of research using university students, the exciting findings inspired 
researchers to begin examining EW effects with a more varied sample. This mostly 
included people in the community who were currently experiencing or had 
previously experienced an upsetting event. These studies revealed interesting 
additional benefits, from increased speed of re-employment (Spera, Buhrfeind & 
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Pennebaker, 1994) to helping male offenders to take fewer hospital trips (Richards, 
Beall, Segal & Pennebaker, 2000). Since then, clinicians have been keen to adapt 
this low cost and accessible technique for use with those suffering from specific 
health risks and diagnosed health conditions. To allow this, researchers have 
started to vary the experimental diameters (including number and duration of 
sessions, instructions and time of follow-up assessment) (Mogk, Otte, Reinhold-
Hurley & Kroner-Herwig, 2006).  
EW generally has an immediate short-term negative cost (i.e., increase in distress, 
negative mood and physical symptoms), although this does not appear to be 
detrimental or pose a longer-term risk to participants (Hockemeyer et al, 1999). 
However, at long-term follow-up, studies continue to find evidence of benefits for 
both objective and subjective physical health and subjective emotional health 
outcomes (Baikie & Wilhelm, 2005). In a meta-analysis of 13 studies of EW with 
physically and psychologically healthy individuals, Smyth (1998) found a moderate 
effect on outcome (d=0.47), representing a 23% improvement in overall health. 
Frisina, Borod and Lapore (2004) conducted a meta-analysis of EW in clinical 
populations and found a significant effect on outcome (d=0.19). They concluded that 
EW can be beneficial but differentially effective for an array of physical and 
psychological outcomes. The most recent and comprehensive meta-analysis by 
Frattaroli (2006) indicated an overall more modest effect size of around d=0.15. 
However, Smyth & Pennebaker (2008) argue that for such a brief intervention to 
have an effect on meaningful outcomes, several weeks afterwards, deserves 
admiration. There is not scope to discuss the entirety of such findings to date in this 
paper but the main results regarding the effects of EW on physical and 
psychological outcomes, relevant to its application within a clinical health setting, 
will be summarised.  
1.7.2 EW: effect on physiological outcomes 
In early studies, some of the most striking benefits of EW were improvements to 
biological measures of immune functioning. T-helper cells and CD4 are types of 
white blood cells which help to protect the body from infection, and can therefore act 
as measures of immune system strength. EW was shown to enhance activity of T-
helper cells in students (Pennebaker, Kiecolt-Glaser & Glaser, 1988) and 
significantly increase CD4+ lymphocyte counts in HIV patients (Petrie, Fontanilla, 
Thomas, Booth & Pennebaker, 2004). Another study focussed on the immune 
response to the Epstein-Barr virus (a virus which most adults carry and which can 
be reactivated by stressful events) (Esterling, Antoni, Fletcher, Margulies & 
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Schneiderman, 1994). This found that participants assigned to express emotions 
about stressful events verbally or through writing had reduced amounts of 
antibodies against the EBV virus. Finally, a study by Petrie, Booth, Pennebaker, 
Davison and Thomas (1995), demonstrated improved responses to hepatitis B 
vaccination in medical students who engaged in EW. 
A number of studies have looked into the effects of EW on other wider parameters 
of immune functioning. For example, clinical trials have shown improved lung 
function in patients with asthma at 4-month follow-up (Smyth, Stone, Herwitz & 
Kaell, 1999). There have also been benefits for patients with rheumatoid arthritis, 
with results indicating improvements in physical functioning (Kelley, Lumley & 
Leison, 1997) and reduction of disease severity (Smyth et al, 1999). In addition, 
Wilmott, Harris, Gellaitry, Cooper & Horner (2011) assessed the effects of written 
disclosure on health care utilization and clinical outcomes in patients who had 
experienced their first MI. The writing procedure was associated with fewer GP and 
hospital visits, less prescribed medication, lower blood pressure and fewer reported 
cardiac symptoms relative to controls. The long-term effects of EW on blood 
pressure has also been shown by McGuire, Greenberg and Gerwitz (2005) who 
found those who participated in the emotional disclosure exhibited lower systolic 
and diastolic blood pressure one month after writing. The effects of lowered health 
care utilisation are of particular interest due to their implication for health care cost, 
and have been investigated by a number of other researchers who have shown 
found similar results for frequent health clinic attenders (Gidron, Peri, Connelly & 
Shalev, 1996) for patients following a minor surgical operation (Solano, Donatti, 
Pecci, Persichetti & Colaci, 2003), and for children with Cystic Fibrosis (Taylor, 
Wallander, Anderson, Beasley & Brown, 2003). 
The benefits of EW have also extended to overall symptom reduction; with 
Broderick, Junghaenel and Chwartz (2005) demonstrating reduced pain and fatigue 
in fibromyalgia patients and Norman, Lumley, Dooley and Diamond (2004) finding 
lower rates of evaluative pain among women with chronic pelvic pain. Finally, a 
number of studies have applied the writing paradigm to cancer patients with positive 
results. In a randomised controlled trial, Stanton, Danoff-Bur, Sworowski, Collins 
and Branstetter (2002) showed that women with breast cancer who were asked to 
express their deepest thoughts and feelings regarding their experience of illness, 
reported significantly fewer negative symptoms and had fewer cancer-related 
medical appointments than the control group at follow-up. 
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1.7.3 EW: effect on psychological outcomes 
As well as the beneficial impact this intervention can have on physical health 
markers, there is substantial evidence that EW can positively affect aspects of 
psychological health. To begin with, all participants in many of the previously cited 
studies consistently reported that writing about emotionally rousing experiences was 
a valuable and meaningful experience. Pennebaker (1989) also remarked on the 
praise given by participants at long-term follow-ups, many of whom commented that 
the process allowed them to think differently about their trauma. 
More substantiated improvements in psychological health have also been 
evidenced. Studies have shown better subjective mental well-being for patients 
following their first MI who take part in EW (Willmott et al, 2011). More recently, 
Craft et al (2012) found that early breast cancer survivors who wrote about the 
trauma of their breast cancer or facts about their breast cancer showed greater 
improvement in their QOL compared to those who did not write or to those who 
wrote about a self-selected traumatic event. Another study focussing on breast 
cancer, instructed participants to focus on their experience of the illness and guided 
them to write four focussed essays on emotional disclosure, cognitive appraisal, 
benefit finding and looking to the future, on four consecutive days (Gellaitry, Peter, 
Bloomfield & Horner, 2010). At six month follow-up, the EW group had higher 
ratings of perceived emotional support which was associated with lower rates of 
depression and anger, and higher rates of social and family well-being. Broderick et 
al (2005) found that EW led to enhanced overall psychological well-being in 
fibromyalgia sufferers. This was measured using a QOL measure, the State-Trait 
Anxiety Scale (STAI-S) which assesses anxiety symptoms and the Beck Depression 
Inventory II (BDI) which assesses symptoms of depressed mood. Finally, Averill, 
Kasarskis and Segerstrom, (2013) have shown that patients with amytrophic lateral 
sclerosis (a fatal neuromuscular disease) reported high levels of psychological well-
being three months after writing, but not at six months. They also found that those 
who were particularly ambivalent about expressing emotion were the most likely to 
benefit from the EW task. However, overall, statistical reviews of these findings 
have asserted that EW effects for psychological health do not appear to be as 
robust or consistent as those for physical health (Frisina et al, 2004).  
1.7.4 EW: theoretical development 
“Two strong conclusions can be made with regard to the benefits of expressive 
writing. First expressive writing has health benefits. Second, no one really knows 
why.”  
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King (2002, p119)  
A range of theories have been proposed to explain the effects of the EW procedure 
(Pennebaker & Chung, 2007). Early researchers argued the effects of the writing 
task were linked to the Freudian concept of catharsis (1904). This theory proposes 
that, following a disturbing or traumatic event, the memory of said event may be 
suppressed, whilst the emotion of the associated affect continues to exist in one’s 
consciousness in the form of anxiety. Therefore, describing such an event in detail 
can have a cathartic effect by revealing the suppressed memory, releasing the 
associated affect. In support of this, Breuer and Freud (1966) recognised that 
‘hysterical’ symptoms were likely to disappear once a patient had described the 
focal event in detail. Pennebaker (1982) expanded on this idea by providing an 
explanation for the effects of EW with the general model of inhibition. This purports 
that, following a traumatic experience, many people may be either unable or 
unwilling to talk about or share their experience with others for fear of shame, 
disapproval or punishment. Pennerbaker et al, 1990 built on this idea by suggesting 
that actively inhibiting ones thoughts and feelings can be harmful since it places 
cumulative stress on the body, also activating the autonomic nervous system and 
putting strain on physiological functioning. This may then have a long-term negative 
impact on health through increased vulnerability to stress-related illness. By default, 
this implies disclosure of trauma-related thoughts and feelings can reduce stress, 
promote good health and encourage positive wellbeing. The findings from 
Pennebaker & Beall’s (1986) seminal study (described above) support this 
hypothesis but a number of studies have since challenged the theory. In one 
example, Greenberg (1995) asked participants to write about either a real or 
imaginary trauma. Contrary to prediction, both groups had similar rates of reduced 
illness-related doctor visits, therefore contradicting the idea that one has to write 
about their personal thoughts and feelings connected to an event, in order to 
acquire the benefits. 
More recently, Pennebaker and others have suggested that emotional expression 
does more than prevent the psychosomatic impact of stress, but believe it is also 
important in facilitating cognitive processing. This thinking occurred as a reaction to 
participants reporting that one helpful aspect of writing was allowing them to gain 
insight (Pennebaker et al, 1990). Cognitive processing refers to the process of 
organising, assimilation and discovery of meaning for a memory that results from 
talking about or confronting an upsetting event.  This method allows individuals to 
simplify complex experiences, gain insight and control and integrate memories into 
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their schema, therefore freeing up energy previously devoted to inhibition, which 
can be utilised more efficiently in the body. To further examine this, Pennebaker 
(1993) developed a computerised text-analysis programme to investigate key words 
used during writing exercises. Findings were in-line with the cognitive processing 
theory, showing that those who had benefited most had increased their use of 
causation and insight words during the course of writing. In other words, those who 
benefitted seemed to begin with poorly organized descriptions and transformed 
them into coherent stories within a linguistic structure. This was therefore 
hypothesised to be a crucial underlying mechanism to the success of EW. However, 
a recent study by Cresswell et al (2007) failed to find evidence to support this theory 
(see below).  
Contemporary researchers have put forward alternative theoretical explanations. 
Some have explained the effects in the context of self-regulatory theory. For 
example, Cameron and Nicholls’s study (1998) used a modified version of the 
writing exercise designed to promote self-regulation. Students described problems 
they encountered in college and generated ways to fix problems, which produced 
the same benefits as EW. King (2001) also reported writing about one’s ‘best 
possible self’ produced reductions in illness visits of a similar effect size to EW 
about trauma. Lepore, Greenberg, Bruno and Smyth (2002) explained how 
experimental disclosure can be thought of as a mastery experience, allowing people 
to observe themselves expressing and controlling their emotion, and providing them 
with a stronger sense of self-efficacy for emotional regulation. Furthermore, a recent 
study found that self-affirmation may act as psychological mechanism for positive 
effects of EW on aspects of health in early-stage breast cancer survivors (Cresswell 
et al, 2007). The authors claimed that, rather than increasing self-efficacy, self-
affirmation acted as a stress buffer. 
The social integration model has also been posited as a possible theoretical 
framework. This argues that disclosure affects the way people interact with their 
social world, consequentially influencing health and well-being. Results from 
Gellaitry et al’s study (2010), as cited earlier, which illustrated the positive effect of 
EW on perceptions of social support, add credence to this theory. However, this 
idea is very new and has only been tested in handful of studies. 
Finally, exposure theory of EW argues the expression of thoughts and feelings 
regarding an upsetting event, is similar to exposure (or flooding therapy) which is 
commonly recommended for treatment of anxiety-based disorders such as phobia 
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or post-traumatic stress disorder. This is grounded in the principle that, when a 
person repeatedly confronts or describes an experience, it is similar to reliving the 
thoughts and feelings about the experience, which should lead to extinction of such 
thoughts over time. However, support for this theory has been mixed (Lepore & 
Smyth, 2002). 
Recently, Smyth and Pennebaker (2008) have stated “there is probably no single 
theoretical process that can explain the findings” (p.3). However, they highlight the 
general agreement that EW leads to emotional change and accumulating evidence 
in support of the process of habituation. They conclude that EW seems to affect 
different people across different dimensions.  
1.8 Summary and Measuring Distress 
To summarise, CKD is a progressive disease which coincides with a gradual 
reduction in kidney functioning which can lead to kidney failure or ESRD. When this 
occurs, patients must adhere to ‘RRT’ in some form, with HD currently the most 
popular modality. The HD treatment regime is extremely intrusive and burdensome 
for patients and many experience high levels of psychological distress, 
encompassing symptoms of depression and anxiety, as a result. Patients who suffer 
from ESRD and co-morbid depression have a lower QOL and higher mortality rate. 
The pathway between depression and poor outcomes is unclear but illness beliefs 
or perceptions have been proposed to play a role (in line with the CSM model) and 
have been shown to have a significant effect on outcomes. A number of 
interventions have been designed and tested in order to improve levels of 
depression and maladaptive illness perceptions, with some positive results. EW is a 
novel intervention which has been successfully applied to many clinical health 
settings, and has proved helpful in relation to many physiological and psychological 
health outcomes. However, no study to date has evaluated the effects of EW on 
patients being treated for kidney failure with HD. 
As described above, much of the research in this field to date has focussed on the 
causes and impact of clinical depression. Due to the fact that EW is designed to 
target well-being, rather than depression as such, this study was designed to 
assess the impact on levels of general psychological distress. In addition, recent 
advances in psychometrics have indicated that bifactor models exist for many 
conventional depression measures. For example, a study by Martin, Tweed & 
Metcalfe (2004) deduced that the Hospital Anxiety and Depression Scale (HADS; 
Zigmond & Snaith, 1983) was unable to accurately and robustly assess independent 
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but related domains of anxiety and depression, since they both correlate with a 
more broad, general factor of ‘distress’. These findings, alongside the fact that this 
study was interested in detecting patients with sub-clinical levels of distress, meant 
that the most popular measure for assessing psychological well-being, the General 
Health Questionnaire-12 (GHQ-12; Goldberg, 1988), was selected as the primary 
outcome measure. It was thought this would be the best way of capturing those 
patients struggling with mood, as well as other social factors, but who are not 
clinically depressed or anxious since such patients may be better suited to higher 
intensity interventions, such as one-to-one psychological therapy. 
1.9 Aims and Hypotheses 
This study was a feasibility study with a related series of questions by which 
feasibility was evaluated. Firstly, it was thought important to examine the 
characteristics of the proposed outcome measure, and thereby establish the 
correlates of psychological distress within the ESRD patients undergoing HD. 
Secondly, several questions related to recruitment and retention of participants 
throughout the study process. Thirdly, safety and acceptability of the EW procedure 
was investigated, and finally, preliminary outcomes of using EW with this population 
were used to judge potential clinical efficacy. The research questions can thus be 
outlined as follows: 
1) What factors are associated with psychological distress within the HD 
population? 
2) In terms of recruitment and retention rates:  
i. What number of patients will agree to be screened? 
ii. What proportion of patients will be screened as eligible for the writing 
intervention (i.e., agree to screening and score 3 or above on the 
distress measure)?  
iii. What number will agree to randomisation?  
iv. What proportion of patients will adhere to the task instructions and 
complete the writing task fully? 
v. What proportion of patients will drop out before follow-up at 3 
months? 
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vi. Is the sample representative of the general dialysis population? 
3) In terms of acceptability and safety of the intervention: 
i. Is it possible to implement the intervention with this client group? 
ii. Is the intervention clinically relevant and generally acceptable to 
participants? 
iii. Are there reports of distress or other problems as a result of taking 
part in the writing task? 
4) In terms of preliminary outcomes, within the context of a small study: 
i. What evidence is there for the likely effect of the intervention on the 
primary outcome of psychological functioning (as indicated by 
psychological distress)? 
ii. What evidence is there for the likely effect of the intervention on the 
secondary outcome of physiological functioning (as indicated by 
blood pressure)? 
In relation to question 1, it was hypothesised that higher levels of distress would be 
associated with negative illness perceptions, high levels of fatigue, pain and 
depression. 
Questions 2 and 3 were purely exploratory questions so no hypotheses were made.  
In relation to question 4, it was hypothesised that the patients randomised to the EW 
group would show improvements in psychological and physiological health at follow-
up, in comparison to those randomised to the neutral writing group. Specifically, it 
was predicted that patients would report reduced levels of psychological distress, as 
measured by the General Health Questionnaire (Goldberg, 1988), and would have 
reduced blood pressure results, at 3 months post-EW intervention. 
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2.0 METHODS 
 
2.1 Design 
 
There were two phases to the study (screening phase and trial phase) which 
followed two different designs. 
2.1.1 Screening phase 
The first phase consisted of screening participants for clinical levels of distress with 
an additional aim of determining which factors were associated with psychological 
distress. A cross-sectional, retrospective questionnaire survey design was used and 
the main dependent variable was psychological distress as measured by the GHQ-
12. Independent variables consisted of the factors investigated as potential 
predictors of distress. These were demographic variables (gender, age, marital 
status, living arrangements and employment) clinical variables (years on dialysis, 
transplant history and co-morbidity), symptom variables (fatigue and pain) and 
illness perceptions. Despite being a similar construct to distress, depression was 
included as an additional variable, in order to look at its relationship with distress. 
The study collected quantitative data for the variables mentioned above.  
2.1.2 Trial phase 
The second phase aimed to determine the recruitment and retention rates, 
acceptability and safety and preliminary outcomes of the EW intervention. This 
phase used a randomised controlled trial (RCT) design with two conditions (EW and 
control) and 3 follow-up assessments which took place pre-intervention, and at 1 
week and 3 months post-intervention. Figure 2 below shows a schema of the study 
design. 
Recruitment and retention rates were determined by recording the number of 
patients who were eligible for screening, the number who agreed to be screened, 
the number who agreed to randomisation following screening, the number who were 
correctly able to adhere to the writing instructions, and the number who completed 
questionnaires post-intervention at 3 month follow-up. Brief qualitative data was also 
collected by asking participants open questions about how useful/helpful they found 
the writing, once their 3-month follow-up was completed and a fidelity check was 
completed, in order to determine acceptability. Safety was established by recording 
any heightened distress and preliminary outcomes by analysing effects on primary 
and additional outcome measures. 
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The main dependent variable for assessing clinical efficacy was self-reported 
distress, and blood pressure was a secondary outcome variable. The main 
independent variable in this phase was the condition patients were randomised into.  
 
Figure 2. Schema representing study design 
2.2 Sample 
The participants for this study were patients undergoing haemodialysis treatment 
recruited from both hospital-based and satellite dialysis units (Astley Cooper, 
Borough, Camberwell and Tunbridge Wells Dialysis Units), all managed by Guys & 
St Thomas’ NHS Foundation Trust. Exclusion criteria (for both the screening and 
trial phases) included patients under the age of 18, those with significant visual or 
physical impairment preventing completion of the questionnaires, inability to speak 
or write in English, known cognitive impairment, and documented history of 
psychiatric illness including severe depression (identified as being under the care of 
a psychiatrist). Those who were actively completing psychological treatment for low 
mood were also excluded to avoid the EW intervention interfering with treatment. To 
be included in the RCT phase of the study, patients needed to demonstrate 
significant distress defined as a score of 3 or more on the GHQ-12.  
2.3 Measures 
The measures were administered in the form of a questionnaire booklet (see 
Appendix H) comprising of the main outcome measure variable (psychological 
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distress), as well as the additional variables of self-reported symptoms (pain and 
fatigue), illness perceptions and depression. These are detailed below. 
2.3.1 Psychological distress 
Psychological distress was captured using the GHQ-12 (Goldberg, 1988), a self-
administered screening instrument designed to measure levels of general distress in 
the community and medical settings. It focuses on two main classes of experience; 
inability to carry out one’s normal healthy functions and, emergence of new 
distressing phenomena (Goldberg & Williams, 1988). The 12-item version is a short 
form of the original GHQ-60 (Goldberg, 1972) and is widely used for screening 
common mental disorders (Goldberg et al, 1997). This version consists of 12 
questions asking respondents to rate how much they have experienced various 
symptoms of psychological well-being over the past few weeks. Answers are given 
on a four-point scale, with higher scores indicating greater distress (Goldberg, 
1992). It is thought to be a highly accurate measure for discriminating ‘cases’ (those 
with probable non-psychotic mental health problem) from ‘non-cases’ (those with no 
significant non-psychotic mental health problem) (Goldberg et al, 1997). Werneke, 
Goldberg, Yalcin & Ulcin (2000) investigated the psychometric characteristics of the 
GHQ-12 using a large sample size factor analysis and concluded it to be a reliable 
instrument for screening and case detection in all clinical settings. However, 
although the GHQ has proven to be a sensitive and specific predictor for mental 
disorder, its relationship with a clinical diagnosis of mental disorder is thought to 
vary for different subgroups. It has therefore been suggested the GHQ-12 score be 
interpreted as an indicator of general mental distress rather than of any specific 
mental disorder (Verhaak, Heijmans, peters & Rijken, 2005) 
There is some debate about the best method of scoring the GHQ-12. Three different 
methods have been used; the standard binary ‘GHQ method’ which assigns a score 
of 1 to symptomatic responses and 0 to non-symptomatic responses (0,0,1,1), the 
Likert type which assigns scores of 0-3 to each item response (0,1,2,3), and the ‘C-
GHQ type’. The latter is less frequently used and involves scoring items that 
measure health as usual but scoring items reflecting illness as 0,1,1,1. In a study 
comparing the GHQ-12 and GHQ-28 across different cultures, Goldberg et al (1997) 
found that the Likert method was less valid than the standard GHQ method for the 
GHQ-12 and that the C-GHQ method was the least valid for both questionnaires. 
Both the binary and Likert type methods of scoring were used for this study. 
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Goldberg and Williams (1988) suggest that the threshold criteria for ‘caseness’ 
should be based on previous studies that have investigated a similar population 
cohort. Studies validating the use of the GHQ-12 with patients within a variety of 
general health care settings have indicated a cut-off score of 2 or 3 to be optimal 
(using the standard GHQ method of scoring) (e.g., Jacob, Bhugra & Mann, 1997; 
Plummer et al, 2000). Since no study is yet to validate the GHQ-12 to detect 
distress for dialysis patients, the threshold score used in this study was based on a 
recent study which used the GHQ-12 with a sample of employees from the NHS 
(Hardy, Shapiro & Haynes, 1999). This found that the best threshold score was 3/4 
(with a specificity of 0.84 and sensitivity of 0.74).  
2.3.2 Illness perceptions 
The Brief Illness Perceptions Questionnaire (BIPQ) was used to assess individual 
illness perceptions. This questionnaire, which is a shorter version of the original 
Illness Perception Questionnaire (IPQ; Weinman et al, 1996) applies a single-item 
scale approach and has been widely used to assess five dimensions within a 
cognitive representation of illness. A revised version of this measure known as the 
IPQ-R (Moss-Morris et al, 2002) extended the original scale by adding more items 
and consisted of 80 items in total. The brief version was developed by Broadbent et 
al in 2006 and generally consists of just 9 items; 8 new items plus part of a causal 
scale previously used in the IPQ-R. Five of the items assess cognitive illness 
representations (consequences, timeline, personal control, treatment control and 
identity), two of them assess emotional representation (concern and emotions) and 
one item assesses illness coherence. The causal representation is assessed via an 
open-ended response item which asks the patient to list the three most important 
causal factors in their illness. The psychometric properties of this measure have 
been assessed using samples from several illness groups, including renal patients 
(Broadbent, Petrie, Main & Weinman, 2006). The results indicated good test-retest 
reliability, validity and moderate to good associations between the Brief IPQ and the 
IPQ-R on all equivalent dimensions. The advantages this brief version offers are 
brevity and speed of completion for patients, as well as easy interpretation of 
scores. Increases in item scores represent linear increases in the dimension 
measure. It is standard practice to adapt the wording of the BIPQ to make it relevant 
to the sample population (i.e., “your illness” was replaced with “your kidney 
problem”). In addition, the version used in this instance omitted the item measuring 
‘identity’ beliefs. This was due to the fact that this would ask about the number of 
symptoms of the illness experienced by the patient, which would potentially inflate 
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the correlation between self-reported symptoms (i.e., fatigue and pain) and the total 
BIPQ score. 
Items 3, 4 and 6 (measuring personal control, treatment control and coherence 
beliefs respectively) of the BIPQ were reverse scored and so had to be transformed 
in the data file, prior to analysis. This meant that higher scores equated to less 
positive views of illness. Internal reliability of the scale was found to be acceptable 
(α = 0.67). 
2.3.3 Depression 
Numerous well-validated questionnaires are available for depression screening, one 
particularly popular measure being the 9-item depression module of the Patient 
Health Questionnaire (PHQ-9) which has been validated in 6000 patients (Spitzer, 
Kroenke & Williams, 1999). This self-administered questionnaire is designed to 
establish DSM-IV criteria-based psychiatric diagnosis of depression. The items are 
therefore derived from the DSM-IV classification system and pertain to; anhedonia, 
depressed mood, trouble sleeping, feeling tired, change in appetite, guilt or 
worthlessness, trouble concentrating, feeling slowed down or restless and suicidal 
thoughts. The two-item version (PHQ-2) is a shortened version which includes the 
first two items of the PHQ-9 measuring symptoms of anhedonia and low mood. It 
asked respondents to estimate the frequency of these 2 symptoms over the past 2 
weeks with 4 response options ranging from “not at all” to “nearly every day”. 
Although it lacks the validity and reliability strength of the PHQ-9, this brief measure 
has demonstrated good criterion and construct validity when used with primary care 
patients and its simplicity make it a suitable screen for depression in this study 
population. The PHQ-2 scores can range from 0-6 and a cut-off score of 3 or above 
is considered a reliable indicator of clinically significant depression (Kroenke, 
Spitzer & Williams, 2003). A recent study by Gyamlani et al (2011) provided support 
for the validity of the PHQ-2 in patients with CKD through observing its correlation 
with CES-D results and functional status. 
2.3.4 Pain 
The Visual Analogue Scale (VAS) is a commonly used pain rating scale. It is 
presented as a 10 cm line, anchored by verbal descriptors, which are usually “no 
pain” and “worst imaginable pain”. The respondent is asked to place a mark on the 
line to indicate pain intensity. A review of this measure in comparison to two other 
commonly used pain rating scales (Numerical Rating Scale and Verbal Rating 
Scale) suggested that statistically, the VAS is the most robust as it can provide ratio 
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level data as well as proving to be reliable and valid (Williamson & Hoggart, 2005). It 
has also been found to have a high degree of sensitivity or discriminating capacity, 
superior to that of other scales (Jamieson et al, 2002). 
2.3.5 Fatigue 
The Chalder Fatigue Scale (CFQ) is a brief self-rated instrument that measures the 
symptoms of mental and physical fatigue. The 14-item version was developed to 
measure fatigue in chronic fatigue syndrome (CFS) patients and component 
analysis revealed good evidence for the distinction between the two constructs of 
physical and mental fatigue (Chalder et al, 1993). Suspected overlap between the 
items prompted Morriss, Wearden & Nullis (1998) to analyse the scale further, 
revealing four constructs of fatigue in CFS patients (subjective cognitive complaints 
and effortful cognition, difficulties maintaining sleep, strength and aerobic 
performance and depression). These study results supported the use of a shorter 
11-item version which omits some items that strongly correlated with symptoms of 
depression. This study used the 11-item scale and was scored ‘bimodally’ (where 
response options “less than usual” and “no more than usual” are given scores of 0 
and “more than usual and “much more than usual” are given scores of 1). Using this 
method, total fatigue score is obtained by adding the scores for all items (with a 
range of 0–11) and a score of 4 or more is thought to indicate ‘caseness’. The scale 
has proved to be both valid and reliable when used with general practice attenders 
and has a high degree of internal consistency (Cronbach’s alpha of 0.89; Chalder et 
al, 1993). 
2.3.6 Demographic and clinical variables 
The demographic variables were collected via a questionnaire (see Appendix G) at 
baseline, and included age, marital status, living arrangements and employment 
status. Clinical variables were recorded using a prof forma (see Appendix F) both at 
baseline and follow-up via electronic medical records and represent those collected 
as standard as part of routine care. They included haemoglobin, serum albumin, C-
reactive protein, Kt/V, potassium, serum phosphate, ferritin, PTH, blood pressure, 
dialysis vintage and past transplant history.  
Co-morbidity burden at baseline was quantified from medical notes using the 
method described by Davies, Philips, Niash and Russell (2002) by a consultant 
nephrologist. One point for each of the following conditions was assigned to: 
ischemic heart disease (defined as prior MI, angina, or ischemic changes on ECG), 
left ventricular dysfunction (defined as clinical evidence of pulmonary oedema not 
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due to errors in fluid balance, or history of congestive heart failure), peripheral 
vascular disease (includes distal aortic, lower extremity, and cerebrovascular 
disease), malignancy, diabetes, collagen vascular disease, and other significant 
pathology. Patients were grouped into co-morbidity categories according to the 
number of co-morbidities present; ‘none’ (score of 0), ‘medium’ (score of 1-2) and 
‘high’ (score of 3 or more). 
2.4 Procedure  
Patients who met the inclusion criteria were identified by a member of the clinical 
team responsible for their care at each of the dialysis sites. A member of the clinical 
team initially approached the patients to ask their permission to be contacted by the 
research team. Those that gave permission were approached by a researcher, who 
informed them verbally that a scientific study was on going, and that its purpose was 
to “learn more about how individuals deal with dialysis treatment” and were provided 
with the Patient Information Sheet (see Appendix C). This specified that, if they 
were to consent, they would be asked to complete some questionnaires and then 
may be randomised into one of two writing conditions that would involve writing 
about aspects of their renal problem and dialysis treatment on three consecutive 
clinic days. Once patients signed the consent form (see Appendix D), which 
included no mention of the expected benefits from the writing sessions, they were 
administered the baseline screening questionnaires. Those who met the screening 
cut-off for distress were randomly assigned to either the EW or control condition. 
Patients were randomised using a computerised stratified block randomisation 
system with fixed block sizes, run by the KCTU randomisation service. The 
stratification factor used was gender. Participants were blind to condition 
assignment and therefore not told which condition they had been randomized to. 
Once randomization was performed, no change to treatment allocation occurred. In 
order to monitor potential distress as a result of writing, the chief investigator 
remained un-blinded to condition assignment. 
Following randomisation, each eligible participant was approached on their next 
dialysis day, and asked again whether they would be happy to complete the writing 
exercise. They were then presented with standardised instructions, according to 
their group condition, and left alone to complete the writing task (whilst dialysis 
treatment was taking place). Patients were provided with a pen and paper to write 
on. The writing sessions were stopped and writing sheets were collected after 
approximately 20 minutes. This procedure was repeated during the patient’s next 
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two dialysis sessions. Once all three writing sessions were completed, the PHQ-2 
questionnaire was re-administered at 1 week follow-up, to check for significant 
depressive symptoms. All psychosocial outcome questionnaires were then repeated 
after 3 months. 
Recent studies showing effectiveness of this intervention with cancer patients have 
instructed participants to write about their illness experiences rather than any 
previous trauma (e.g., Corter & Petrie, 2011). This study followed a similar method 
which meant that the two sets of instructions emulated those typically used in 
studies of EW, but modified so that they were disease-specific. The EW group were 
asked to write about their thoughts and feelings connected with dialysis treatment. 
The control group were asked to write about unemotional neutral topics, related to 
the patient’s day-to-day management of the disease, as suggested by Pennebaker 
(1989). The instructions are outlined below. 
EW condition 
“What we would like you to write about for these three sessions are your thoughts 
and feelings regarding your experience of undergoing dialysis treatment. We realise 
that individuals undergoing this treatment experience a full range of emotions and 
we want you to focus on any of them or all of them. You might think about all the 
various feelings and changes that you experienced before starting the dialysis 
treatment, after it had started and at present. Whatever you choose to write, it is 
important that you really focus on feelings, thoughts, or changes that you have not 
discussed in great detail with others. You might also relate your thoughts and 
feelings about your experiences of dialysis treatment to other parts of your life – 
your childhood, people you love, who you are or who you want to be. Again, the 
most important part of your writing is that you focus on your deepest emotions and 
thoughts. The only rule we have is that you write continuously for the entire time. If 
you run out of things to say, just repeat what you have already written. Don’t worry 
about grammar, spelling or sentence structure. Don’t worry about erasing or 
crossing things out. Just write.” 
Neutral condition 
“What we would like you to write about for these three sessions are detailed 
accounts of the facts about different features of your life in relation to your dialysis 
treatment. We are interested to know the specifics about how lifestyle differs among 
individuals undergoing dialysis treatment. Therefore, it is important you try to 
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provide a detailed account of the facts concerning the different topics outlined 
below. We realize that individuals with undergoing dialysis treatment experience 
many emotions, but in your writing we want you to focus only on the facts, not on 
your emotions. 
In the first session, we would like you to focus the subject of your writing on diet. 
You might write about what advice you were given about diet when you started 
dialysis treatment and then a detailed description of what you have eaten over the 
last week. 
In the second session, we would like you to focus the subject of your writing on 
exercise and movement. You might write about what advice you were given about 
exercise when you started dialysis treatment and then a detailed description of your 
exercise and movement in a typical week. 
In the third and final session, we would like you to focus the subject of your writing 
on medication. You might write about what medication you took leading up until the 
start of dialysis treatment, and how this has changed over time, including the names 
and dosages (if you know them).” 
2.4.1 Experimental manipulation check 
An independent rater not involved in the study and unaware of condition 
membership judged whether each participant’s writing session pertained to the EW 
or control condition instructions.  This was cross-checked with actual treatment 
allocation.   
All participants were randomly assigned to the experimental conditions following 
completion of baseline measures.  
2.5 Ethical Considerations 
This study was approved by the NRES Committee London – Camden and Islington 
(study reference 12/LO/1858), and research governance was received by Guy‘s and 
St Thomas‘ Research and Development Office (registration number RJ113/N009). 
The approval letters for both can be seen in Appendices A and B. 
The main ethical considerations were related to the possibility of heightened 
distress as a result of taking part in the writing task and being assigned to the EW 
condition. This task asked participants to reflect on deep thoughts and feelings, 
many of which may have been difficult or painful, or which they had not expressed 
to others. Some authors have speculated there is a risk of short-term increase in 
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distress occurring (e.g., Hockemeyer et al, 1999). In order to address this, 
participants were followed up after one week and asked to complete the PHQ-2 
questionnaire. At this point, they were asked about their initial reactions. If a 
significant rise in emotional distress was detected, they were identified to the 
consultant nephrologist for further assessment or onward referral to the Renal 
Psychology Service (who were aware of the research taking place).  
Any patient identifiable data was stored securely in accordance with clinical 
governance requirements. The participants’ writing scripts and experimental data 
from questionnaires were stored anonymously using a patient identifier number. 
Letters were sent to patients’ GPs to inform them of their participation in the study 
(see Appendix E). 
2.5.1 Piloting 
Another ethical consideration was the possibility of increased discomfort as a result 
of the physical burden of writing whilst undergoing dialysis. Therefore, following the 
review by the Renal Project Board Steering Committee, the procedure was piloted 
for feasibility with permission from a consultant nephrologist, and in accordance with 
the Guys & St Thomas' Trust policies and procedures. This involved approaching a 
small number of patients and asking them about the practicality of writing whilst 
undergoing dialysis and whether they had any concerns. A few patients were also 
asked to write about a topic of their choice for ten minutes. Most patients were 
happy to comply and able to complete the writing without discomfort. The main 
problems identified were feeling too tired to write or the fistula being located in their 
writing arm, making it difficult to write. As a result, instructions for completing the 
writing task were altered so participants were offered to take a break half way 
through the writing, if required. In addition, patients were given the option of writing 
during the second half hour of dialysis, giving time for them to settle and so as not to 
interfere with the usual medical procedure. No further amendments to the procedure 
were needed. The questionnaires did not require piloting since they were 
considered sufficiently validated for use with this population. 
2.6 Statistical Analyses 
SPSS Statistical Package (version 21.0) was used for the analysis of the study 
results. Descriptive statistics were used to illustrate the demographic, clinical and 
psychological characteristics of the sample. For the initial cross-sectional phase, 
correlational analyses were used to investigate which of the variables were 
associated with the main outcome measure of distress. Those variables which 
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correlated with distress were entered into a hierarchical regression in order to 
explore how strongly they were able to predict distress, whilst taking covariance into 
account. An additional regressional analysis was completed to investigate the 
relationship between individual illness perceptions and distress in more detail.  
For the second trial phase, recruitment and retention rates were established through 
the procedure outlined previously (see section 2.1.2). Fidelity of the randomisation 
conditions was established using an independent rater who judged group condition 
from the writing scripts. Potential clinical efficacy was determined by analysing 
differences between group means at the 3-month follow-up time point and a 
regression was carried out to explore whether the group differences were able to 
predict changes to distress over time. Since this was a feasibility study, the sample 
size meant that the statistical tests lacked sufficient power to show statistically 
significant differences. Therefore, effect sizes were used to provide an indication of 
difference between groups. Cohen (1988, 1992) has made some suggestions about 
what constitutes a large (0.8), medium (0.5) and small (0.2) effect, and these are 
generally accepted conventions for specifying the magnitude of effect size within 
research.  
. 
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3.0 RESULTS 
3.1 Sample Characteristics  
The sample (n=97) comprised of 51 males and 46 females with a mean average 
age of 62 years (median=68, SD=16, range 26 – 87). At baseline, the majority of 
participants were married or living with a partner (n=50, 51.5%) with the second 
biggest proportion identified themselves as ‘single’ (17.5%). In addition, the majority 
of participants (n=62, 57.7%) were living with at least one other person (26.8% with 
a partner; 20.6% with a partner and children; 10.3% with other relatives) and 32% 
were living alone. In terms of working status, a relatively small number (n=13, 
13.4%) of participants were in employment (6.2% full-time and 7.2% part-time), 
approximately one third (34%) were unable to work due to poor health, 46.4% were 
retired and the remainder were either unemployed (3.1%) or full-time home-makers 
(1%).  
The sample characteristics can be seen in Table 1. 
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Table 1. Frequency data for demographic characteristics of the sample 
 N (%) 
Gender  
Males 
Females 
 
51 
46 
 
52.6 
47.4 
Relationship status 
Married 
Living with partner 
Widowed  
Divorced 
Separated 
Single Parent 
Never Married 
Single  
Other 
 
46 
4 
8 
10 
6 
2 
2 
17 
2 
 
47.4 
4.1 
8.2 
10.3 
6.2 
2.1 
2.1 
17.5 
2.1 
Living arrangements 
Live alone 
Live with partner 
Live with partner and children 
Single parent with children 
Live with other relatives 
                                        
                             31 
26 
20 
10 
10 
                                       
                                     32 
26.8 
20.6 
10.3 
10.3 
Employment status 
Working full-time 
Working part-time 
Retired 
Full-time home-maker 
Unemployed 
Not working due to ill health 
Other 
 
6 
7 
45 
1 
3 
33 
2 
 
6.2 
7.2 
46.4 
1 
3.1 
34 
2.1 
 
3.2 Disease-Related Information 
The average dialysis vintage for this sample was 5.8 years (SD=6.6, range 0-37). In 
terms of transplantation, 20.6% (n=20) had undergone at least one previous kidney 
transplant and 79.4% had not. In addition, 32% were on the transplant list, 61.9% 
were not on the list and 6.2% were unaware of their listing status.  
With regards to co-morbidity, 66% of the sample had a ‘medium’ co-morbidity 
burden (one or two co-morbid conditions), 18.6% had a ‘high’ co-morbidity burden 
(three or more co-morbid conditions) and 15.5% had no existing co-morbid 
conditions. 
Descriptive statistics for clinical outcomes are shown in Table 2. 
 
 PART A: MAIN PROJECT  JENNIFER HUNT 
 
 
54 
 
Table 2. Descriptive statistics for clinical outcomes 
Clinical outcome Mean (SD) 95% CI 
Hb g/dl 10.5 (1.2) 10.2-10.7 
Albumin g/dl 40.0 (5.6) 38.8-41.0 
Kt/V 1.8 (0.5) 1.7-1.9 
Phosphate mg/dl 1.5 (0.6) 1.4-1.6 
SBP mmHg 137.7 (22.0) 133.3-142.2 
DBP mmHg 74.3 (14.3) 11.7-16.8 
Potassium mmol/l 8.8 (23.3) 4.6-14.2 
PTH pg/ml 404.7 (360.7) 332.4-479.2 
Ferritin ng/ml 787.1 (575.4) 676.8-902.0 
SD, standard deviation; CI, confidence interval; Hb, haemoglobin; Kt/V, measure of 
treatment adequacy; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
PTH, parathyroid hormone 
C-reactive protein (CRP) is recorded differently in medical records to other clinical 
outcomes. It is recorded as an exact value where the level is greater than 5 
(suggesting inflammation) and recorded as ‘<5’ (suggesting non-inflammation) when 
the level is less than five. For data analysis, CRP scores were therefore assigned 
values to denote high or ‘inflamed’ (CRP>5), and low or ‘non-inflamed’ (CRP<5) 
levels. According to these re-coded values, approximately half the sample was 
inflamed (51.5%) and half was non-inflamed (48.5%).  
3.3 Self-reported Symptoms, Illness perceptions and 
Psychological Outcomes 
3.3.1 Pain and fatigue 
The mean ratings of pain intensity were 3.6 (SD=3.3) at rest and 3.9 (SD=3.4) when 
moving. The mean rating of pain unpleasantness was 4.2 (SD=3.5).   
The mean fatigue score was 4.5 (SD=3.4). In terms of ‘caseness’ (denoted by a 
score of 4 or above), approximately two thirds of the sample was clinically fatigued 
(61.9%). 
3.3.2 Illness perceptions 
The total and subscale mean scores for the BIPQ are detailed in Table 3. The 
highest mean scores (and therefore the most negative illness perception) was for 
item 2, which measured timeline (mean=7.8, SD=3.0).The lowest mean scores (and 
therefore most positive illness perceptions) were for item 4 which measured 
treatment control (mean=1.8, SD=2.5) and item 6 which measured treatment 
coherence (mean=2.4, SD=3.0). The average total illness perception score was 
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35.4 (SD=10.5). The total illness perception score was also calculated excluding 
‘concern’ and ‘emotions’ items, since these are measuring emotional 
representations, which are likely to correlate with the other psychological variables 
(such as distress and depression). This new scale could therefore be considered a 
measure of illness cognitions only, and had an average score of 23.9 (SD=7.1). This 
new score indicating illness cognitions was used in subsequent analysis. 
Table 3. Brief Illness Perception Questionnaire (BIPQ) scores  
BIPQ Item Mean (SD) 95% Confidence Interval 
IP1, Consequences  
IP2, Timeline  
IP3, Personal control 
IP4, Treatment control 
IP5, Concern 
IP6, Coherence 
5.9 (3.4) 
7.8 (3.0) 
5.8 (3.1) 
1.8 (2.5) 
6.4 (3.5) 
2.4 (3.0) 
5.4 - 6.7 
7.1 – 8.3 
5.3 – 6.5 
1.4 – 2.4 
5.8 – 7.1 
1.8 – 3.0 
IP7, Emotions 5.0 (3.7) 4.4 – 5.8 
Total Score 34.9 (10.8) 33.4 – 37.5 
Total Score (excluding 
Concern and Emotions) 
23.9 (7.1) 22.4 – 25.2 
 
3.3.3 Depression 
The median total PHQ-2 score was 1 (interquartile range=2). In terms of ‘caseness’ 
(denoted by a score of 3 or above), 23.7% of the sample was clinically depressed. 
3.3.4 Psychological distress 
For the purposes of analysis, the Likert-types scores of the GHQ-12 were used 
since this provides a wider variation of scores and therefore added depth to the 
analysis. The average total GHQ-12 score was 13.3 (SD=6.3) out of a possible 31. 
In terms of ‘caseness’ (denoted by a score of 3 or above when using binary 
scoring), 44.3% of the sample was clinically distressed. 
3.4 Correlates of Distress 
3.4.1 Univariate analysis 
In order to examine the association between clinical, demographic and 
psychological variables with the main outcome variable of psychological distress, 
correlations were generated between these variables and the GHQ-12 scores. 
These correlations are reported in Table 4.  
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Table 4. Pearson’s r correlations between demographic, clinical and psychological outcome measures 
  1 2 3 4 5 6 7 8 
1 GHQ-12 Score 1        
2 Age -.235* 1       
3 Years on dialysis -.027 -.148 1      
4 BIPQ Score .382** -.174 -.016 1     
5 CFQ Score .616** -.134 -.084 .360** 1    
6 VAS-Pain Score (at rest) .376** -.193 .138 .316** .400** 1   
7 VAS-Pain Score (rating) .379** -.095 .110 .239* .444** .726** 1  
8 PHQ-2 Score .712** -.391** -.041 .363** .513** .565** .485** 1 
*p<0.05, **p<0.01; GHQ-12, General Health Questionnaire; BIPQ, Brief Illness Perceptions Questionnaire; CFQ, Chalders Fatigue Scale; VAS-Pain, Visual Analogue Scale-Pain; PHQ-2, Patient 
Health Questionnaire.  
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It can be seen that significant correlations exist between the GHQ-12 scores and 
illness perceptions, fatigue, pain at rest, unpleasantness of pain and depression (as 
measured by the BIPQ, CFQ, VAS-Pain and PHQ-2 scores). GHQ-12 scores also 
significantly correlated with age, although they did not correlate with any of the 
clinical variables collected. Scatter plots showing correlations between GHQ-12 
scores and BIPQ, CFQ, VAS-Pain and PHQ-2 scores are shown in Figures 3, 4 and 
5. 
Figure 3. Scatter plot showing correlation between BIPQ and GHQ-12 scores 
The above scatter plot shows the positive correlation (r=.382, p<0.01) between 
illness perceptions (BIPQ) and distress (GHQ-12) scores. If we were to interpret 
Pearson’s correlation coefficient as an effect size, according to Cohen (1988, 1992), 
r=0.38 represents a medium effect size, accounting for roughly 9% of the total 
variance in the data. 
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Figure 4. Scatter plot showing correlation between CFQ and GHQ-12 scores 
 
The above scatter plot shows the positive correlation (r=.616, p<0.01) between 
fatigue (CFQ scores) and distress (GHQ-12 scores).  Again, by interpreting the 
correlation coefficient as an effect size, r=0.62 would represent a large effect size, 
accounting for over 25% of the variance in the data. It is evident that a number of 
patients scored 0 on the CFQ measure. 
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Figure 5. Scatter plots showing correlation between VAS-Pain (at rest and 
unpleasantness) and GHQ-12 scores 
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The above scatter plots show the positive correlations between ratings of pain at 
rest (r=.376, p<0.01) and ratings of pain unpleasantness (r=.379, p<0.01) (VAS-
Pain scores) with distress (GHQ-12 scores). Neither of these ratings of pain 
correlated as strongly with distress as illness perceptions or fatigue, but both 
correlation coefficients would be considered medium effect sizes. The graphs also 
show a number of patients scored 0 on the VAS-Pain measure.  
In order to test whether distress differed across any other demographic variables, 
appropriate statistical tests were carried out to compare groups. An independent 
samples t-test was used for the two-category variable (gender) and a one-way 
ANOVA was used for variables with more than two categories (relationship status, 
living arrangements). Cohen’s d or eta squared (η²) were also calculated for each 
result. The results of these analyses are reported in Table 5. 
Table 5. GHQ-12 scores across demographic variables 
Demographic 
Variable 
 
Cases (n) GHQ-12 mean 
score (SD)    
Independent 
samples t-test or 
one way ANOVA 
result 
Effect 
Size 
(Cohen’s 
d or η²) 
Gender 
Male 
Female 
 
45 
51 
 
14.09 (6.58) 
12.57 (6.02) 
 
t(94)=1.18, p=.240 
 
d=0.24 
Relationship 
status 
Married 
Not married 
 
 
45 
51 
 
 
13.31 (6.78) 
13.24 (5.79) 
 
 
t(94)=0.05, p=.957 
 
 
 
d=0.01 
 
Living 
arrangements 
Live alone 
Not living alone 
 
 
31 
65 
 
 
13.16 (5.50) 
13.34 (6.69) 
 
 
t(94)=0.13, p=.898 
 
 
d=0.02 
 
As can be seen in Table 5, distress scores did not vary significantly as a function of 
gender, relationship status, living arrangements, although there was a small effect 
size detected for gender (d=0.24). 
Similar tests were carried out to compare the distress levels across groups with 
different clinical variables. Independent samples t-tests were carried out to establish 
if there was a significant difference between the GHQ-12 scores for inflamed and 
non-inflamed groups (according to CRP scores) and between those with and 
without transplant history. A one-way ANOVA was used to establish whether 
distress levels differed according to co-morbidity. 
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Table 6. GHQ-12 scores across clinical variables 
Clinical Variable Cases 
(n) 
GHQ-12 
mean score 
(SD) 
Independent 
samples t-test or 
one way ANOVA 
result 
Effect size 
(Cohen’s d 
or η²) 
CRP 
Low (non-
inflamed) 
High (inflamed) 
 
47 
49 
 
12.30 (6.28) 
14.22 (6.24) 
 
t(94)=-1.51, p=.135 
 
d=0.31 
Transplant Hx  
Yes 
No 
 
20 
76 
 
12.75 (6.10) 
13.42 (6.38) 
 
t(94)=0.42, p=.674 
 
d=0.11 
Co-morbidity 
None 
Medium 
High 
 
15 
64 
17 
 
11.33 (4.98) 
13.59 (6.29) 
13.82 (7.36) 
 
F(2,93)=0.86, 
p=.428 
 
η²=0.13 
 
As can be seen in Table 6, distress scores did not vary significantly as a function 
inflammation, transplant history or co-morbidity, although there was a small to 
medium effect size detected for levels of inflammation (d=0.31). 
3.4.2 Multivariate analysis 
A hierarchical linear regression was used to assess the ability of the symptom 
variables (fatigue and pain) and illness perceptions to predict levels of distress, after 
controlling for the influence of gender, age and co-morbidity.  
Given the exploratory nature of the hypothesis, before the regression was carried 
out, the data was examined in order to satisfy normality assumptions. This meant 
creating histograms for age, GHQ-12, BIPQ, CFQ and VAS-Pain scores. In addition, 
the data was checked for multi-collinearity by examining correlations between the 
predictor variables. As is shown in Table 4, there is a strong correlation between 
VAS-Pain (at rest) scores and VAS-Pain (unpleasantness) scores (r=.726). This is 
to be expected since both scales measure a construct linked to pain. In addition, 
there is a strong correlation between PHQ-2 and GHQ-12 scores (r=.712). Again, 
this is unsurprising, since both scales measure depressive symptoms. However, no 
strong correlations (r>0.7) exist between illness perceptions, fatigue and pain at 
rest, suggesting no evidence of multi-collinearity which meant these factors were 
entered into the model. A substituted mean was used in statistical computation (for 
missing value, participant 1). 
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The results can be seen in Table 7. Gender, age and co-morbidity were entered at 
block 1, explaining 10.5% of the variation in distress levels, which was found to be 
significant (F change (4,89)=2.62, p=.040). After entry of illness perceptions, fatigue 
and pain at block 2, the total variance explained by the model as a whole was 
45.6%, indicating that the symptoms and illness perception variables explain an 
extra 35.1% of the variance, which was found to be significant (F change (3, 
86)=18.48, p=.000). In the final model, three variables were statistically significant, 
with age (standardised β=-.22, p=.012), illness perceptions (standardised β=.24, 
p=.013) and fatigue (standardised β=.44, p=.000) shown to be independent 
predictors of distress. The standardised beta (β) values show that as age increases 
by one standard deviation, GHQ-12 scores decrease by .22 standard deviations; as 
BIPQ scores increase by one standard deviation, GHQ-12 scores increase by .24 
standard deviations and as CFQ scores increase by one standard deviation, GHQ-
12 scores increase by .44 standard deviations.  
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Table 7. Linear model of predictors of distress, with 95% percentile confidence 
intervals reported in parethenses 
B = Beta; β = Standardised Beta 
Step1: R²=.105, ∆ R²=.065, F(4,89)=2.62, p=.040 
Step2: R²=.456, ∆ R²=.412, F(3, 86)=18.48, p=.000 
Since total BIPQ scores were shown to be a significant predictor of levels of 
distress, additional linear regressions were carried out to determine the predictive 
value of each individual illness perception. Each regression controlled for age, sex 
and co-morbidity. 
The results for these additional regressions can be seen in Table 8. Only one of the 
individual illness perceptions was shown to significantly predict the variance in 
distress levels, which was item 1 measuring ‘consequences’ (b=0.95, β=.52, 
 b SE B β p 
Step 1     
Constant 19.10 
(12.92, 25.29) 
3.11  p=.000 
Gender -1.64 
(-4.19, 0.91) 
1.28 -.13 p=.204 
Age -0.11 
(-0.19, -0.03) 
0.04 -.27 p =.009 
Co-morbidity1 
(medium vs other) 
2.19 
(-1.35, 5.72) 
1.78 .17 p =.222 
Co-morbidity2 
(high vs other) 
3.05 
(-1.28, 7.37) 
2.17 .19 p=.165 
Step 2     
Constant 9.11 
(3.39, 14.83) 
2.88  p=.002 
Sex -0.60 
(-2.67, 1.48) 
1.04 -.05 p=.569 
Age -0.09 
(-0.16, -0.02) 
0.03 -.22 p= .012 
Comorbidity1 1.08 
(-1.75, 3.92) 
1.42 .08 p=.450 
Comorbidity2 1.08 
(-2.43, 4.60) 
1.77 .07 p=.543 
BIPQ Score 0.21 
(0.04, 0.37) 
0.08 .24 p=.013 
CFQ Score 0.83 
(0.48, 1.18) 
0.18 .44 p=.000 
VAS-Pain Score 0.15 
(-0.19, 0.49) 
0.17 .08 p=.379 
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p=.000), which accounted for 32.5% of the variance in distress scores. The β value 
indicates that, as the measure of perceived consequences increases (which implies 
a more negative perception) by one standard deviation, GHQ-12 scores increase by 
.52 standard deviations. The total variance explained by this model was 32.5% 
which was found to be significant (F(5,90)=8.67, p=.000). 
Table 8. Independent linear models of individual illness perceptions as predictors of 
distress  
 b SE B β p 
IP1 
(consequences) 
0.95 0.17 .52 p=.000 
 
R²=.325, ∆R²=.288, F(5,90)=8.67, p=.000 
IP2 (timeline) 0.39 0.22 .19 p=.076 
 
R²=.136, ∆R²=.087, F(5,89)=2.79, p=.022 
IP3 (control) 0.41 0.22 .20 p=.070 
 
R²=.127, ∆R²=.078, F(5,89)=2.60, p=.031 
IP4 (tx control) 0.48 0.26 .18 p=.084 
 
R²=.123, ∆R²=.075, F(5,90)=2.53, p=.034 
IP6 (coherence) 0.18 0.23 .09 p=.432 
 R²=.100, ∆R²=.050, F(5,90)=1.99, p=.087 
B = Beta; β = Standardised Beta 
3.5 Recruitment and Retention  
3.5.1 Rates of participation 
In order to answer the feasibility question regarding recruitment and retention rates, 
a recruitment flow-chart was developed (see Figure 6). 
  
 PART A: MAIN PROJECT  JENNIFER HUNT 
 
 
65 
 
 
Figure 6. Recruitment flowchart 
The total number of potential participants at the time of recruitment (or consort 
figure) was 311. This consisted of patients dialysing across four different units run 
by Guys and St Thomas’ NHS Trust. The groups of patients at each unit is split by 
dialysis schedule; approximately half dialyse on a Monday, Wednesday and Friday 
and half dialyse on a Tuesday, Thursday and Saturday. These groups are further 
split into three shifts; those that dialyse in the morning, in the afternoon, and in the 
evening (known as the ‘twilight’ shift). All patient groups at these four units were 
screened for eligibility, apart from those on twilight shifts, and those dialysing on a 
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Tuesday, Thursday and Saturday afternoon at Tunbridge Wells unit (these groups 
were not screened due to time limitations). 
Of the total number of potential participants, approximately 277 (89%) met eligibility 
criteria for screening and of these, 97 (35%) consented to the distress screening 
phase of the study and thus completed the baseline questionnaires. A total of 43 
(44%) of these patients met the cut-off for distress on the GHQ-12 and were 
therefore deemed eligible for the trial phase. Of these, 30 (70%) agreed to complete 
the writing task. Reasons for not wanting to complete the writing task included; it 
being too difficult to write whilst dialysing, lack of confidence in writing ability and not 
being well enough to write. Out of the 30 who agreed to write, 16 were randomised 
into the EW condition and 14 into the control condition. Within the EW condition, 5 
patients discontinued the intervention (1 moved to a different ward, 2 declined 
without giving reason, 1 found writing too stressful whilst dialysing and 1 found the 
writing too upsetting). Within the control condition, 6 patients discontinued the 
intervention (3 declined without giving a reason, 2 found it too difficult, and 1 went 
into hospital). In the EW condition, 1 was lost to follow-up (they were recruited too 
late in order to collect follow-up data prior to analysis) and in the control condition, 2 
were lost to follow-up (one died and one went into hospital). Therefore, the attrition 
rate for the trial phase of the study was 19/43 or 44.2%.  
3.5.2 Differences between participant groups 
Table 9 below displays differences in demographic and clinical data between those 
that completed the baseline screening phase, those who were eligible for the EW 
trial phase, those who consented to the EW trial phase, those who completed all 
three writing sessions and those who failed to complete all three writing sessions. 
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Table 9. Demographic and clinical data for screening and trial phase participants 
Variable Sample 
consenting to 
screening 
phase 
Participants 
eligible for 
EW trial 
Participants 
consenting 
to EW trial 
Completed 
writing? 
 Y               N 
Gender 
(male/female) 
 
51/46 20/23 13/17 8/11 4/6 
Age (mean 
years)  
 
62.4 59.8 60.3 61.3 57.3 
Dialysis 
vintage (mean) 
 
5.8 6.09 6.33 4.1 9.0 
Mean GHQ-12 
score  
13.3 18.55 19.14 18.5 20.5 
 
As the table shows, there does not appear to be any important differences in gender 
or age between the different groups of participants. GHQ-12 scores are higher for 
participants eligible for the EW trial by design (only patients who scored as clinically 
distressed were eligible). The mean dialysis vintage does not appear to differ for the 
first three groups but is quite different when comparing those who successfully and 
unsuccessfully completed the writing task (those who were successful appear to 
have spent a lower number of years on dialysis than those who were unsuccessful). 
The result of a t-test comparing these two groups was not significant (t(27)=2.01, 
p=.054), although a large effect size was calculated (d=0.68). 
3.6 Acceptability and Safety 
Acceptability was described based on treatment fidelity and patient evaluation data.  
To determine fidelity, an experimental manipulation check was carried out. This 
involved requesting an independent rater not involved in the study and blinded to 
condition membership to judge whether each participant was randomized to either 
the EW or neutral writing condition, by reading through each writing script (i.e., were 
they writing about thoughts and feelings or about facts?). The answers were then 
cross-checked with actual treatment allocation. Table 10 shows the results.  
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Table 10. Table displaying results of fidelity check 
 
Patient 
identifier 
Actual treatment 
allocation 
Independent rater: EW or 
Neutral? 
M03 EW EW 
M05 EW EW 
T11 Neutral Neutral 
T12 EW EW 
T13 Neutral EW 
T16 EW EW 
T17 Neutral Neutral 
J09 EW EW 
J14 Neutral Neutral 
J17 Neutral Neutral 
J20 Neutral Neutral 
J23 EW EW 
J32 EW EW 
J46 Neutral Neutral 
J47 Neutral Neutral 
J50 EW EW 
J58 EW EW 
J72 EW EW 
J73 EW EW 
 
According to the table, the independent rater correctly judged 18/19 conditions 
correctly. This meant a fidelity accuracy rate of 95%. 
Those who successfully completed the writing task mostly gave positive feedback, 
reporting that they found it beneficial. Qualitative data was gained informally by 
simply asking participants how they had found the EW task following their final 
session. Some of the positive qualitative responses included: 
“Yes, I liked it; it was helpful to get my thoughts on the page”. 
“It was something to do to fill the time”. 
“I was surprised by how much anger it brought out, I can see why it is helpful”. 
“Yes, I found it somewhat helpful, I enjoy writing anyway”. 
Some of the less positive comments included: 
“I did not find it particularly helpful since my problems are not connected to dialysis 
but to other things happening in my life”. 
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“I found it difficult to do on one of the days because I had a fistula put in my writing 
arm”. 
“I am not sure what I have written about is the ‘right’ thing”. 
One participant who was randomised into the control condition commented “I was 
surprised that the instructions did not ask me to write about feelings since it is the 
feelings evoked by medications that are important”. In addition, another participant 
commented that it would be easier to complete the writing at home and said “I get 
too distracted when I’m in the ward. At home I can think more easily and 
concentrate”. Finally, as previously mentioned, a small number of participants who 
initially consented to the EW trial, failed to complete the writing task. Most of the 
reasons for this related to the writing being too physically demanding whilst on 
dialysis (they were either too unwell or felt too tired).  
Safety of the procedure was determined based on whether there were any reports 
of increased distress or other problems, as a result of the intervention. In order to 
examine whether there was a short-term increase in distress, an ANCOVA was 
completed to compare the depression (PHQ-2) scores for the two groups at one-
week post-intervention. According to the ANCOVA result, there was no significant 
effect of condition on depression scores at one week follow-up, when controlling for 
baseline depression scores, F(1,16)=1.90, p=.187, partial η²=.11. The mean 
depression score for the EW group was 2.45 (SD=2.11) and was objectively higher 
than the score for the control group, which was 1.12 (SD=1.89), at one week, 
although scores for both groups had decreased since baseline (see Table 9). One 
lady reported that she found the writing too upsetting and therefore no longer 
wanted to continue. Her heightened distress was highlighted to the medical care 
team. 
3.7 Preliminary Outcomes 
3.7.1 Differences at follow-up 
Preliminary outcome data were derived from the GHQ-12, as well as the measures 
of self-reported symptoms, illness perceptions and clinical health markers, to 
explore the potential clinical efficacy of the EW procedure. Ideally, a multi-level 
model would have been computed to quantify significant changes at follow-up, thus 
determining efficacy of the intervention. This would have consisted of evaluating the 
changes in effects between groups with respect to mean values at each 
assessment (baseline and 3 months) and within the same group over time with a 
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repeated-measurement analysis of variance, using a mixed-effect modeling 
procedure. However, the final sample size was too small to be able to power robust 
statistical analysis. Therefore, differences in mean scores between groups at 3 
months were measured using independent sample t-tests and effect sizes were 
calculated. Table 11 below displays the results 
Table 11. Differences between groups at 3-month follow-up (means, standard 
deviations, 95% confidence intervals, results of independent samples t-test and 
Cohen’s d effect size) 
Variable 
Mean (SD) 
[95% CI] 
3-month follow-up T-test result Effect size 
(Cohen’s d) EW Neutral 
Primary Variable 
GHQ-12 
score 
16.20(7.06) 
[12.33, 20.78] 
17.67 (5.82) 
[12.60, 
22.50] 
t(14)=-0.43, 
p=.676 
d=0.23 
Secondary Variables 
BIPQ score 
 
27.60 (5.52) 
[24.38, 31.17] 
31.00 (5.10) 
[27.00, 34.67] 
t(14)=-0.23, 
p=.241 
d=0.63 
VAS-Pain (at 
rest) score 
3.20 (2.97) 
[2.75, 7.00] 
4.67 (2.73) 
[1.80, 5.00] 
t(14)=-0.98, 
p=.342 
d=0.52 
CFQ score 
 
5.80 (3.68) 
[3.67, 8.08] 
4.33 (3.88) 
[1.40, 7.67] 
t(14)=0.76, 
p=.461 
d=0.39 
PHQ-2 score 3.40 (2.80) 
[1.80, 5.00] 
3.50 (2.60) 
[1.60, 5.50] 
t(14)=-0.72, 
p=.944 
d=0.04 
SBP mmHg 142.20 (29.82) 
[124.0, 160.27] 
159.67 (17.73) 
[148.17, 
177.60] 
t(14)=-1.29, p= 
.217 
d=0.71 
DBP mmHg 76.10 (16.29) 
[66.00, 85.44] 
77.67 (7.39) 
[71.33, 84.0] 
t(14)=-0.22, 
p=.829 
d=0.12 
SBP, Systolic blood pressure; DBP, diastolic blood pressure 
As the above table shows, none of the variables showed statistically significant 
differences between the group conditions at 3 month follow-up. However, the t-test 
results represent some important effect sizes. There was a small effect size for 
group differences in distress, with the EW group having lower scores at 3 months. 
There was also a small-medium effect size for differences in fatigue, and a medium 
effect size for pain, with both scores being lower in the EW group. There was a 
medium–large effect size for illness perceptions, with a lower (and therefore more 
positive) score in the EW group, and finally, a medium-large effect size for systolic 
blood pressure, with lower scores in the EW group. 
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Finally, two simple linear regressions were carried out to determine whether group 
condition could predict distress levels or illness perception scores at 3 months, 
when controlling for baseline GHQ-12 and BIPQ scores respectively. The results 
are shown in Table 12 and Table 13.  
Table 12. Linear model of group condition as predictor of distress at 3-months 
(controlling for baseline GHQ-12 scores), with 95% confidence intervals reported in 
parentheses 
 b SE B β p 
Constant 6.58 
(-5.39, 18.54) 
5.54  p=.256 
Group condition -1.74 
(-8.30, 4.82) 
3.04 -.14 p=.576 
Baseline GHQ-12 
score 
0.59 
(0.02, 1.16) 
0.27 .52 p=.045 
R²=.533, ∆R²=.284, F(2,13)=2.58, p=.114 
The total variance explained by the above model was 53% which, overall was not 
found to be significant F(2,13)=2.58, p=.114. Baseline GHQ-12 score was a better 
predictor of GHQ-12 score at follow-up than group condition, although it did not 
have a significant predictive value. For group condition, the beta values indicate that 
the GHQ-12 scores at 3 months were -.14 standard deviations lower in the EW 
group than the control group, but this difference was not statistically significant. 
Table 13. Linear model of group condition as predictor of illness perceptions at 3-
months (controlling for baseline BIPQ scores), with 95% confidence intervals 
reported in parentheses 
 b SE B β p 
Constant 18.54 
8.06, 29.04) 
4.85  p=.002 
Group condition -2.63 
 (-0.84, 6.62) 
2.30 -.24 p=.275 
Baseline BIPQ 
Score 
0.50 
 (0.12, 0.85) 
0.18 .58 p=.016 
R²=.656, ∆R²=.343, F(2,13)=4.92, p=.026 
The total variance explained by the above model was 65% which, overall was found 
to be significant F(2,13)=4.92, p=.026. Baseline BIPQ score was a significant 
predictor of illness perceptions at follow-up (b=0.50, β=.58, p=.016), with the results 
indicating that as the baseline BIPQ score increased by one standard deviation, 
BIPQ score at 3-months increased by .58 standard deviations. For group condition, 
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the beta values indicate that the BIPQ scores at 3 months were -.24 standard 
deviations lower (and therefore more positive) in the EW group than the control 
group, but this difference was not statistically significant. 
3.7.2 Randomisation 
Despite the small numbers, it was thought pragmatic to complete a randomisation 
check to determine whether the two group conditions were significantly different at 
baseline or not. Table 14 below shows the results from comparing the two 
randomisation conditions across important demographic (gender and age), clinical 
(dialysis vintage and co-morbidity), and psychological (depression and distress) 
variables, symptoms (fatigue and pain), and illness perceptions. Depending on the 
type of variable, the table displays differences in numbers, means and standard 
deviations, and the corresponding effect sizes.  
Table 14. Differences between randomisation conditions (EW and Neutral writing) 
at baseline 
Variable EW group 
(n=16) 
Neutral 
writing  
group (n=14) 
T-test or chi-
square result 
Effect size 
(OR or 
Cohen’s d) 
Gender (n) 
(male/female) 
9/7 8/6 χ²(1)=0.00, 
p=.626 
OR = 0.96 
Mean age (SD) 57.88 
(15.62) 
63.00 (14.6) t(28)=-0.92, 
p=.364 
d=0.34 
Mean Dialysis 
Vintage (SD) 
6.38 (8.13) 6.29 (5.99) t(28)=0.03, 
p=.973 
d=0.01 
Co-morbidity (n) 
(None/Medium/High) 
1/11/4 3/9/2 χ²(2)=1.74, 
p=.419 
N/A 
SBP 134.00 
(20.91) 
138.79 
(24.67) 
t(28)=-0.58, 
p=.570 
d=0.20 
DBP 75.81 
(11.40) 
75.64 (16.09) t(28)=0.03, 
p=.973 
d=0.00 
Mean GHQ-12 score 
(SD) 
19.69 (5.74) 18.46 (6.25) t(27)=0.55, 
p=.587 
d=0.20 
Mean BIPQ score 
(SD) 
41.87 (8.06) 38.93 (10.26) t(28)=0.25, 
p=.806 
d=0.31 
Mean CFQ score 
(SD) 
7.38 (2.25) 7.14 (2.88) t(28)=0.25, 
p=.806 
d=0.09 
Mean VAS-Pain (at 
rest) score (SD) 
5.38 (3.48) 4.14 (3.18) t(28)=1.07, 
p=.323 
d=0.37 
Mean PHQ-2 score 
(SD) 
3.00 (2.03) 2.14 (1.83) t(28)=1.21, 
p=.238 
d=0.44 
OR, Odds Ratio; SBP, Systolic blood pressure; DBP, diastolic blood pressure; N/A, 
not applicable. 
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As the table shows, the two group conditions did not significantly differ on gender, 
age, dialysis vintage, co-morbidity, blood pressure, illness perception score, fatigue, 
pain, depression or distress (all p>0.05, odds ratio=0.96). However, the Cohen’s d 
calculations indicate that there were small-medium sized effects for differences in 
age, distress, illness perceptions, pain at rest and depression.  
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4.0 DISCUSSION 
This study consisted of two phases in order to answer different research questions, 
with different corresponding designs. The first phase used a cross-sectional, 
questionnaire design with the aim of establishing which factors were associated with 
heightened distress. The second phase used a two-armed randomised-controlled 
trial design with one follow-up time point. This phase aimed to establish the 
practicality of using an EW intervention with dialysis patients, and whether it had 
any effect on any variables at follow-up, thereby establishing its potential clinical 
efficacy. No previous research has examined the correlates of distress using the 
GHQ-12 measure with dialysis patients. Furthermore, this is the first study to 
investigate using EW as an intervention with this particular health population. 
This section will discuss the findings of the study, firstly by referring to the 
characteristics of the sample, and then in relation to the research questions set out 
in the introduction. Attention will be drawn to the limitations of the study and 
recommendations for future research. 
4.1 Findings  
4.1.1 Sample characteristics  
The study sample was split equally by gender and encompassed a wide range of 
ages (26 to 87), with a median age of 68. The median age of prevalent patients in 
the UK on HD is currently 66 years (UK Renal Association, 2013). Therefore, in 
terms of demographics, the sample can be considered representative of the general 
dialysis population. A relatively small proportion of the sample was in employment 
(13.4%) and a third of the sample was unable to work due to their health. This fits 
with existing studies, which have highlighted the difficulties for dialysis patients to 
remain in work after beginning treatment (e.g., van Manen et al, 2001).  A relatively 
large proportion of the sample was retired (46.4%), which makes sense considering 
the average age demographic.  
The average length of time on dialysis for this sample was approximately 6 years 
and the majority also suffered from at least one other co-morbid condition. 
Considering the substantial length of time on dialysis and high level of co-morbidity, 
it is not surprising that a large number of patients were suffering from significant 
levels of fatigue (62%). This result is similar to other studies which have recognised 
that fatigue is one of the most frequent symptoms for dialysis patients (e.g., Jhamb, 
Weisbord, Steele & Unruh, 2008). However, the average recorded values for pain 
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were 3.2 and 3.9 out of a possible 10, which is not as high as other researchers 
have suggested (e.g., Gamondi et al, 2013). Overall, fatigue seemed the more 
common and more burdensome symptom for this sample.  
Consistent with previous studies in dialysis patients (e.g., Weisbord et al, 2005), the 
results showed that a sizable proportion of the sample was experiencing high levels 
of psychological distress, with 44.3% meeting the clinical cut-off on the GHQ-12. In 
addition, 24% of the sample met the clinical cut-off for depression on the PHQ-2, 
which fits with recent study findings that have estimated the prevalence of 
depression to be between 20 and 30% (Wilson et al, 2006; Martin et al, 2004). The 
discrepancy between the number of ‘depressed’ and the number of ‘distressed’ 
patients supports the idea that dialysis patients are experiencing a myriad of 
psychologically relevant problems, above and beyond diagnosable ‘depressive 
symptoms’ and therefore supports the use of a more generalised measure, such as 
the GHQ-12,  to capture this spectrum of problems. 
In terms of illness perceptions, the most negatively rated item was the one 
assessing timeline. In other words, within this sample, patients were likely to 
perceive that their kidney problem would continue for a long time. The fact that 
patients were likely to hold this belief is understandable, since kidney disease is a 
chronic condition, a fact that would have been made clear to them upon diagnosis. 
As outlined in the introduction, previous studies have shown timeline beliefs to be 
particularly important for dialysis patients as they can influence adherence to self-
care behaviour (e.g., Chilcot et al, 2010). Within this study sample, perceptions of 
treatment control were rated more positively than the other illness perceptions 
assessed. This may have been due to the fact that, in order for patients to cope with 
the reality of dialysis treatment and feel able to dedicate so much of their daily lives 
towards it, they have to believe that the treatment is ultimately helpful and capable 
of keeping them alive. Furthermore, patients completed the questionnaires whilst 
treatment was concurrently taking place, which may have increased its salience and 
prompted respondents to rate this item more positively. Whatever the reason, it is 
encouraging to know that this group of patients perceived dialysis treatment to be 
beneficial overall. Illness coherence was also rated relatively positively, meaning 
that these patients believed they had a good understanding of their kidney problem, 
which is also encouraging.  
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4.1.2 What factors are associated with distress? 
The first aim of the study sought to establish which factors are associated with 
psychological distress for dialysis patients. The results from the first phase showed 
that distress was significantly associated with the self-reported symptom variables 
(fatigue and pain), illness perceptions, depression and age, but with none of the 
clinical variables. These relationships will be discussed in further detail below. 
There was a significant relationship found between depression and distress, which 
is unsurprising. Most research on psychological factors in HD patients has focussed 
on measuring symptoms of depression and anxiety, rather than general distress. 
For the purposes of this study, distress was chosen as the main dependent variable 
because it was thought to be more clinically relevant for this patient group. The 
finding is enlightening since, unlike similar existing findings, it is not contaminated 
by the overlap between the somatic symptoms of depression and the physical 
symptoms of renal failure and side effects of treatment. It therefore highlights the 
usefulness of using a more general measure of distress, such as the GHQ-12, for 
this population.  
Another significant relationship was discovered between distress and fatigue. The 
higher a patients fatigue, the more distressed they were, which supports the 
hypothesis. As previously discussed, fatigue is a common complaint for patients 
undergoing dialysis treatment and could therefore explain its strong correlation with 
distress. In addition, the CFQ measure is sensitive to mental fatigue (Cella & 
Chalder, 2010) which has shown an association with emotional distress in other 
chronic illnesses, such as heart failure (Falk, Patel, Swedberg & Ekman, 2009). 
Previous research has indicated that there are a number of physiological, 
behavioural, treatment-related and individual characteristics which may correlate 
with fatigue and that it is related to impaired QOL (Jhamb et al, 2008). Some of the 
physiological causes are thought to include anemia, malnutirition, uremia, dialysis 
inadequacy, hyperparathyroidism, coexisting chronic illness, sleep disorders, 
depression and side effects of medication. Fatigue and depression are also closely 
interrelated, for example Liu (2006) found that fatigue scores were significantly 
higher for those HD patients who were depressed than for those who were not 
depressed, and that depression was a significant predictor of fatigue. Some 
researchers have postulated that depression may contribute to fatigue through 
inflammatory pathways (e.g., Lee et al, 2004).  
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Illness perceptions were also found to significantly correlate with distress. As 
predicted, the more negatively patients rated their illness perceptions, the more 
distressed they were. This has face validity since the concept of ‘illness perceptions’ 
relates to how patients think about their illness and refers to patients’ interpretation 
of how their illness affects them; how long their illness will last; how much control 
they have over it; how much they understand it and, how much it affects them 
emotionally. Research on illness perceptions in HD patients is gaining momentum 
and this result replicates those of previous studies which have demonstrated a 
relationship between illness perceptions and psychosocial outcomes. For example, 
Chilcot et al (2011b) found that the addition of illness perceptions explained a 
further 24.3% of variance in depression scores, over and above demographic and 
clinical factors. Timmers et al (2008) also found that illness perceptions significantly 
explained the variance in HRQOL scores in dialysis patients (as measured by the 
Short Form Health Survey) and a group of studies have shown that the perception 
of the burden of illness is associated with general well-being, happiness and 
depression (Kimmel, 2000).  
The second regression model revealed that the specific perception of illness 
consequences was a significant independent predictor of distress, implying patient 
distress is strongly related to how negatively patients view the effects of their illness. 
This adds to previous research on illness perceptions in dialysis patients which has 
found perceived consequences to be an important determinant of depression 
(Chilcot et al, 2011b; Griva et al, 2010). Interestingly, in this case, perceived control 
did not have a significant impact on distress scores. This is in contrast to existing 
literature which has shown control beliefs to be highly related to emotional distress 
(Christensen and Ehlers, 2002). Christensen, Turner, Smith, Holman and Gregory 
(1991) speculate that patients’ control appraisals depend on the degree to which 
they are congruent with contextual or situational factors. In this study, it may have 
been that patients held strong beliefs in the health-providers ability to control 
outcomes, which meant their perceptions of personal control were relatively neutral 
and therefore did not impact on their distress. 
In addition, pain (both rates of pain intensity and unpleasantness) was found to 
significantly correlate with distress. Again, the direction of the hypothesis was 
confirmed; the higher patients rated their pain and the more unpleasant their 
experience of it, the more distressed they were. This finding is in agreement with 
existing evidence suggesting a relationship between pain and depression (e.g., 
Binik et al, 1982) and QOL (Shayamsunder et al, 2005). One study found that 
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chronic pain experienced by ESRD patients was associated with a two-fold increase 
in depression (Davison & Jhangri, 2005).  
The results of the regressional analysis showed that symptom variables and illness 
perceptions explained an extra 35% of the variance in levels of distress, over and 
above gender, age and levels of co-morbidity. Demographics and co-morbidity only 
accounted for small proportion of the variance (10.5%). Of these variables, fatigue 
was the strongest predictor, followed by illness perceptions. This indicates that 
patients’ levels of fatigue and illness beliefs are crucial when assessing distress in 
this population. This finding supplements existing research which has established 
the importance of psychosocial factors in determining outcomes in dialysis patients. 
For example, Vasquez et al (2005) found that anxiety and depressive symptoms 
explained additional variance in HRQOL above that accounted for by demographic 
and clinical factors. In addition, a meta-analysis by Chan et al (2012) showed that 
the association between psychosocial factors and QOL had a medium effect size of 
0.38.  
Finally, distress significantly correlated with age in that, the older the patients were, 
the more likely they were to be distressed. This result was not hypothesised but is 
interesting to consider. The fact that distress and depression is higher in older 
dialysis patients has been reported in a number of studies (e.g., Theofilou, 2011; 
Iacovides et al, 2002). It is possible this is due to the decline in physical health with 
age, an effect which is exaggerated in patients with a chronic illness.  
The fact that distress was not associated with any of the clinical variables, 
underscores the relative importance of self-reported symptoms and illness beliefs in 
determining levels of distress. In addition, there were no significant differences 
across other demographic or lifestyle factors but small effect sizes were found for 
gender (men were slightly more distressed that women).The lack of effect found for 
gender contradicts studies which have shown female patients to have higher 
distress scores than males (e.g., Theofilou, 2011). Previous research has also 
shown that being married is related to better emotional health (Chiang et al, 2005), 
which was thus not supported by this study’s results. There were also no statistically 
significant differences when comparing distress levels between those with high and 
low levels of inflammation (as measured by CRP), although a small effect size was 
detected (those more inflamed were slightly more distressed). This is interesting 
considering the research linking depression with inflammation in renal patients (e.g., 
Bossola et al, 2010) and suggests that a significant difference may be revealed with 
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a larger sample. It is also possible that a stronger effect size would have resulted if 
depression was examined as the main dependent variable, or if a more sensitive 
measure of depression were used, such as the PHQ-9 or BDI. In this study sample, 
distress levels were unrelated to years on dialysis or co-morbidity. This is in contrast 
to previous results which have indicated that depression is associated with these 
factors (Hedayati et al, 2008). However, Chilcot et al (2011a) also found that there 
was no evidence of an association between depression and co-morbidity.  
4.1.3 Feasibility of EW: recruitment and retention rates, acceptability and 
safety 
Since recruiting and retaining participants is crucial for any research design 
intended to document evidence-based treatment, the second aim of the study 
sought to determine whether the EW intervention was feasible with regards to 
recruitment and retention rates. About a third (35%) of those patients screened as 
eligible agreed to take part in the first phase of the study. Of the 43 who met 
inclusion criteria, 30 agreed to take part in the second phase, which involved trialling 
the EW intervention. This meant the recruitment rate for the intervention phase was 
70%. However, only 16 participants (37%) completed all three writing sessions, as 
well as baseline and 3 month follow-up measures. Participation rates for previous 
trials of EW with other chronic health populations have varied. In a study aiming to 
implement EW in a cancer clinic, Morgan et al (2008) achieved a participation rate 
of 72%, but in Halpert, Rybin and Doros’ study (2010) of EW with IBS patients, only 
53% complete all four days of writing, and in Broderick et al’s study (2004), 49% 
completed the full protocol. Broderick et al argued that this percentage was an 
accurate reflection of the degree to which patients adhere to self-administered 
interventions in the community. Looking further afield, some studies investigating 
alternative low intensity interventions for chronic health populations have recorded 
retention rates of less than 50%. For example, the retention rate was 40% for a brief 
psychological intervention for families with children newly diagnosed with cancer 
(Kazak et al, 2005) and in a pilot study of online breast cancer support; only 49% of 
those expressing an interest in the study, provided informed consent to enrol. 
Therefore, in relation to other trials of similar interventions, our participation rate 
seems comparatively high, whereas the retention rate is comparatively low. This 
suggests that, for those patients who are dialysing and who are clinically distressed, 
EW presents an interesting and viable method of self-guided support. However, the 
retention rate within this study was relatively low due to the percentage of 
participants who were unsuccessful in completing all three writing sessions since 
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they found it overly stressful or upsetting. Overall, this indicates that, although 
dialysis patients may endorse the idea of EW and can feasibly write whilst dialysing, 
there are a number of implementation issues relating to the practicality and process 
of writing, which represent significant challenges. Many of the participants 
commented that they would be willing to complete the writing sessions at home, in 
their own time. Some also commented that they would be happy to talk about their 
kidney problem, and would prefer this to written disclosure. Previous studies have 
suggested a number of methods that could be used to overcome the 
implementation issues and improve adherence rates (see section 4.3 below). 
No statistically significant differences were detected between the groups of patients 
at different stages of the study (those eligible for the trial phase, those that 
consented to take part and those who successfully and unsuccessfully completed 
the writing sessions). However, there was a minor difference between those who 
completed the intervention; those who were successful had experienced a lower 
number of years on dialysis on average than those who were unsuccessful. This 
information could be used to identify those more likely to complete the study and 
therefore benefit from it. If this difference were detected with a larger sample, the 
intervention may need to be tailored to target those with a shorter dialysis vintage. 
Kimmel (1990) proposes that the course of HD can be understood as being 
composed of several stages of varying lengths (e.g., initial treatment, maturity 
phase and final phase of death and dying) and that different challenges are posed 
by each of these stages. It may be the case that the EW intervention is most 
beneficial for those who are in the period of ‘initial treatment’ since at this time, 
patients are undergoing a considerable amount of adjustment, and could therefore 
represent the time that patients’ views of their illness are most amenable to change.  
When considering fidelity, the experimental manipulation check confirmed that the 
independent rater could correctly identify the conditions for 18 of 19 writing scripts 
(95%), which means that the different instructions produced different therapeutic 
experiences and that they were clear enough for patients to adhere to them fittingly. 
In terms of the safety of the intervention, the results indicated that there was no 
short-term increase in distress (as measured by the PHQ-2 at one week follow-up) 
following the intervention, and there was only one anecdotal report from a 
researcher regarding a single patient who became distressed, following their first 
writing session. This reaction was realised upon collection of their second writing 
script and relayed to the appropriate staff on the renal team, prior to the patients’ 
withdrawal from the study. No other patients who completed the writing became 
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significantly distressed. This is reassuring as it suggests this type of intervention can 
be safely applied in a renal clinic setting, despite studies suggesting that people can 
feel more distressed in the hours immediately after writing (Pennebaker & Seagal, 
1999). 
4.1.4 Feasibility of EW: preliminary outcomes 
Finally, the study sought to verify preliminary outcomes and therefore the potential 
clinical efficacy of using EW for those on dialysis. To ensure group equality, a 
randomisation check was performed. The two groups did not differ significantly 
across any of the demographic, clinical, psychological and symptom variables. 
Although, according to the effect sizes, there were small differences in terms of age, 
blood pressure, distress, illness perceptions and medium differences in depression. 
This may have impacted on differences in the outcomes at 3 month follow-up. 
Analysis of a larger trial sample would determine if this were the case. 
Results from the trial phase showed that there were no statistically significant 
differences between the groups on self-reported symptoms, illness perceptions or 
clinical outcome variables. It is possible that this was largely due to the size of the 
sample, which meant there was limited power to determine significant variances. 
However, the effect sizes did provide some useful and clinically meaningful results. 
There were at least small effect sizes detected for differences in distress, fatigue, 
pain and illness perceptions at 3 months.  
In terms of the primary outcome variable of psychological distress, there was a 
small-sized effect for differences between scores at the 3 month end point (d=0.23), 
which is larger than the modest effect size found by Frattaroli (2006, d=0.15). The 
distress levels were also lower in the EW group than the control group at follow-up. 
This difference is in-line with the original hypothesis and indicates that the 
intervention had some positive effect on distress levels, supporting previous findings 
that have shown a similar effect on emotional well-being for other medical 
populations (e.g., Gellaitry et al, 2010). 
With regards to the additional variables, although there was an effect for fatigue 
score, it was relatively small (d=0.39). This may signify the fact the fatigue is an 
enduring problem for patients on dialysis and is perhaps more directly linked to 
clinical health markers, and therefore not so amenable to change. There was a 
medium effect size for the difference in the two group’s pain at rest scores (d=0.52) 
and the pain scores were lower in the EW group. A medium-large sized effect was 
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detected for differences in illness perceptions (d=0.63). Overall, these findings 
suggest the EW intervention had positive effects for levels of fatigue and pain, in 
line with previous studies that have suggested benefits of symptom reduction may 
be gained through used of this technique for with people with medical conditions, 
such as fibromyalgia (Broderick et al, 2005).  
In terms of physiological outcomes, there was also a medium-large effect size 
detected for differences in systolic blood pressure (d=0.71) with these values being 
lower in the EW group. Therefore, the EW intervention also had some important 
beneficial effects on the clinical outcome of blood pressure. This result is consistent 
with individual studies and reviews which have indicated the effectiveness of EW on 
physiological outcomes (e.g., Frisina et al, 2004). For example, Pennebaker, 
Hughes and O’Heeron (1987) found systolic blood pressure and heart rate dropped 
to levels below baseline following the disclosure of traumatic topics, but not 
superficial topics. In addition, McGuire et al (2005) found that elevated blood 
pressure significantly decreased over time, following emotional disclosure, (d=0.36 
for SBP and d=0.21 for DB, although they found no effect of group condition. 
Despite this study’s result, it is important to consider the fact that in this study, blood 
pressure was not recorded in a systematic way; the most recent blood pressure 
recorded by the renal team was used, which was not always on the same day as 
follow-up took place.  
The first of the two final regression outputs show that group condition and baseline 
distress levels did not significantly predict distress levels at follow-up. Despite this, 
distress levels were objectively lower for both groups at 3 months, than they were at 
baseline. The second output indicated that baseline illness perceptions significantly 
predicted illness perceptions at 3 months, but showed no group effect. Similarly, 
there was an objective difference between the two group scores (perceptions were 
more positive in the EW group) and scores had decreased for both groups, since 
baseline. There was a larger effect size for difference in illness perceptions (d=0.63) 
than distress (d=0.23) which seems to suggest the writing had a bigger impact on 
patients’ beliefs about their illness, than their distress. This could indicate that EW 
helps patients to modify illness/treatment specific distress, since patients were 
encouraged to write about their treatment, but that this change does not translate to 
their general distress levels (at least within this follow-up time period). This could be 
because ‘distress’ is also related to non-illness-related factors, such as personal or 
social issues. Replication of this finding with a larger sample and with a longer 
follow-up would be needed to confirm the nature of this time-group interaction. 
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4.2 Implications for Theory  
Although the current study did not directly test a specific theory or model of EW, the 
findings do have some implications for the theory underlying the relationship 
between illness perceptions and distress, and for the theoretical mechanisms 
underpinning the intervention.  
The current findings lend support to the strength and usefulness of the Common 
Sense Model of Self-Regulation (Leventhal et al, 1997), which suggests illness 
perceptions inform and direct coping behaviour. Hagger and Orbell’s (2003) meta-
analysis showed that when patients have more positive beliefs in controllability and 
curability of illness, it positively influences their well-being. Evidence to support this 
model co-exists with a number of studies of ESRD patients which have shown 
illness perceptions are predictive of health-related outcomes, including survival 
(Chilcot et al, 2011a; Van Dijk et al, 2013) and non-adherence (O’Connor et al, 
2008; Chilcot et al, 2010). Theoretically, maladaptive illness beliefs are likely to be 
associated with poor coping behaviour, which could impact on ability to manage 
physical health and ultimately, survival. Longitudinal studies looking at the pattern of 
illness perceptions and health outcomes over time, in chronic illness, has mostly 
been a recent development. For example, Dempster et al (2010) found that 
oesophageal cancer sufferers, whose personal and treatment control beliefs 
decreased over time, were more likely to become anxious and depressed. Further 
research is necessary to understand how exactly illness perceptions influence 
coping behaviour for dialysis patients, and what factors mediate the relationship 
between them.  
This study provided the important finding that perceived consequences 
independently predicted distress. Prior to the development of ‘illness perceptions’ as 
an idea, a group of studies by Devins and colleagues studied the idea of ‘illness 
intrusiveness’ in ESRD patients. This was defined as “illness induced disruptions to 
valued activities and interests that limit the availability of personally rewarding 
experience and compromise quality of life” (Devins et al, 1983). Conceptually, this 
appears similar to the more modern construct of ‘illness consequences’. Their 
findings supported the claim that patients’ perceptions of increased intrusiveness 
were associated with distress. They also found that the relationship was moderated 
by identity and hypothesised that patients whose self-definitions are strongly tied to 
their illness role, may perceive fewer potential rewarding non-illness experiences 
and therefore experience greater emotional distress (Devins et al, 1997). It is 
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possible that this was also true of the relationship found in this study, but it cannot 
be verified since the perception of illness identity was not measured.  
The fact that distress was strongly related to self-reported pain and fatigue, as well 
as illness perceptions, is also of theoretical interest. According to the CSM model, 
pain and fatigue can be viewed as symptoms within the perception of illness 
‘identity’, and therefore as directly related to the cognitive representation of illness. 
Results of this study lend support to this theory which implies that subjective 
appraisal of these factors effects the outcome of psychological distress. Pain and 
fatigue are both considered multidimensional concepts made up of physical, social 
and psychological components (e.g., Davison & Jhangri, 2005; Jhamb et al, 2008) 
and have both shown relationships with illness perceptions (Alsen, Brink, Persson, 
Brändström, & Karlson, 2010; Foster et al, 2008). However, patient ratings of fatigue 
and pain could be unrelated to dialysis treatment and thus viewed as independent 
health-related outcomes (as they were in the second phase of the study). More 
research is required to disentangle the relationship between each construct, but the 
fact that all three seem to share a common cognitive component, indicates an area 
of potential change to be targeted. 
In this study, EW was the chosen intervention to implement change. The observed 
differences between the randomisation groups at follow-up suggest something 
about the EW procedure was more effective than writing about emotionally neutral 
topics. The differences appear to support Pennebakers’ original theoretical model 
and results of other studies which suggest the effects vary as a function of 
experimental parameters and fits with the idea that it is the formation of a narrative 
which is important. However, other studies have concluded contradictory outcomes, 
for example Craft, Davis & Paulson (2013) found EW had an improvement overall 
but found no difference between groups. The precise mechanism by which writing 
confers health benefits remains unclear. It is possible EW works by re-framing 
memories and thoughts, similar to cognitive reappraisal in CBT (Pennebaker et al, 
1990). The fact that this study showed a medium sized effect for differences in 
illness perceptions at follow-up indicates that the modification of cognitive illness 
appraisals may be a contributory factor. Formal linguistic analysis would be required 
to discover whether there are objective differences in language (see section on 
future research). The fact that EW had an effect on blood pressure also supports 
the theory that unexpressed emotion can affect physical health by raising the 
sympathetic nervous system and that, by default, expressing emotion can lead to 
lowering of blood pressure (Mauss & Gross, 2004). Overall, the finding that EW had 
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a relatively stronger effect on blood pressure than distress fits with the opinion that 
self-report outcomes generally do not bring about as significant findings as objective 
health outcomes (Pennebaker & Chung, 2011). 
It has been proposed that the reason no single theoretical perspective has yet 
explained effects of EW could be because it affects people on number of different 
levels. In other words, the effect sizes are small due to moderators, such as 
demographics or social environments (Lu & Stanton, 2010). The current study 
results indicate that those with a shorter dialysis vintage were more likely to 
complete the intervention, suggesting it may be more useful for those who are in the 
initial stages of adjustment. Furthermore, this would suggest a potential need to 
provide booster sessions to respond to changes in situation and emotions 
confronted at different stages of the illness. There is some evidence that benefits 
are larger for men (Smyth, 1998), for those who are ambivalent about disclosing 
emotions (Averill et al, 2013) and that benefits can vary according to ethnicity (Lu & 
Stanton, 2010). Norman et al (2004) also found higher baseline negative affect 
predicted improved positive affect and daily disability for chronic pelvic pain patients 
2 months after disclosure writing. The wording of the instructions may have also 
influenced the precise psychological processes targeted, and therefore the 
outcomes (i.e., writing about illness rather than writing about any stressful 
experience or trauma). Although most recent studies have used specific 
instructions, Pennebaker and Chung (2011) recommend that researchers provide 
sufficiently open instructions to allow participants the flexibility to address any issue 
of importance. A larger sample size would be needed to identify moderators of the 
effects, and to determine individual difference variables that predict who is most 
likely to benefit from EW and under what conditions.  
4.3 Implications for Clinical Practice  
From a practical perspective, the results indicate that a large proportion of dialysis 
patients are clinically distressed, which needs to be addressed. Although more 
research is needed to examine precisely how distress is linked to outcomes, this 
study highlights the potential utility of measuring distress, rather than depression 
within the dialysis population. This echoes findings in research investigating 
depression versus distress in type 2 diabetes. A study by Fisher et al (2007) found 
that 70% of patients with type 2 diabetes who scored above cut-off on the CES-D, 
but were not clinically depressed, displayed significant biological and behavioural 
outcomes usually expected to be a function of clinical depression. The authors 
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discussed that items on the CES-D may have reflected symptoms of anxiety, 
substance use and general distress, rather than clinical levels of depression and 
concluded that distress is more common and more has more impact than clinical 
depression alone. Similarly, in this study the GHQ-12 may have identified a broader 
more heterogeneous range of factors related to general distress, including anxiety, 
as well as depressive affect. 
This study demonstrated that fatigue, pain and personal beliefs about illness have a 
more important impact on mood, than age and disease characteristics. This is 
important since it could help clinicians decide where to focus interventions. CBT has 
shown promise for ameliorating depressive symptoms in dialysis patients (e.g., 
Duarte et al, 2009), and has also shown benefits of reducing pain and fatigue in 
other illness populations (e.g., White et al, 2011; Morley, Eccleston, & Williams, 
1999). Some studies have shown also that illness perceptions can be changed and 
that this influences outcomes (e.g., Broadbent et al; Petrie et al, 2002). Since this 
study discovered that specific beliefs about consequences have the most significant 
impact on distress, clinical staff may wish to focus efforts on changing how much 
patients perceive their illness is affecting them. This may be challenging, 
considering the fact that treatment for ESRD represents a huge burden. Potential 
interventions could involve finding out exactly how the illness is affecting patients’ 
lives and applying practical solutions, or using solution-focussed therapy to help 
them successfully adapt and integrate the treatment into their daily lives.  
In terms of feasibility, the study’s retention rates revealed that EW whilst dialysing is 
not entirely feasible, due to the fact that many patients were simply too distressed, 
or physically unwell to complete the writing task. This outcome resembles that of a 
feasibility trial of EW patients in palliative care which also showed limited adherence 
(Bruera, Willey, Cohen & Palmer, 2008). The authors suggested modifying the 
methods and concluded that patients may need to undergo coping skills training 
prior to participation, since they may have been too traumatised to cope with writing. 
Despite the relatively poor uptake, the current study findings indicated some 
potential clinical efficacy for EW by demonstrating that disclosing thoughts and 
feelings helps patients to feel less distressed, less pain and fatigue and lowered 
their blood pressure. Therefore, the EW paradigm does show promise for use with 
dialysis patients, with some potential modifications, since it allows a way of 
addressing distress using a method that is short-term. EW also requires minimal 
professional involvement, whilst allowing easy monitoring due to frequent contact 
with the medical care system. Furthermore, management of kidney failure is 
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extremely costly in comparison to other medical conditions (accounting for ~1-2% of 
the total NHS budget) and is set to rise with increasing demand (Klebe et al, 2007; 
Baboolal et al, 2008). Such an intervention would thus provide a useful way of 
managing patient distress and improving health outcomes, whilst minimising costs.  
Some of the implementation issues related to the fact that patients found the 
procedure too difficult to adhere to in written form. One could therefore implement 
alternative methods of disclosure, such as a self-administered video-based delivery 
system, or encourage patients to discuss issues and problem either informally or in 
a more structured support group. Support groups have been growing in popularity 
for those with chronic diseases, over the past 20 years (Jacobs and Goodman, 
1989). This type of intervention may help patients to acknowledge their emotions 
and construct a narrative, within the context of a group but would require careful 
setting up and facilitation by a staff member in order to ensure a narrative focus.  
4.4 Limitations 
There are a number of limitations which should be considered when interpreting the 
insights gained from this study. Firstly, the findings are susceptible to the 
shortcomings associated with self-report methods, for example the possibility of  
participants misinterpreting the question, responding in a biased manner, or making 
an error in transcribing his or her response (Streiner & Norman, 2008). In addition, 
there were a number of other drawbacks to using the specific measures chosen. 
Firstly, the BIPQ was used to assess illness perceptions, rather than the IPQ-R, 
since it is quicker and easier to administer and reduces questionnaire burden for 
patients. This was considered a priority when designing the study since many of the 
participants were elderly and/or unwell. However, the item measuring identity beliefs 
was omitted from the adapted BIPQ version used, and therefore not included in 
analysis. In addition, causal beliefs were assessed but not included in the analysis 
since the item necessitated an open-ended response and therefore required 
additional coding into appropriate response categories, for example risk factors that 
cannot be changed (e.g., hereditary, aging), and those that can be (e.g., diet, lack of 
exercise). Since the perceptions of illness identity and causes were excluded from 
analysis, it is impossible to say whether these influenced the findings in any way. 
Also, anecdotally, some of the participants commented that they found the wording 
of the item measuring ‘consequences’ confusing (i.e., ‘how does your kidney 
problem affect you currently?’). This was also an issue for the GHQ-12 measure 
which some participants queried regarding whether the responses should be in 
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relation to their dialysis treatment or kidney problem, rather than their life in general. 
This often required clarification and in future, instructions could be altered to be less 
ambiguous. Completing the questionnaires whilst dialysing may have also biased 
the results since dialysis is likely to have enhanced symptoms such as fatigue and 
pain, and possibly had an impact on distress levels and illness perceptions. It would 
be useful to compare the outcomes of patients completing questionnaires when on 
and off dialysis, in order to clarify whether this has an effect, and to see whether it 
should be considered a confounder. 
Reliance on quantitative measures for measuring complex constructs, such as 
distress, can also generate some limitations. Although they are time and resource 
efficient, such questionnaires attempt to quantify patients’ subjective experiences by 
imposing categories important to researchers onto participant’s experiences rather 
than allowing them to define what is important in their own terms. They are therefore 
unlikely to capture the diverse aspects of patients’ experiences, life situations and 
practical issues. Focus groups could be used as a way of gathering such 
information, which would complement quantitative data. These types of measures 
also tend to be culturally biased since many are validated using predominantly white 
participant samples. Furthermore, due to the lack of consensus regarding how to 
measure distress and depression in this particular clinical group, a wide variety of 
measures have been previously used, which make it difficult to place the present 
study findings within the context of existing literature. It is also difficult to make 
detailed comparisons due to overlap between different symptoms and factors. 
Research within this field needs to become more standardised with regards to the 
types of measured used. This would enable researchers to find out more about how 
distress (as measured by GHQ-12) impacts on health-related outcomes, and would 
promote a more in depth understanding of the relationship between variables, and 
therefore areas for possible intervention.  
Another factor that might limit interpretation of the study was the sample. Regarding 
the sample characteristics, the participants were recruited from four different units 
which varied in location (South London and Tunbridge Wells) and were therefore 
likely to be diverse and representative. However, ethnicity was not captured so 
generalizability cannot be assumed. Also, there may have been important 
differences in demographic factors and access to services across units (i.e., 
difference between inner London and suburbs) which were not recorded and 
therefore not accounted for in the results. It is also important to be aware of the 
ways in which the selection criteria may have biased the current sample e.g. by not 
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approaching anyone where it was deemed as clinically inappropriate by the direct 
treatment team,  and the fact that the inherent nature of the intervention required 
patients to be able to read and write. Furthermore, it is possible that those who 
dialysed on a ‘twilight’ shift (in the evening), although small in number, may have 
differed either on demographic or socio-economic dimensions, to those who 
dialysed at other times of the day. For example, it is possible this group were more 
likely to be in employment, younger and therefore fitter and healthier, and thus more 
inclined to agree to participate and adhere to requirements of the EW procedure.  
Since this subsection of patients was not approached, the results of the current 
study cannot be generalised to this group. Results of the trial phase were also 
limited by the small sample size, compared to other studies, and would require a 
larger sample to draw firm conclusions about the efficacy of the EW intervention.  
It is also important to mention some limitations concerning the study’s two different 
design phases. The first phase was cross-sectional with correlational analyses, 
which means the causative mechanism cannot be determined. The correlational 
analyses identified that negative illness perceptions and fatigue are significant 
predictors of distress, but cannot infer the direction of causality. It may be that, if a 
patient constructs a negative perception of their illness and/or is more fatigued, they 
are more likely to experience psychological distress as a result. However, negative 
illness perceptions and greater fatigue can also be interpreted as a manifestation of 
psychological distress. Since cross-sectional analysis relies on data from a 
snapshot in time, prospective, longitudinal studies would be required to examine 
whether distress fluctuates over time and would therefore substantiate which one of 
these is more likely. In addition, when considering correlational results, it is 
important to consider the possibility that a third unidentified, extraneous variable 
may be impacting on the relationship between the other two variables, which is 
often referred to as a ‘tertium quid’ (Field & Davey, 2005). There are an infinite of 
possible extraneous variables, independent of kidney failure and its treatment, some 
of which have been shown to influence psychosocial parameters, for example social 
support correlates with depression (Kimmel, 2000). It is impossible to account for all 
of these and many may change over time e.g., relationship status and financial 
circumstances. However, some more easily quantifiable disease-related variables 
could have been measured, and therefore controlled for in the results, including 
years since diagnosis, treatment with erythropoietin (a drug used to control 
anaemia) and compliance with dialysis.  
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In relation to the trial phase, the EW condition instructions required participants to 
focus the subject of their writing on their dialysis treatment, which assumed this to 
be their main stressor. However, other stressors may have been inflicting a higher 
amount of strain on a patients’ life than their dialysis treatment or kidney problem 
and would make such a focussed intervention unlikely to have an effect. Future 
studies could therefore trial a similar procedure using different instructions, or give 
several options so patients can choose to write about a stressor of their choice. 
There is also an ongoing debate about the best form of control group to employ in 
disclosure studies. Norman et al (2004) argue in favour of asking the control group 
to write about positive experiences, since this is emotionally relevant and has face 
validity to reduce stress. They also point out the possible adverse effects of 
participants learning about and consenting to a disclosure study, and then being 
randomised to a control group that is not asked to disclose. However, this method 
does not enable comment on inhibition mechanisms, since positive writing can 
produce positive effects. To enable comment on inhibition mechanisms, the control 
group were asked to write about emotionally neutral, but still disease-related, topics. 
However, this also meant the control group was active and could have been 
considered an intervention in itself. A more complex design would have included the 
addition of a waiting list or treatment-as-usual group, in order to further help 
determine the precise effects of the EW intervention. Furthermore, patients were not 
isolated when writing and may have been aware of other participants completing the 
same procedure, which could have contaminated results. One way to prevent this 
would be to carry out a randomised cluster trial with several sites. However, this 
was not possible due to the limited number of sites granted access under the ethical 
agreement. Furthermore, such contamination was unlikely to have occurred in this 
instance since only a small sample number entered into the trial phase. 
Finally, in terms of the trial phase, there were some barriers to implementing the 
writing intervention. First of all, unlike other studies which have used a private 
space, the participants were asked to complete the writing task whilst dialysing in 
the renal clinic, which is a public place and largely uncontrolled. This increased 
external validity but meant the procedure was subject to a number of real-world 
confounds, such as preoccupation with treatment, presence of others and frequent 
interruptions by members of staff or other patients. The presence of such 
confounding factors could be considered threats to internal validity and may have 
reduced effect sizes by increasing error variance. However, strict adherence to the 
EW procedure meant that initial recruitment into the trial phase was quite slow. 
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Some adaptations to the method were therefore permitted (for example, allowing 
patients to take the scripts home), in order to reach sample size. In addition, 
patients may have felt uncomfortable about disclosing extremely upsetting 
experiences whilst situated in a public place, or after being informed the scripts 
would be read by a member of the research team which possibly impacted on 
numbers consenting to take part in the trial phase. 
4.5 Future Research  
The section above outlines a number of possible directions for future research, 
many of which would overcome some of the limitations. This study also gained 
some important insights which warrant further analysis.  
Firstly, the findings support the idea of a link between fatigue and distress. So far, 
researchers are confident in knowing that fatigue is a significant problem for dialysis 
patients (Horigan, 2012), but research examining the relationship between fatigue 
and psychosocial variables is not extensive. Further investigation is therefore 
required to determine whether distress and fatigue are consistently related in 
dialysis patients and the exact nature of this relationship, for example whether it 
operates at the biological (i.e., via inflammation markers), behavioural (i.e., via non-
adherence to treatment and being unable to manage symptoms properly) or 
cognitive (i.e., via limitation in performing activities leading to a sense of diminished 
integrity and low independence and therefore helplessness) level. There is also the 
possibility that the relationship is reciprocal.  
Future research could also investigate the feasibility of interventions designed to 
target illness perceptions, particularly beliefs about consequences, and determine 
whether this improves adaptive functioning. For example, Tsay, Lee & Lee (2004) 
found that an adaptation training programme helped improve perceived stress, 
depression and quality of life for ESRD patients. Illness perceptions are thought to 
be complex and dynamic, and are therefore constantly updated over time. 
Additional studies could investigate how the pattern of illness perceptions change, 
and at what point in the course of illness it is best to intervene. It might also be 
interesting to extend research to see if the same relationship between illness 
perceptions and distress exists in PD patients. Finally, illness perceptions could also 
vary according to personality and cultural factors (Kutner and Devins, 1998) which 
warrants more inquiry in this population. 
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Even though the statistical gains were slight, the current results suggest dialysis 
patients showed a positive response to the EW intervention. It would be important to 
replicate this study with a sample to enable survival analysis of the EW and neutral 
writing groups using a large multi-site trial. More recently, research into EW has 
placed a stronger emphasis on examining the ways people write and the types of 
individuals suited to EW. A larger sample would allow analysis of such moderators. 
The current data represent improvements over only 3 months of follow-up and 
maintenance of these effects over time is critical to improving long-term outcomes 
for patients with ESRD. Therefore, it would be important to conduct a longitudinal 
study to establish durability of effects over time. It would also be important to 
consider some of the already suggested modifications to the writing protocol, for 
example increasing flexibility, or focussing on those patients in early stages of 
dialysis, as well as perhaps increasing available staff and resources, in order to 
improve adherence and obtain larger effects. 
It would be worthwhile conducting a qualitative analysis of the types of words used 
to explore differences in linguistic content. The Linguistic Inquiry and Word Count 
Software developed by Pennebaker & Francis (1996) is a program which analyses 
writing scripts in text format. It computes the percentage of words that reflect 
negative emotions, positive emotion, causation, insight and other dimensions. This 
can therefore show differences in word usage across a variety of categories 
including affective processing, cognitive processing, social processing, time and 
metaphysical. By analysing past scripts, Pennebaker, Mayne & Francis (1997) have 
found that when people used more positive-emotion words, and a moderate amount 
of negative words, the more their health improved. They also found the related to 
increases in words reflecting causality and insight. Pennebaker et al (1997) believe 
these linguistic changes reflect cognitive processes associated with encoding and 
storing features of the experiences ”in a more organised coherent and simplified 
manner…that reduced the associated emotional arousal” (p.864). Analysis of this 
type would therefore provide a useful insight into the mechanism of change and the 
degree of cognitive processing. Using a no treatment control group would help to 
further tease apart the effects of different conditions 
Future studies could also consider modifying the paradigm used, for example by 
giving guidance on structure of writing or allowing more flexibility, in order to 
establish the optimal conditions for writing. It could adopt a similar method to 
qualitative studies which have asked participants to focus on concerns specific to 
dialysis patients e.g., freedom and control, social relationships, anxiety, role 
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function, energy and body image (Tong et al, 2009). We should also consider the 
possible future directions of EW in relation to technology, for example using a 
secure internet website to type instead of hand writing. This method has been tried 
and tested in previous studies with promising outcomes (e.g., Halpert, Rybin & 
Doros, 2010; Morgan et al, 2008). Alternative modalities could include using audio 
recorded statement or telephone interviews. A few studies have compared writing 
with talking into a tape recorder with comparable effects (Pennebaker & Seagal, 
1999). Adequate discussion of appropriate times/setting for writing and more flexible 
approach could also be implemented to maximise the likelihood of adherence. 
However, it is important to establish treatment efficacy first (maximising internal 
validity) before establishing effectiveness (maximising external validity). Other 
studies which have applied the EW paradigm to a community-based setting have 
shown good results with regards to feasibility (Broderick et al, 2004).  
Finally, in order to further establish treatment fidelity, it would be useful to ask 
participants some writing process questions e.g., how upsetting or uplifting they 
found it or how they think the writing has changed their thoughts or feelings. It is 
important to note that, in this study, qualitative responses were not collected in a 
systematic way and some participants did not wish to give a reason for withdrawal. 
Future studies could therefore establish feasibility in a more standardised way, for 
example by asking participants to what extent they found the task difficult, stressful, 
enjoyable and helpful, similar to Morgan, Graves, Poggi & Cheson’s study (2008).  
4.6 Conclusions  
In spite of the limitations outlined in the section above, this study has a number of 
strengths. It was the first study to analyse correlates of distress using the GHQ-12 
for dialysis patients, and to trial EW as a novel intervention in this patient group. The 
focus on distress, rather than depression, as the primary outcome measure, meant 
that there was no overlap in somatic symptoms. Also, the inclusion of illness 
perceptions enabled valid insights to be gained about their relation to distress and 
enhanced understanding of their relevance to EW effects. It was particularly 
important that emotional illness perceptions were discounted from the final 
analyses, which meant the illness perceptions variable represented a distinct scale 
of illness cognitions, with no influence of emotions.  
Overall, the findings supported the well-established fact that HD patients suffer from 
high levels of physical and psychological distress, and further expanded on studies 
investigating psychosocial factors. The results concluded that fatigue and illness 
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perceptions are stronger predictors of distress than age or co-morbidity, and that, 
more specifically, beliefs about illness consequences predict distress levels. This 
advances existing work on quantifying distress in ESRD, informs clinicians of what 
to look out for and of who is likely to suffer distress, and signifies areas for potential 
intervention which could improve distress, and therefore illness outcomes. 
Psychological treatments are becoming increasingly accepted, and effective for at 
least a subset of dialysis patients. Findings from this study add to this by showing 
that EW is feasible for use with dialysis patients, but with adaptations, and that it is 
potentially clinically effective with regards to reducing distress, improving illness 
perceptions, symptoms of pain and fatigue, and blood pressure. The broad 
psychological and physical health benefits (e.g., Smyth, 1998) together with these 
findings suggest that EW can produce health benefits in clinically distressed dialysis 
patients. Considering these data as pilot information, a larger multisite randomized 
controlled trial is certainly warranted. These current findings therefore provide a 
solid platform for future studies which should continue to explore this reactive 
support modality as a way of providing patients with an important tool for coping 
with distress related to dialysis treatment. 
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Abstract 
Since the Increasing Access to Psychological Therapies (IAPT) scheme was 
established, a few studies have looked at drop-out rates but there is little research 
investigating those who are re-referred for a second course of therapy. The aim of 
this audit was to explore the reasons clients re-present for therapy within Lambeth 
IAPT, to find out whether the second treatment episodes were useful, and whether 
any factors were associated with usefulness. Data was collated and analysed from 
the existing IAPTus database on 82 clients, who met eligibility criteria, which was 
supplemented by data collected from questionnaires e-mailed out to therapists 
within the service. The results indicated that clients who had completed a second 
course of treatment since 2009, were most likely to be White females, aged 25-34 
with a diagnosis of depression on both occasions, many with a secondary diagnosis 
of personality disorder or associated traits. They were most likely to require more 
treatment because their original symptoms had continued or worsened. 
Approximately 45% of clients recovered during their second treatment, regardless of 
initial treatment outcome. Within the group who did not recover first time, differences 
between those who did and did not recover second time were examined. This 
showed that the Generalised Anxiety Disorder Questionnaire (GAD-7) scores at the 
end of the first treatment episode were significantly higher for the group who did not 
recover. However, this difference was not large enough to allow generation of a ‘cut-
off’ point on the GAD-7 to distinguish between the groups. These findings are 
discussed in terms of clinical and service implications. Recommendations are made, 
particularly in the context of the recently proposed IAPT expansion to encompass 
more complex referrals. It is hoped this research framework can be replicated and 
applied to similar audits in future. 
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1.0 INTRODUCTION 
1.1 Mental Health Problems in Primary Care 
The high prevalence of mental health problems in the UK has generated increasing 
concern, particularly over the past ten years. According to the Adult Psychiatric 
Morbidity Survey (McManus et al, 2007), 16% of working age adults in the UK have 
a mental illness. A report by the World Health Organisation (2001) recognised the 
huge burden presented by mental health problems and recommended treatment 
should be widely based in primary care services. Goldberg and Gournay (1997) 
designed a useful typology of mental health disorders which made a distinction 
between ‘severe’ and ‘common mental health disorders’ (e.g., schizophrenia and 
personality disorder versus depression and anxiety disorders). Bower and Gilbody 
(2005) consider this conceptualisation in their paper, which proposes that the 
‘common disorders’ be viewed as the main focus and remit of primary care services.  
A study by the Sainsbury Centre for Mental Health, (2003) found that approximately 
76% of individuals with common mental health problems were not receiving any 
form of treatment in the year 2000. This was one of the statistics which prompted 
Lord Layard’s highly influential report in 2005, proposing a change to the way 
mental health problems are managed within the National Health Service (NHS) This 
report highlighted the fact that mental illness in the UK not only causes misery and 
distress for a large percentage of the population, but also creates a huge drain on 
the economy as a consequence of reduced output.  
1.2 NICE Guidelines  
Since the invention of modern psychiatric drugs in the 1950s, effective 
psychological treatments such as cognitive-behavioural therapy (CBT) have been 
developed and refined for use with a variety of mental health problems. CBT is a 
structured, goal-based talking therapy largely rooted in the cognitive theory of 
depression, originally developed by Beck in 1970. CBT involves the therapist 
working collaboratively with the client through a process of ‘guided discovery’ with 
the ultimate goal being for the client to understand how their problems are 
maintained through a vicious cycle of negative thoughts, feelings and behaviours 
and to teach them skills which enable them to break out of this cycle.  
In 2004, the National Institute for Health and Clinical Excellence (NICE) 
systematically reviewed the evidence for the effectiveness of a variety of 
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interventions for common mental health disorders, the results of which suggested 
that psychological therapy (such as CBT) and combined therapies (such as CBT 
and medication together) are effective for treating both anxiety and depression. In 
addition, several meta-analyses have shown that depressed clients treated with 
both drugs and CBT have significantly better outcomes than waiting list controls 
(e.g., DeRubeis, Gelfand, Tang & Simons, 1999). Furthermore, research indicates 
that patients favour talking therapies when given the choice (Warner, Mariathasan, 
Lawton-Smith, & Samele, 2006). 
Following these convincing findings, NICE published a series of clinical guidelines 
(e.g., NICE, 2004a, 2004b) which advocate both the prescription of medication and 
the application of CBT as optional treatments for depression and all anxiety 
disorders. In light of evidence that some individuals respond well to ‘low intensity’ 
interventions, the guidelines suggest a ‘stepped-care’ approach to the delivery of 
these treatments (see Figure 1 below). This means matching the level of care 
intensity to the severity of the disorder so that those with mild symptoms of 
depression and anxiety are offered an assessment, support, psycho-education and 
active monitoring (step 1); those with mild to moderate symptoms are offered  ‘low 
intensity’ treatment (in the form of guided self-help and computerised CBT); and 
those with moderate to severe symptoms are offered a combination of 
antidepressant medication and ‘high intensity’ psychological interventions (either 
interpersonal therapy, or individual CBT) (step 3). Finally, those who have more 
complex needs that cannot be treated at step 3 are referred to specialist mental 
health services that can provide multi-disciplinary care. 
 
Figure 1. A diagram representing the ‘stepped care model’ used for treating 
common mental health problems in primary care in the UK (NICE, 2011) 
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1.3 Development of Increasing Access to Psychological Therapies 
(IAPT)  
Following development of the NICE guidelines, economists and clinical researchers 
used a cost-benefit analysis to argue that investment in psychological therapies 
would largely pay for itself by reducing other depression and anxiety-related public 
costs and increasing revenues with fewer state benefits and more people working 
(e.g., Layard, Bell, Clark, Knapp & Mayraz, 2007). In response, the UK government 
pledged a commitment to increase the availability of evidence-based psychological 
treatments and in 2006, decided to fund two projects piloting a scheme to put this 
idea into practice (Clark et al, 2009; Richards & Suckling, 2009). Following their 
success, in 2007 it was announced that the government would fund a national roll-
out of this initiative .The scheme would aim to train at least 3,600 new psychological 
therapists between 2008 and 2011 and deploy them, along with existing clinicians, 
in new psychological treatment services for patients with depression and anxiety 
disorders (Department of Health, 2008). 
The general framework for IAPT services specifies several key principles including; 
the option of access through self-referral as well as referral by a general 
practitioner, a person-centred assessment that establishes key problems and goals 
for therapy, access to an employment adviser if employment is identified as an 
issue, and weekly supervision for therapists (Department of Health, 2008). There is 
also an emphasis on obtaining outcome data which means therapists are required 
to administer patient-reported outcome (PRO) measures at each contact with the 
client. This has enabled on-going monitoring and evaluation of performance, as well 
as measurement of financial benefits. 
The introduction of the IAPT programme has marked an important shift in the focus 
on public mental health and well-being and has recently been described as “one of 
the most important advances for NHS services in a generation” (as cited in Ghosh, 
2009, p. 186).  Since it was first implemented, IAPT services have been established 
in 95% of primary care trusts (PCTs), trained 4,000 new therapists in CBT, seen 
399,460 people (compared to a target of 400,000), moved 13,962 off sick pay 
and/or state benefits (compared to a target of 11,100) and have recovery rates 
approaching 45 % (compared to a target of 50%) (Clark, 2011). However, the 
scheme is still in its’ relative infancy and a recently established ‘second phase’ aims 
to develop certain aspects of the programme, for example, updating clinicians’ skills 
in non-CBT based therapies and broadening access to sub-sections of the 
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population such as older adults and ethnic minorities. Further initiatives are to 
provide specialist training for therapists to help manage patients with chronic health 
problems and medically unexplained symptoms (Department of Health 2011a, 
2011b) and to extend services to provide help for those with more complex or 
severe mental health problems, such as bipolar disorder and personality disorder. 
Finally, a new version of the IAPT programme for children and young people is in 
the process of implementation. 
1.4 Dealing with Relapse 
This service evaluation is focussed on those clients who have re-presented for step-
3 treatment at Lambeth IAPT since September 2009 and July 2012, and therefore 
includes a high proportion of those who have suffered a ‘relapse’. It is now widely 
recognised that depression is a recurrent problem and that patients who suffer from 
an initial episode of depression have a high likelihood of experiencing another 
episode at least once within their lifetime (Keller, Lavori, Lewis & Klerman, 1983). 
Research has shown that following recovery from an initial episode, depressive 
symptoms often persist (known as ‘residual’ symptoms) and can trigger the onset of 
an additional episode (or ‘relapse’) despite the prolific use of on-going treatment 
using anti-depressant medication (e.g., Ramana et al, 1995). Since these findings 
emerged, support has accumulated for CBT as a viable alternative to medication for 
preventing depressive relapse. For example, the Cambridge-Newcastle study 
(Paykel et al, 1999) compared a control group receiving clinical management to a 
treatment group receiving clinical management plus 16 sessions of CBT over 20 
months with two booster sessions. Relapse rates were lower for the CBT group 
after treatment (29% compared to 47%). A follow-up study (Paykel et al, 2005) 
showed that these effects gradually diminished over time, although the reduced 
relapse rates in the CBT group outlasted the control group.  
Questions remain regarding the mechanism integral to CBT which actively lessens 
the likelihood of relapse. A complex analysis was undertaken following the 
Cambridge-Newcastle study (Teasdale et al, 2001) which examined possible 
cognitive mechanisms contributing to change and found that movement from 
extreme cognitions to more balanced cognitions was a key factor. Another 
possibility is that CBT provides a coping framework to empower the patient and 
provide them with active strategies to employ when their symptoms are starting to 
return or worsen (Paykel, 2007). Currently, the CBT protocols adopted by IAPT 
services outline relapse prevention as an important part of treatment and dedicate 
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the final three or four treatment sessions to exploring potential warning signs of a 
relapse. This includes reviewing coping strategies and collaboratively building a 
treatment ‘blueprint’ for patients to take away with them and refer to in the future. 
Research studies examining patient variables which heighten the likelihood of 
relapse have mostly focussed on clinical features of the disorder (Judd, 1997). 
These variables include the number of past depressive episodes, the quality of 
remission at 3 or 6 months and psychiatric co morbidity (see below) (Segal, 
Pearson & Thase, 2003). Such findings have led to development of cognitive 
models of relapse vulnerability, the most prominent being Teasdale’s Differential 
Activation Hypothesis (Teasdale, 1988). This theory suggests that individuals who 
have previously suffered from depression, are prone to the negative patterns of 
thinking (or ‘depressogenic schema’) being activated. In addition, the events that 
trigger this activation become less significant at each moment of relapse (also 
known as the ‘kindling effect’). This had led to the development of modified CBT 
therapies such as mindfulness-based cognitive therapy or MBCT (Teasdale, Segal 
& Williams, 1995; Teasdale, 1995) which focuses on the relationship one has 
towards their thoughts, rather than their specific content, which has good evidence 
for preventing relapse (Teasdale et al, 2000). 
Research shows the long-term clinical course of anxiety disorders is less clear, 
partly due to ongoing diagnostic changes for categories such as GAD (Schweizer, 
1995) and as well as difficulties defining criteria for recovery or remission (e.g., 
Keller et al, 1994). However, according to recent surveys such as the National 
Comorbidity Survey Replication, anxiety disorders are the most common of all 
psychological disorders and research illustrates that these disorders tend to be 
chronic (Yonkers et al, 1998, Yonkers, Dyck, Warshaw & Keller,  2000; Yonkers, 
Dyck & Keller, 2001). It is therefore highly likely that a client with an anxiety disorder 
such as panic disorder or GAD, will relapse following initial remission. Furthermore, 
it is common for anxiety disorders to be co-morbid with depression (Kessler, Chiu, 
Demler & Walters, 2005), which is in turn associated with higher relapse rates 
(Schaffer et al, 2012). 
1.5 Previous Research on Re-referral to IAPT 
Previous research concerning patients who re-refer to IAPT for further treatment is 
limited, with the majority of research focussing on premature termination of therapy 
by patients. Drop-out rates are routinely reported as high (e.g., Wierzbicki & 
Pakarik, 1993) and are detrimental to the overall service efficacy, representing a 
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waste of resources and continued psychological distress. This research has failed to 
find any simple demographic characteristic which consistently predicts client drop-
out rates (Garfield, 1994), apart from socio-economic variables (Grilo et al, 1998). A 
recent small study by Cairns (2013) examined the re-referral patterns and 
complexity level of patients who access the service for more than one episode of 
treatment, in order to establish what clinical factors distinguish this client population. 
The study generated descriptive statistics on a random sample of 50 clients who re-
referred between June 2009 and June 2010 and found that clients did not differ in 
the route to which they accessed the service, and that a high proportion had no 
contact with the service at all, despite re-referral. The sample analysed were also 
more likely to present with co-morbidity, depression with anxiety and DSM-IV 
disorders, and increasing levels of complexity (for example history of abuse, mental 
disorder and drug and alcohol problems). Finally, the results showed that only a 
small number of those re-referred (16/50) went on to complete treatments, and that 
those who did, showed a marked preference for a counselling intervention.  
1.6 Aims of Study 
Since January 2011, the Lambeth IAPT service has treated approximately 2500 
people at step-3 level and achieved an average recovery rate of 43%. However, the 
service has noted that a proportion of clients are re-presenting for more than one 
episode of treatment. The aim of this audit was to explore the reasons that clients 
re-present for a second episode of treatment within the IAPT service and to discover 
whether these second episodes are useful (in terms of service definition of recovery, 
and therapist ratings). The audit also aimed to discover any factors associated with 
the rate of re-presentation to see whether this information could be used to identify 
those less likely to benefit from a second treatment episode, and therefore help to 
enhance service efficiency. 
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2.0 METHODS 
2.1 Setting 
This audit was commissioned by the IAPT service based in Lambeth, a borough of 
South London. Initially, the intensive (step 3) element of the service was designed to 
offer one course of CBT therapy as a short-term intervention (usually between 10 
and 20 weekly sessions) for adults experiencing depression and anxiety, in line with 
NICE guidelines. In August 2012, the service was successful in tendering to provide 
an integrated Primary Care Talking Therapy Service offering a wide range of 
psychological treatments including CBT for those with suspected or diagnosed 
severe or common mental health disorders, as well as counselling for those with 
psychological distress due to adjustment difficulties. In line with the aims outlined for 
IAPT’s ‘second phase’ (2011), the service has consequently expanded its’ client 
base and offers further therapy choices such as MBCT and interpersonal therapy as 
well as links to community and voluntary sectors. A specialist employment 
consultancy, (‘Status’) offers advice on employment and receives referrals for those 
who are out of work or experiencing issues retaining their existing job. 
In terms of routes to treatment, the typical care pathway begins with a telephone 
triage appointment lasting 20 to 30 minutes during which the assessor, together with 
the client, can determine what would be the most suitable type of treatment for the 
identified problem. Computerized CBT, guided self-help and group workshops are 
offered as first line treatments for those with mild to moderate disorders who have 
not tried CBT before. Those with more severe difficulties or who have completed a 
course of ‘low intensity’ or ‘step-2’ treatment and failed to recover are then offered 
one-to-one sessions of CBT with a ‘high intensity’ or ‘step 3’ therapist.  
2.2 Outcome Measures 
The outcome measures used for this study were those which are mandated 
nationally for IAPT services to collect and monitor client outcomes, namely the 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001) and the 
GAD-7 Spitzer, Kroenke, Williams and Lowe, 2006). The PHQ-9 is designed to 
measure the severity of nine depressive symptoms on a Likert scale, in-line with the 
DMS-IV criteria for a psychiatric diagnosis. It is a well-validated scale (Kroenke et al, 
2001) with good sensitivity to change (e.g., Lowe, Kroenke, Herzog & Grafe, 2004). 
The GAD-7 is a brief, valid and reliable tool to assess the severity of seven anxiety 
symptoms, also answered on a Likert scale.  
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2.3 Sample 
A retrospective search was conducted on the ‘IAPTus’ database (an electronic 
database used by Lambeth IAPT to record data for clients entering the service and 
monitor their progress through the care pathway) which identified those clients who 
had completed more than one course of treatment at step 3 level, since September 
2009 and July 2012. This date was used since it marked the time when data began 
to be consistently and accurately recorded. This generated a list of roughly 160 
clients. 
Each client on the list then had to be checked to ensure the sample was a true and 
accurate representation of those who had re-presented for a ‘treatment episode’. 
Clients who were discounted included those whose ‘second episode’ referred to 
attendance at a group or employment advice; those who had seen therapists who 
were no longer employed by Lambeth IAPT for both episodes of treatment; and 
those whose first or second episode consisted of an assessment only. It was 
decided at least one logged session of therapy was required to be considered a 
‘treatment episode’ for the purposes of analysis. Only two cases were identified as 
having re-presented for three separate ‘treatment episodes’, which were discounted 
for consistency of analysis. The final sample list, consisting of 82 clients, was 
anonymised and inputted into an Excel data file. Additional data extracted from 
IAPTus at this stage included demographic variables (gender, age and ethnicity) 
and clinical variables (primary and secondary diagnoses, number of sessions and 
pre and post-treatment PHQ-9 and GAD-7 scores). 
2.4 Questionnaires 
In order to supplement the data collected from IAPTus, two different questionnaires 
were developed to collect data pertaining to each client’s treatment episode from 
the therapists’ perspective (see Appendix A and B). One version was dedicated to 
collecting data about the first treatment episode, and another about the second 
treatment episode. It was necessary to have two versions since often it was the 
case that different therapists had treated the same client at different times. 
Questions included asking therapists to rate the usefulness of the treatment, to 
provide reasons for the first episode ending and the second one beginning and to 
give their opinion about whether having the same therapist was useful. Both 
questionnaires were sent to three clinicians for piloting before being fully deployed, 
in order to flag up potential problems. Suggested amendments included defining 
reasons for treatment ending such as “failure to engage”. Most questions required 
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fixed choice responses (usually ‘yes/no/don’t know’) and some allowed a more 
open, qualitative response.  
2.5 Data Collection 
Questionnaires were distributed via e-mail to all high intensity therapists who 
remained employed by the service. In order for therapists to correctly identify clients 
and provide answers about their treatment accordingly, the relevant IAPTus 
numbers were inserted at the top of each copy of questionnaire. Once the 
completed questionnaires were sent back, each question response was coded and 
data was transferred into the anonymised Excel data file. 
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Project
3.0 RESULTS 
3.1 Descriptive Statistics 
3.1.1 Demographics  
The final sample analysed consisted of 82 cases, 23 of which were male (28%) and 
59 of which were female (72%). A simple frequency calculation showed that, with 
regards to age split, the largest group were aged 25-34 (n=32, 39%), followed by 
those aged 35-44 (n=29, 35.4%). The smallest group consisted of those aged 65+ 
(n=1, 1.2%). In terms of ethnicity, the same frequency calculation showed that the 
largest group were categorised as White (n=59, 72%), followed by those 
categorised as Black or Black British (n=14, 17.1%). The pie charts below (Figure 2, 
Figure 3 and Figure 4) show the age, sex and ethnicity percentages for the sample 
analysed for this project, in comparison to a sample of those discharged from IAPT 
over a three month period. The comparison indicates that the demographic profile of 
the project sample was quite similar to that of overall IAPT sample. The main 
differences were that the project sample consisted of a higher proportion of females 
(72% vs 62%), a higher proportion of clients aged 35-44 (35% vs 25%) and a higher 
proportion of clients categorised as White (72% vs 65%). 
 
 
Figure 2. Pie charts showing the male/female ratio of the project sample (those who 
re-presented for step-3 treatment at IAPT between September 2009 and July 2012) 
compared to a representative sample of IAPT users 
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Figure 3. Pie charts showing age groups of the project sample (those who re-
presented for step-3 treatment at IAPT between September 2009 and July 2012) 
compared to a representative sample of IAPT users 
 
 
 
Figure 4. Pie charts showing ethnicities of the project sample (those who re-
presented for step-3 treatment at IAPT between September 2009 and July 2012) 
compared to a representative sample of IAPT users 
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3.1.2 Clinical data 
Table 1 below gives a summary of the clinical data collected, including the most 
common primary and secondary diagnoses, the mean average number of sessions, 
the mean pre and post-treatment PHQ-9 and GAD-7 scores, the mean average 
PHQ-9 and GAD-7 score changes, the percentage of those who reached ‘caseness’ 
and finally, the percentage of those who recovered. ‘Caseness’ was defined as a 
score of ten or above on the PHQ-9 or a score of eight or above on the GAD-7. For 
a client to be considered as ‘recovered’, it was necessary for both post-treatment 
scores to be below ‘cut-off’ (i.e., below ten on the PHQ-9 and below eight on the 
GAD-7). ‘Recovery’ is an important issue for IAPT services because it is a key 
performance requirement of the services, with every service being monitored 
against a target of 50% of clients moving from above to below ‘caseness’ over the 
course of treatment. The table displays the differences between the clinical 
variables for the ‘first episode’ and ‘second episode’ data sets. Notably, the second 
treatment episodes had a lower number of sessions that the first (11 versus 13), 
started with slightly lower PHQ-9 and GAD-7 scores and consequently had smaller 
PHQ-9 and GAD-7 score changes.  The second episode data set had a slightly 
higher ‘recovery rate' than the first (45.1% versus 41.5%), although the lower 
number of clients who reached the criteria for ‘caseness’ in the second episode 
(92% versus 98%), could account for this difference (those who did not reach 
‘caseness’ could not technically ‘recover’ which meant the relative proportion of 
clients in the sample reaching criteria for recovery was inflated).  
Further analysis showed 44% of the client sample was given the same diagnosis in 
their first and second episodes, which means 56% had a different diagnosis and so 
were treated for a different disorder in their second treatment episode. 
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Table 1. Clinical data split into first and second episode data sets 
 First Episode Second Episode 
Most common primary 
diagnosis 
Depressive episode 
(25.6%) 
Depressive episode (24%) 
Most common 
secondary diagnosis 
Personality Disorder/Traits 
(3.7%) 
Recurrent depressive 
disorder and Personality 
Disorder/Traits (both 4%) 
Mean number of 
sessions (SD) 
13.4 (7.3) 10.8 (6.1) 
Mean pre-treatment 
PHQ-9 (SD) 
16.0 (6.3) 14.7 (6.6) 
Mean post-treatment 
PHQ-9 (SD) 
10.0 (7.0) 9.8 (6.6) 
Average score change 
PHQ-9 (SD) 
-6.1 (7.3) -4.8 (6.6) 
Average pre-treatment 
GAD-7 score (SD) 
14.7 (4.5) 13.4 (4.9) 
Average post-treatment 
GAD-7 (SD) 
9.1 (5.9) 9.2 (5.4) 
Average score change 
GAD-7 (SD) 
-5.7 (6.4) -4.2 (6.0) 
% ‘caseness’ 98% 92% 
% recovered 41.5% 45.1% 
 
3.1.2 Therapist data 
Frequency calculations indicated that the most common reason for first treatment 
episode ending was “natural end with symptom improvement” (49%). The same 
reason was the most common given for the second treatment episode ending (38%) 
and there was a higher percentage of ‘drop outs’ in the second episode (16%) than 
in the first episode (13%) (see Figure 5). The profile splits of therapist ‘usefulness’ 
ratings were very similar across both episodes, with the majority reporting a 
“significant positive difference”, (38% for first episode and 44% for second episode; 
see Figure 6). The main reason for offering an additional episode of treatment was 
“original symptoms continuing or worsening” (62%) followed by “presented with new 
problem” (32%; see Figure 7). This is in contrast to the diagnosis data from IAPTus 
which indicates the majority of clients were given a different diagnosis in the second 
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episode.  48% of second treatment episodes definitely involved a ‘new therapeutic 
element’; of those who had the same therapist for the second episode, 32% thought 
this made a significant positive difference (although largely this was not applicable); 
and of those therapists treating a client for a second episode, 54% thought more 
CBT would be helpful. 
 
 
Figure 5. Bar chart showing split of reasons for first and second treatment episodes 
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Figure 6. Bar chart showing split of therapist ratings of usefulness for first and 
second treatment episodes 
 
Figure 7. Bar chart showing split of reasons for offering additional treatment 
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3.2 Main analysis  
3.2.1 Recovery groups 
In order to determine how to differentiate between clients recovering and those not 
recovering in the second treatment episode, the sample was divided into the 
following groups in relation to the patterns of recovery: 
1. Those that recovered on both episodes (R,R) 
2. Those that did not recover on either episode (NR,NR) 
3. Those that recovered on the first episode but did not recover on the second 
(R,NR) 
4. Those that did not recover on the first episode but recovered on the second 
(NR,R) 
A small number (n=10) were discounted for this analysis as they did not reach the 
criteria for ‘caseness’ on either the PHQ-9 or GAD-7 measures, and therefore did 
not meet criteria for recovery. It is possible they may have reached ‘caseness’ on 
additional anxiety measures (e.g., those measuring phobias) but this data was not 
collected. Table 2 below shows the number of clients in each recovery group. 
Table 2. The frequency and percentages of clients in each ‘recovery group’ 
 Frequency Valid Percent 
Valid 
Recover, Recover (R,R) 14 19.4 
Not recovered, Not recovered 
(NR,NR) 28 38.9 
Recovered, Not recovered 
(R,NR) 15 20.8 
Not recovered, Recovered 
(NR,R) 15 20.8 
Total 72 100.0 
Missing System 10  
Total 82  
 
Table 2 shows that, of the clients who did recover the first time, 14 out of 29 (about 
50%) recovered the second time and that, of the clients who did not recover the first 
time, 15 out of 43 (35%) recovered the second time. When split this way, the largest 
group was the ‘NR,NR’ group (n=28, 39%). This group represents those clients who 
did not seem to significantly benefit from treatment either initially or when repeated. 
Table 3 below compares the clinical data for the ‘NR,NR’ group with the ‘NR,R’ 
group. Notably, the average second episode pre-treatment PHQ-9 and GAD-7 
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scores are higher for the ‘NR,NR’ group. The average first episode post-treatment 
PHQ-9 and GAD-7 scores are also higher for this group. In addition, the second 
episode mean score changes for the ‘NR,NR’ group are extremely low (just -0.75 for 
PHQ-9 and -0.74 for GAD-7).  
Table 3. Clinical data showing differences between first and second episodes within 
the ‘NR.NR’ and ‘NR,R’ groups 
 NR,NR group NR,R group 
 Ep 1 Ep 2 Ep 1 Ep 2 
Most common 
primary diagnosis 
Depressive 
episode 
(32.1%) 
Depressive 
episode 
(21.4%) 
Depressive 
episode and 
GAD (both 
20%) 
Depressive 
episode 
(26.7%) 
Mean number of 
sessions (SD) 
13.1 (7.9) 12 (5.9) 12.3 (9.3) 12.7 (5.9) 
Mean pre-
treatment PHQ-9 
(SD) 
18.9 (4.7) 17.6 (5.4) 14.8 (5.4) 14.4 (6.0) 
Mean post-
treatment PHQ-9 
(SD) 
15.4 (6.1) 12.4 (4.9) 12.7 (4.2) 6.0 (3.1) 
Average score 
change PHQ-9 (SD) 
-3.4 (5.3) -0.75 (4.6) -2.07 (5.9) -8.33 (5.1) 
Mean pre-
treatment GAD-7 
score (SD) 
16.6 (3.1) 15.1 (3.5) 13.9 (4.4) 13.1 (5.0) 
Mean post-
treatment GAD-7 
(SD) 
14.6 (4.1) 14.2 (4.0) 11.5 (3.9) 5.1 (1.7) 
Average score 
change GAD-7 (SD) 
-2.07 (4.7) -0.74 (4.7) -2.4 (5.3) -8.0 (5.3) 
 
3.2.3 T-tests 
In order to distinguish any variables which could identify those likely to recover in 
the second episode, following a lack of recovery in the first, independent samples t-
tests were performed to examine whether any differences between the continuous 
variables for the ‘NR,NR’ and ‘NR,R’ group were significant. The results showed 
that the first episode pre-treatment PHQ-9 score was significantly higher for the 
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‘NR,NR’ group (M=18.9, SD=4.7) than the ‘NR,R’ group (M=14.8, SD=5.4; 
t(41)=2.61, p=.013).The first episode pre-treatment GAD-7 score for the ‘NR,NR’ 
group (M=16.6,SD=3.1) was significantly higher than the ‘NR,R’ group 
(M=13.9,SD=4.4; t(41)=2.36, p=.023. Finally, the first episode post-treatment GAD-7 
score was significantly higher for the ‘NR,NR’ group (M=14.6, SD=4.1) than the 
‘NR,R’ group (M=11.5, SD = 3.9; t(41)=2.36, p = .023). Therefore, the three 
variables which significantly differentiated these two groups were first episode pre-
treatment PHQ-9 score, pre-treatment GAD-7 score and post-treatment GAD-7 
scores. 
3.2.4 ROC curve analysis 
A ROC curve was calculated using the first episode post-treatment GAD-7 scores to 
see whether an acceptable “cut off point” could be achieved on the GAD-7 measure 
which could help predict whether a client is likely to recover in the second episode, 
and therefore give one indicator of the predicted usefulness of offering further 
treatment. A ROC curve plots the true positive rate (sensitivity) against the false 
positive rate (100-specificity) for different cut-off points on a particular measure. The 
area under the curve (AUC) relates to the discriminating accuracy and predictive 
ability of the measure.  
Figure 8 below shows the ROC curve which plots sensitivity versus specificity for all 
the possible cut-offs on the GAD-7 (a score of 7 or above denotes ‘caseness’ and 
21 is the maximum possible score). The AUC of the ROC curve can be considered 
‘fair’ at 0.715 (SE=0.08; 95% CI=0.56-0.84, p<0.01). 
Positive actual state = NR,NR
 
Figure 8. ROC Curve plotting possible cut-offs for first episode GAD-7 measure 
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Table 4. Operating characteristics of GAD-7 cut-off points 
GAD-7 
score 
(more than 
or equal 
too) 
Sensitivity Specificity Positive 
Predictive Value 
(PPV) 
Negative Predictive 
Value (NPV) 
8 26.67 96.43 63.55 84.93 
9 33.33 89.29 63.97 70.13 
10 53.33 82.14 70.00 69.26 
11 60.00 67.86 69.22 58.48 
12 66.67 64.29 71.89 58.48 
13 80.00 60.71 70.71 56.14 
14 86.67 42.86 73.96 51.35 
16 93.33 35.71 78.03 50.42 
17 93.33 25.00 83.24 48.42 
19 93.33 14.29 73.96 45.09 
20 100 14.29 100 46.81 
 
Table 4 displays the operating characteristics of the GAD-7 cut-off points from 8 to 
21. The sensitivity score refers to the probability that, for someone who has the 
characteristic being measured, the test result will be positive (i.e., true positive rate, 
expressed as percentage). In this case, the figure represents the probability that 
those who will not recover in the second episode, will score more than or equal to a 
set cut-off score on the GAD-7 (or be in the ‘NR,NR’ group). Specificity refers to the 
probability that, for someone who does not have the characteristic being measured, 
the test result will be negative (i.e., true negative rate, expressed as percentage). In 
this case, this figure represents the probability that those who recover in the second 
episode, will score below the set cut-off score of the GAD-7 (or be in the ‘NR,R’ 
group).Two other quantities that are also often used in association with sensitivity 
and specificity are positive predictive value (PPV) and negative predictive value 
(NPV), which are also displayed in the table. PPV indicates that, if the test is 
positive, the likelihood that the person has the characteristic being measured. In this 
case, it relates to the likelihood that those who score more than or equal to a cut-off 
on the GAD-7, will not recover in the second episode. Following on from this, NPV 
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indicates that, if the test is negative, the likelihood that the person does not having 
the characteristic being measured. In this case, it relates to the likelihood of those 
who score less than the cut-off on the GAD-7, will recover in the second episode.  
The choice of an optimal cut off value is usually informed by an attempt to maximise 
the difference between sensitivity and 1-specificity, but is difficult in this case due to 
the high amount of overlap between the scores. If the GAD-7 is to be used as a 
screening measure, a high PPV is preferable (in order to rule out those who are 
unlikely to recover and retain those who are likely to do so). Therefore, according to 
the table, a cut-off of 12 would be preferable as it has relatively good sensitivity 
(64.3%) and specificity (66.7%) as well as a PPV of 71.9%, meaning it is a good 
way of predicting those who will not recover in the second episode. However, it has 
a NPV of 58.5% which means it is less good at predicting those who will recover in 
the second episode. Since the service operates with an approach of including 
clients on the basis of capacity to benefit, rather than excluding them based on rigid 
criteria, it would not support a cut-off measure that would potentially exclude clients 
who could benefit. 
3.3 Subsidiary Analyses 
Chi-square analyses were also conducted in order to compare the categorical 
variables (i.e., yes/no answers) which yielded no significant differences when 
comparing the four ‘recovery groups’. This was partly due to the small numbers in 
each group which meant the analysis lacked the power required. However, when 
collapsed into two groups instead of four (those who did recover versus those who 
did not recover in the second episode), a significant difference was found between 
the groups for therapist opinion about the helpfulness of further CBT, X2 (2, n=82) = 
11.51, p = .003. The 2-by-2 cross-tabulation results indicated that significantly more 
therapists thought that more CBT would be helpful for those who recovered in the 
second treatment, than those who did not. 
Further analysis was conducted to examine the relationship between the therapist 
usefulness ratings and the clinical variables. Although the small sample violated the 
‘minimum expected cell frequency’ for a valid chi-square calculation, some 
interesting trends were found. In the first episode data set, there was a significant 
relationship between therapist usefulness ratings and mean score change in PHQ-9 
(but not pre or post-treatment PHQ-9 scores, or GAD-7 scores), X2 (63, n=82) = 
94.41, p = .006. Figure 9 shows a boxplot which provides a visual representation for 
the pattern of scores. The pattern of median scores (represented by the middle line 
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in each box) indicates that the higher the PHQ-9 score change, the higher the rating 
of usefulness. There were no significant relationships found between therapist 
usefulness ratings and other clinical variables measured. 
 
 
 
Figure 9. A box plot showing the relationship between mean score change for PHQ-
9 (episode 1) and therapist usefulness ratings.   
Analysis of the second episode data set showed a different trend. There was a 
significant relationship between therapist usefulness ratings and the post-treatment 
PHQ-9 score, X2 (88, n = 82) = 115.43, p = .270. Figure 10 shows a box plot which 
provides a visual representation of the pattern of scores. The pattern of median 
scores indicates that the lower the post-treatment PHQ-9 score, the higher the 
therapist rating of usefulness. There were no significant relationships found between 
therapist usefulness ratings and the other clinical variables measured. 
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Figure 10. A box plot showing the relationship between the post-treatment PHQ-9 
score (episode 2) and therapist usefulness ratings 
 
Finally, no significant differences were found between data sets for those who had 
the same therapist in their second treatment, and those who had a different 
therapist. 
3.4 Qualitative Data 
The questionnaires allowed for collection of some qualitative data with regards to 
different factors which contributed to the therapist-rated usefulness of the treatment, 
and factors which may have prevented the clients from returning to IAPT for more 
therapy. In terms of factors which were thought to be associated with a positive 
treatment outcome, some of the ‘client factors’ included willingness to engage in the 
CBT approach, level of motivation to change, awareness of the benefits of CBT and 
socialisation to the model. ‘Therapist factors’ included tailoring treatment to 
individual problems, being flexible, having specialist knowledge or experience and 
having a thorough understanding of the formulation and ability to explain this clearly 
to the client. Some ‘treatment factors’ included having a strong therapeutic bond 
and a focus on relapse prevention (for example ensuring the client is learning how 
to approach potential problems, rather than be provided with solutions once the 
problem has occurred). Finally, in terms of the possible prevention of additional 
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treatment, many therapists believed that this would not have been possible due to 
the client presenting with a different problem when they returned for treatment, the 
interference of social factors such as employment or child care, and clients not 
following their ‘blueprint’. This final point was especially important with clients who 
suffered from anxiety disorders which require on-going behavioural experiments and 
an appreciation of the importance of safety behaviours. In addition, several 
therapists mentioned that the clients’ personality traits meant that they either 
required longer-term treatment or were not willing to become their ‘own therapist’ 
due to dependency issues. Some suggested options for potential prevention of 
additional treatment included a longer initial treatment episode, more long-term 
follow-up sessions, and engagement with the community or a mutual support group.  
3.5 Dissemination of Findings 
The findings of this audit were initially presented at a clinical leads meeting in July 
2013. Following this, a briefer version of the presentation was used to disseminate 
findings to the wider team during a whole team meeting in October 2013.   
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4.0 DISCUSSION 
4.1 Summary of Findings 
The results of this audit show that approximately 82 clients returned to Lambeth 
IAPT for an additional episode of step-3 treatment between September 2009 and 
July 2012. The demographic profile of the sample analysed was found to be 
generally quite similar to that of the overall sample of clients treated by IAPT with 
the majority being female, between the ages of 25 and 34 and of white ethnicity. 
Comparison of the clinical data from the first and second episode data sets, shows 
that the most common diagnoses were very similar, with most clients being given a 
primary diagnosis of ‘depressive episode’. Interestingly, when a secondary 
diagnosis was given, the most common was ‘personality disorder’ or traits of 
personality disorder, although for the second episode, ‘recurrent depression’ also 
featured highly. Although the sample was too small to provide much useful 
information in terms of diagnosis breakdown, 56% of the sample was given a 
different diagnosis in their second episode. This could mean that slightly over half 
the sample did not have their main problem identified in the first episode of 
treatment, or that they suffered from co-morbid disorders which were not fully 
recognised at initial assessment and therefore were not included in the formulation. 
The additional clinical data comparison shows that the first episode data set had a 
slightly higher average number of sessions (13 versus 11) and higher pre-treatment 
PHQ-9 and GAD-7 scores. The post-treatment scores were the same for both data 
sets. This meant that the average score changes for the PHQ-9 and GAD-7 
measures were higher for the first episode than second episode, although a slightly 
higher proportion recovered in the second episode (45%) than in the first (42%). In 
other words, clients tended to have higher depression and anxiety scores when first 
entering the service, which meant the score reduction during initial treatment was 
high. However, when returning for further treatment, clients tended to begin with 
lower depression and anxiety scores, and therefore had a lower score reduction but 
were more likely to ‘recover’ (i.e., finish with both post-treatment scores below cut-
off). 
The therapist data indicated that the reasons for ending both first and second 
episodes were encouraging, with the most common reasons being “natural end with 
symptom improvement”. This result correlated with the ‘usefulness’ data which 
showed most therapists rated the treatment as making a “significant positive 
difference” to the client. Interestingly, the overall outcomes were rated slightly more 
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positive for the second episode than for the first. This also correlates with the clinical 
data showing a slightly higher recovery rate in the second episode. The most 
common reason for offering a second episode was “original symptoms continuing or 
worsening”, followed by “client presented with a new problem”. Taken together with 
the diagnosis data, this could infer that original symptoms identified in the first 
episode were re-triggered, or returned in a slightly different form, which perhaps 
warranted a different diagnosis. One would expect the diagnoses give in the second 
episode to be slightly different and favour those which depict a chronic status, for 
example “recurrent depression’ rather than “depressive episode” or “GAD” rather 
than “panic disorder”. 
Dividing the sample into ‘recovery groups’ provided way of identifying any factors 
which could account for differences in recovery rates, and therefore further 
information to determine whether the second treatment was useful. Of the 72 clients 
grouped according to recovery, a relatively large proportion did not recover on either 
episode. According to the therapist data for this group, the reason given for ending 
the first episode was less likely to be “natural end with improvement” and the reason 
for offering further treatment was more likely to be “original symptoms continued or 
worsened”. Although these differences were not significant, they could imply that the 
clients unlikely to benefit from either episode are less likely to engage fully first time 
round, or that an incident or change in circumstances occurs which ends the first 
episode pre-maturely. This could also account for the fact that this group were more 
likely to re-present due to their original symptoms continuing or becoming worse, 
since they did not engage in the first episode well enough to have sufficient impact 
on their original symptoms. In terms of clinical data, further analysis is needed on a 
larger sample to be able to determine an accurate cut-off point on GAD-7  but 
overall, the results imply that the higher the final GAD-7 score, the less likely clients 
are to recover when returning for more ‘step 3’ CBT treatment. 
4.2 Clinical Implications  
The results of this audit provide some interesting clinical implications. Following the 
first treatment episode, high levels of anxiety, rather than depression, were 
predictive of a lower probability of recovery during the second episode. One 
hypothesis for this could be linked to the effectiveness of CBT for anxiety disorders. 
A number of controlled trials and meta-analyses have demonstrated strong effect 
sizes of CBT for many anxiety disorders; including social phobia (Feske & 
Chambless, 1995), OCD (Abramowitz, 1997), PTSD (Bradley, Greene, Russ, Dutra 
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& Westen, 2005) and GAD (Borkovec & Ruscio, 2000) and it is thought to be 
particularly efficacious for panic disorder (Chambless & Gillis, 1993). However, 
some studies have suggested that the treatment efficacy for GAD and PTSD is not 
as strong as that of other anxiety disorders (e.g., Brown, Anthony, & Barlow 1995, 
Norton, Asmundson, Cox & Norton, 2000). Therefore, one could speculate that 
short-lived anxiety symptoms, such as panic attacks, are highly responsive to CBT 
techniques and likely to be reduced to a non-clinical level when treated using this 
approach, either during initial or repeated treatment. However, persistent anxiety 
symptoms such as ‘worry’ (a key feature of GAD), could be considered more difficult 
to successfully eradicate with short-term CBT. This means that the continued 
presence of GAD-like symptoms following an initial CBT treatment episode could be 
indicative of a lack of suitability to the CBT approach, which would explain the low 
rate of recovery following a second treatment. However, it would be unjustified to 
base a service change on this hypothesis since the GAD-7 simply assesses 
symptoms of generalised anxiety. Specific anxiety measures would need to be used 
to further explore this relationship. 
Another interesting theoretical point highlighted by the diagnoses data and 
qualitative therapist responses from this audit, was that a relatively large proportion 
of clients who failed to recover in either their first or second episode, were noted to 
have features of personality disorder, or other co-morbidities. It is widely known that 
a high proportion of clients with a principal anxiety disorder, also meet criteria for at 
least one additional anxiety or mood disorder (Brown & Barlow, 1992). In their 
review, Mennin and Heimberg (2000) conclude that the presence of co-morbid 
diagnoses can interfere with the treatment of panic disorder, and that personality 
psychopathology in particular, has a detrimental effect on treatment outcome. They 
suggest this is due to the fact that clients with comorbid disorders challenge the 
implementation of manualized treatments as they may behave quite differently to 
those presenting with one primary disorder. Furthermore, Durham, Swan and Fisher 
(2000) explain that when a client presents with co-morbidity, the tasks of developing 
a formulation and treatment plan are more complex and demanding for the therapist 
and that such clients are likely to require more intensive therapy and more careful 
follow-up. 
This audit also highlights the fact that clients with suspected Personality Disorder 
(PD) or traits of the disorder can present their own unique challenges. PD is 
frequently described as likely to contribute towards risk of relapse and poor 
recovery, but confusion concerning the definition means that such outcomes lack 
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validity (Segal et al, 2003). Some researchers have proposed that PD can be 
difficult to treat successfully due to the construct of neuroticism. Individuals scoring 
highly on measures for this trait tend to amplify shame, worry and interpersonal 
sensitivity (Kendler, Neale, Kessler, Heath & Eaves, 1993). Other researchers 
advocate that the perceived criticism aspect of expressed emotion by significant 
others, is another related construct of PD which creates barriers to successful 
treatment outcomes in CBT (Butzlaff & Hooley, 1988). Individuals with PD are often 
thought to be better suited to longer-term psychotherapy as they are more likely to 
have a complex history, attachment issues and related interpersonal difficulties, 
which makes it more difficult for them to form a strong therapeutic alliance and 
therefore benefit from a short-term intervention (Parry & Richardson, 1996).  
4.3 Service Implications and Recommendations 
The results showed that, of those who return for more treatment, about 45% 
recovered in the second episode, which indicates that further treatment can often be 
helpful. Therapists were likely to rate treatment episodes as useful, regardless of 
whether it was a first or second episode, and endings tended to be because there 
was natural symptom improvement. The majority of clients were offered further 
treatment because they presented with a new problem, however, further information 
from the questionnaires inferred that clients would present with different symptoms 
linked to the same disorder, or with a co-morbid problem which had not been 
discovered in the first treatment. This implies that it is important for therapists to 
conduct a thorough assessment at the beginning of treatment in order to determine 
the presence of any co-morbid disorders or symptoms, so that these can be fully 
integrated into the formulation. The recent expansion of primary care services such 
as IAPT means that the service is likely to receive more referrals for severe, chronic 
and complex cases, with a higher probability of personality traits being present. 
Successful treatment of such clients may therefore require an even more enhanced 
focus on relapse prevention with the use of booster sessions, longer-term follow-ups 
or extended episode lengths.  
More generally, the implications of the audit findings highlight the difficulty for 
primary care services to strike the right balance between efficiency and 
effectiveness. As the audit shows, clients with more severe, complex or chronic 
problems (e.g., PD, GAD and co-morbidities) are more likely to return for treatment 
and many do not recover. This creates a dilemma since although offering these 
clients a CBT intervention through IAPT may be efficient, it may not be the most 
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effective option of treatment in the long-term. In addition, pressure to accept a large 
number of complex referrals may lead therapists to spend a long time attempting to 
engage clients with little aptitude or motivation and therefore spend too little time 
working with those who are motivated and prepared for therapy. (Durham, Swan & 
Fisher, 2000). Looking forward, the new phase of IAPT is hoping to continue 
increasing access of evidence-base psychological treatments to the wider 
population, but we might ask the question “at what cost?” This audit supports the 
need to consider adapting and adjusting services to ensure they can accommodate 
client needs at an idiographic level, rather than assume a “one size fits all” 
approach.  
Finally, on a more practical level, it may be beneficial for the IAPTus system to 
become equipped so it is able to label those clients who have been seen for a 
second or third ‘treatment episode’ which meets the criteria specified in this audit 
(i.e., more than one assessment session and not counting those as part of a group 
or for employment advice). This would make it easier and less time consuming to 
produce similar audits in the future. 
4.4 Methodological Limitations 
Despite the interesting results, this audit did suffer from several methodological 
limitations. Firstly, it was difficult to gain significant results from many of the 
statistical tests, particularly when comparing differences between the four smaller 
‘recovery groups’ on the therapist data. This was due to a large percentage of 
missing data and resultant lack of power. Many of the therapists who had treated 
clients in the sample, had left the service within the period specified for analysis, 
and about a quarter of questionnaires e-mailed to therapists were not returned. 
Although clinical data was more easily obtained due to routine collection via the 
IAPTus system, there were some problems with the accuracy of the search results. 
For the purposes of the study, an ‘episode’ related to ‘more than one session of 
CBT treatment with a step-3 therapist’. However, many of the clients listed in the 
search output had ‘episodes’ registered on the system which related to alternative 
criteria. Therefore, data had to be double-checked for each client listed which was 
time-consuming. On a broader epistemological level, one of the main aims of the 
study was to verify the “usefulness” or effectiveness of the second treatment 
episodes. One could argue that simply measuring usefulness via score change on 
objective symptom measures is rather reductionist, and fails to consider a number 
of extraneous variables which could have a significant impact on outcome, such as 
 PART B: SERVICE EVALUATION PROJECT  JENNIFER HUNT 
 
174 
 
previous therapy, personality traits, family history or client expectations. In reality, 
reasons for returning for therapy and the perceived usefulness of therapy are 
complex and multi-factorial.  
The questionnaires themselves could also be subjected to criticism. Since the 
therapists were keen to provide a holistic view of each client’s treatment, some 
found it difficult to quantify their opinions using categorical responses. For example, 
the answers to the question about factors contributing to perceived ‘usefulness’ of 
the episode, which gave the option of ‘therapist’, ‘client’ and ‘treatment’ factors, was 
limited in use for quantitative analysis. This was due to the fact that many therapists 
gave answers which fitted with more than one factor since they are inextricably 
linked. Such therapeutic or process factors are difficult to define objectively and can 
vary according to individual interpretation. This was also a limitation when asking 
the therapists to consider whether the treatment used a “new therapeutic element”. 
The subjectivity and biased nature of the questionnaires can also be applied to the 
symptom measures upon which ‘recovery’ is based (i.e., the PHQ-9 and the GAD-
7). One could argue this method for measuring ‘recovery’ is more service than 
client-centred, and fails to consider the broad range of factors which are integral to a 
client’s overall well-being. “Reasons for ending” and “returning for treatment” are 
also wide-ranging, and open to subjectivity.  
The answers to the therapist questionnaires were contingent upon the therapists’ 
memory of the clients in question, many of whom were treated over a year prior to 
the study.  Furthermore, a few therapists commented that the fact the 
questionnaires were focussing on reasons for clients returning, and possible ways 
of preventing their return, implied they had failed as therapists and discounted the 
potential positive aspects of clients re-presenting for further treatment. Since many 
of the clients who did not recover in the first episode, did in fact recover in the 
second, this indicates that a re-referral to IAPT can often lead to a positive outcome.  
4.5 Conclusions and Areas for Future Study 
Responding to the original aims, the results of the audit conclude that clients return 
for treatment usually because their original symptoms continue, worsen or take on a 
slightly different form and that about 40% recover on return for more treatment. 
Therefore, the additional treatment offered to clients in the time-span measured, 
could be considered to be useful (according to service policy and therapist opinion). 
Post-treatment scores on the GAD-7 measure were associated with usefulness, but 
this relationship needs further analysis to warrant any broad service changes. 
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The findings offer wide scope for future research. It would certainly be useful to 
collect data using specific anxiety disorder measures to further understand the 
relationship between anxiety levels throughout the course of therapy and levels of 
CBT-responsiveness. It may also be worth repeating a similar analysis after a few 
years, in order to obtain a larger sample which would give higher power for 
statistical analyses, and perhaps collect data on additional variables such as risk 
levels and complexity (e.g., history of abuse) as well as information about whether 
clients had been ‘stepped up’ from low intensity level. It may also be of interest to 
compare the sample from this audit to those who completed one episode of 
treatment in the same period, in order to establish differences in clinical variables 
and ways of predicting the likelihood of being re-referred for more treatment. It may 
be useful to collect data via responses from clients, as well as therapists, in order to 
investigate whether the answers match in terms of perceived usefulness of 
treatment, and perhaps leave space for clients to suggest improvements. Finally, 
due to the complexity and variety of factors involved in ‘usefulness’ or ‘efficacy’ of 
treatment, it would be beneficial to examine these constructs with detailed 
qualitative analyses.  
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Appendix B Additional episode questionnaire 
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